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Abstract
Simultaneous cardiac positron emission tomography and magnetic resonance (PET-
MR) imaging is a promising non-invasive hybrid technique for comprehensive assess-
ment of cardiovascular disease in a single examination. However, image degradation
due to respiratory and cardiac motion during data acquisition remains a major chal-
lenge that has hindered the adoption of PET-MR in the clinical setting.
State-of-the-art PET-MR technical developments have focused on using MR in-
formation for improving PET image quality. However, this significantly increases
the overall examination time, since diagnostic MR images need to be acquired after
the PET-MR scan. Furthermore, this approach leads to misaligned PET and MR
images that are difficult to interpret together.
In this thesis a novel framework for truly simultaneous motion-corrected cardiac
PET-MR has been developed. This was achieved by designing an MR acquisition
sequence that allowed the measurement of physiological respiratory and cardiac
motion while producing coronary MR angiography (CMRA) images, and a recon-
struction scheme that included this motion information to produce co-registered
motion-corrected cardiac PET and CMRA images from a single efficient examina-
tion with short and predictable scan time.
This general framework was implemented for three applications. First, a scheme
that enables respiratory motion-corrected PET-CMRA was developed. The scheme
was validated in healthy subjects, oncology patients and patients with cardiac dis-
ease, enabling assessment of myocardial viability by PET and visualisation of coro-
nary artery anatomy by CMRA. The second application extended this scheme to
include both cardiac and respiratory motion-correction of PET and CMRA data. In
this approach, left ventricular function can also be measured by MR, potentially al-
lowing for a comprehensive assessment of coronary artery disease from a single scan
of ∼12 minutes. Finally, the proposed scheme was extended to perform water-fat
CMRA imaging, enabling the simultaneous visualisation of coronary anatomy and
cardiac fat, and estimation of respiratory-resolved attenuation correction maps to
further improve the quantification of the cardiac PET images.
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Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting
for 31.5% of the total number of deaths in 2015, according to the Global Burden
of Disease Study [1]. Although the age-standardised death rates associated to CVD
have decreased by more than 20% during the last three decades thanks to improve-
ments in management of risk factors, and better treatments and therapies, CVD still
causes 45.2% of all deaths associated to non-communicable diseases. Amongst all
the cardiovascular diseases, coronary artery disease (CAD), also known as coronary
heart disease and ischaemic heart disease, has the highest mortality rate and it is
overall the most common cause of death globally, producing about 14.8% of the total
deaths every year [1]. Moreover, CAD is not only prevalent in high-income coun-
tries, but it also affects low- and medium-income countries [2], and its prevention
and control is one of the major challenges for healthcare systems worldwide [3].
CAD is caused by the accumulation of calcium, fatty lipids and inflammatory
cells within the wall of the coronary arteries, as shown in Figure 1.1. This accu-
mulation will then result in the progressive formation of atherosclerotic plaques in
different locations within the coronary tree. Depending on the composition of the
atherosclerotic plaque, coronary disease can lead to a steady progressive narrowing
of the vessels, chronically reducing the myocardial blood flow supply, and/or can
result in total occlusion of the vessels due to the sudden rupture of some of these
plaques, causing acute myocardial infarction and in severe cases, sudden death [4].
In the chronic condition, the imbalance between the demand and supply of oxygen-
rich blood flow to the myocardium triggers a pathophysiological response known as
ischaemic cascade [5]. At the beginning of the cascade, the flow imbalance produces
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In addition, endothelial dysfunction leads to an increase in vascular permeability that gives rise to 
the accumulation of blood-born macromolecules (e.g., LDL) in the vessel wall causing a chronic 
inflammatory response. Endothelial dysfunction is typically followed by the so-called “positive 
vessel wall remodeling” [13], consisting of outward growth of atherosclerotic plaque within the 
coronary vessel wall with preserved lumen size. Ongoing inflammation results in progressive accu-
mulation of inflammatory cells (e.g., macrophages), lipid and matrix proteins that augment lesion 
size. This results in actual narrowing of the coronary lumen that can lead to reduced perfusion 
of the myocardium and predispose to subsequent myocardial infarction. During this pathologi-
cal evolution, the fibrotic cap of the plaque becomes weaker and, as a consequence, can become 
unstable. At these advanced stages, the coronary plaque also may develop intraplaque hemorrhage 
(IPH), thus enhancing its degree of instability [14–16]. Plaque rupture may lead to obstructive intra-
luminal coronary thrombosis; additionally, embolic material following coronary plaque rupture 
and thrombosis can result in microvascular obstruction of the distal vessels (e.g., at the level of the 
carotid arteries, thus causing cerebral stroke) [7]. The presence of CAD can remain unnoticed for a 
prolonged period of time, and often will reveal itself only at advanced stages of disease. Therefore, 
and due to the inhomogeneous nature of CAD manifestation, a non-invasive imaging modality 
for monitoring the progression of CAD would be highly desirable. While X-ray angiography and 
multidetector computed tomography (CT) can image the coronary lumen at high resolution, ICA is 
invasive and both modalities involve the exposure to ionizing radiation, with assessment of athero-
sclerotic plaque characteristics limited to patterns of either calcification or low X-ray attenuation 
(a marker of lipid content within the necrotic core). Recently, coronary magnetic resonance imag-
ing (MRI) has emerged as a promising non-invasive imaging modality for the diagnosis of CAD. 
Even though coronary MRI does not currently achieve the sub-millimeter spatial resolution, it can 
generate different imaging contrasts that hold promise for both the detection and characterization 
of plaque and monitoring of multiple stages of CAD. This chapter reviews the most prominent 
technical challenges as well as the latest developments aimed at addressing those challenges. MRI 
strategies for the assessment of different CAD stages will be described and reviewed; furthermore, 
a brief overview on coronary vein MRI—currently gaining relevance in the field of interventional 
cardiac procedures—will be provided.
15.2 TECHNICAL CHALLENGES IN CORONARY MRI
The unique nature of the coronary arteries challenges MRI acquisition strategies in comparison to 
similar sized vessels elsewhere in the body, as coronary arteries exhibit near-constant motion due 
FIGURE 15.1 Schematic of CAD progression. 1) Normal and healthy coronary artery. 2) Early stages of 
CAD may involve coronary endothelial dysfunction without important structural changes at the level of both 
the coronary lumen and the coronary vessel wall. Initiation of the plaque deposition progress can cause posi-
tive remodelling of the coronary vessel wall, consisting on the outward growth of the vessel wall itself without 
any actual luminal narrowing. 3–5) Progressive luminal narrowing occurs with the development of the pathol-
ogy. During these stages, intraplaque haemorrhage may occur within the atherosclerotic plaque; the plaque 
can therefore become at risk and prone to rupture. Progressive luminal narrowing as well as sudden plaque 
rupture can cause intraluminal thrombosis, one of the main manifestations of acute CAD.
BK-TandF-9781498797580_TEXT_BAZ-180615-Chp15.indd   322 13/08/18   4:49 PM
Figure 1.1: Schematic of CAD progression. 1) Healthy vessel. 2) In early stages,
initial deposition of plaque occ rs withou major changes in the vessel lumen and
wall. 3-4) Progressive narrowing of the lumen of the artery due to the accumu-
lation of plaque. In these stages, intraplaque haemorrhage may occur within the
atherosclerotic plaque, which becomes prone to rupture. 5) Sudden plaque rupture
can cause intraluminal thrombosis, and occlude the downstream blood flow in the
vessel, which is one of the main manifestations of acute CAD. Reprinted from Ginami
G et al. Technical Advances and Clinical Perspectives in Coronary MR Imaging. In
Cardiovascular Imaging and Image Analysis. Taylor & Francis, 2018 (in press) [6]
a regional hypoperfusion in the myocardium, which in time leads to diastolic and
systolic dysfunction. With further progression of the disease, this chronic occlusion
of the arteries can lead to angina or heart failure, and an increased risk of acute
myocardial infarction.
During the last decades, different medical imaging modalities have been proposed
for the diagnosis of CAD through its multiple pathophysiological manifestations by
either assessing the presence of vessel narrowing, and more recently the composition
of atherosclerotic plaques, or by evaluating the induced changes in regional myocar-
dial p rfusion (Figure 1.2). These imaging techniques may allow for early diagnosis
of the disease, even before the onset of clinical symptoms, improving prognosis and
aiding therapy planning for both stable and acute coronary disease [7].
Invasive X-ray coronary angiography remains the reference modality for imaging
of the coronary artery lumen and detection f coron ry stenosi . The procedur
for X-ray angiography requires catheterisation of the arteries, the use of iodinated
contrast agents, and exposes the patient to ionising radiation. Computed tomogra-
phy (CT) and magnetic resonance (MR) imaging have been proposed as alternative
non-invasive diagnostic tools for the detection of stenosis. According to a meta-
analysis study including 695 patients [10], the sensitivity of 64-section CT coronary
angiography (CTCA) for detecting > 50% stenosis compared to X-ray angiogra-
phy was 97% on a patien level, with a specificity of 90% and nega ive pre i tive
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Figure 1.2: Role of PET and MR imaging in the diagnosis and monitoring of CAD
progression. Plaque location and composition can be visualised by both PET and
MR, while visualisation of the vessel wall integrity is a promising technique in MR.
After the onset of ischaemia, both modalities offer great potential for assessing the
extent of the hypoperfused areas in the myocardium, while MR allows for visuali-
sation of the coronary lumen and evaluation of cardiac function. After myocardial
infarction, MR can be used for scar imaging, while myocardial viability PET can be
used for predicting potential functional recovery in the myocardium. Throughout
the development of the disease, quantitative MR techniques such as T1 and T2 map-
ping allow for detection of diffuse fibrosis and oedema in the myocardium, respec-
tively. *Adapted with permission from Joshi N.V. et al. 18F-fluoride positron emis-
sion tomography for identification of ruptured and high-risk coronary atherosclerotic
plaques: a prospective clinical trial. The Lancet 2014;383:705–13 [8]. **Adapted
with permission from Tarkin J.M. et al. Detection of Atherosclerotic Inflammation
by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging. Journal of the
American College of Cardiology 2017;69:1774–1791 [9].
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value of 96%. Although CTCA has the advantage of being a non-invasive proce-
dure, it results in an average radiation dose of 16 mSv (range of 5 to 32 mSv) to
the patient [11]. On the contrary, MR is a radiation-free imaging modality, which
also allows visualisation of the coronary arteries using a variety of techniques col-
lectively referred to as coronary magnetic resonance angiography (CMRA). The
reported sensitivity of CMRA compared to X-ray angiography in a meta-analysis
study from 2004 including 607 patients was 88% with a specificity of 56% on a
patient level [12]. New technical developments have significantly improved CMRA
performance, particularly when performed in 3 T scanners, achieving a sensitivity
of 93% and specificity of 83% compared to X-ray angiography according to a more
recent study [13]. Furthermore, MR allows the performance of several tests that can
be used for a comprehensive assessment of cardiovascular disease, including assess-
ment of cardiac function and regional myocardial wall motion, presence and size of
infarcted areas, myocardial oedema, and more recently, parametric tissue mapping
techniques that enable a quantitative analysis of tissue changes throughout disease
progression [14]. Nonetheless, several technical challenges remain open problems in
cardiac MR imaging. In particular for coronary artery imaging, the small diameter
and tortuous path of the vessels result in requirements of volumetric coverage and
high spatial resolution that are challenging to attain within a reasonable scan time.
Data acquisition in cardiac MR is in general slower than physiological motion, so
mechanisms for compensating the effect of the motion are fundamental for obtain-
ing good quality images. Furthermore, in order to obtain a good depiction of the
vessels, robust techniques that allow suppression of the signal arising from tissues
surrounding the coronary arteries are required.
CAD can be also diagnosed by assessing myocardial perfusion and viability:
while the extent and severity of myocardial perfusion defects can be used for risk
stratification of CAD patients [15], the presence of viable myocardium can be used
to guide therapy decision making, as it has been shown to predict potential func-
tional recovery in patients with chronic disease after revascularisation therapy [16].
Although several imaging modalities have been proposed for both perfusion and
viability myocardial imaging, the most well-established methods are single-photon
emission CT (SPECT) and positron emission tomography (PET) [14]. While con-
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ventional SPECT is widely available and less expensive than PET, it has several
technical disadvantages compared to the latter, including lower sensitivity, lower
spatial resolution and less suitability for absolute quantification. The recent devel-
opment of high-speed dedicated cardiac SPECT cameras, such as D-SPECT [17] or
Discovery NM530c [18], has alleviated some of these pitfalls, offering a 5 to 10-fold
increase in sensitivity and some gains in spatial resolution [19]. Such improvements
have enabled a reduction in scan time, and therefore, decreased cost and improved
patient comfort compared to conventional SPECT. However, absolute quantification
remains a challenge due to the difficulty of performing accurate attenuation correc-
tion. Furthermore, sensitivity of 3D PET remains an order of magnitude higher than
dedicated SPECT systems [20]. Therefore, PET has been established the reference
modality for the assessment of myocardial perfusion [21], with a reported sensitivity
and specificity of 93% and 92% respectively for the diagnosis of CAD, according to
a meta study including 791 patients [22].
Despite being the reference modality, the accuracy of the quantitative assessment
of myocardial perfusion and viability is limited by the low spatial resolution of car-
diac PET images, compared to other imaging modalities such as MRI. Even though
modern clinical PET scanners can achieve a spatial resolution of up to 4 mm full-
width at half-maximum (FWHM), in practice this resolution can not be achieved in
cardiac PET imaging due to the extensive motion of the heart during data acquisi-
tion. Both the cardiac- and respiratory- induced motion can degrade image quality,
compromising the detectability of small myocardial lesions due to image blurring.
Moreover, quantitative PET imaging requires a number of data corrections. One of
the most relevant of such data corrections is the so-called attenuation correction,
which accounts for the effect of varying tissue densities in the resultant measured
data. In cardiac PET imaging, motion-induced mismatches between the emission
data and the attenuation maps can lead to inaccurate PET images and potentially to
erroneous diagnosis, such as the detection of false myocardial perfusion defects [23].
The recent development of hybrid PET-MR systems has opened new possibilities
for a comprehensive non-invasive assessment of cardiovascular disease, by enabling
the simultaneous acquisition of complementary anatomical and functional informa-
tion in a single scan session [24]. In particular for CAD, PET-MR systems offer great
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potential for simultaneous assessment of myocardial integrity (perfusion or viability)
by PET and coronary lumen integrity by CMRA in a single examination. However,
image degradation due to cardiac and respiratory motion during data acquisition in
both modalities remains a major challenge.
Conventionally, the effect of cardiac and respiratory motion in both CMRA and
PET imaging has been mitigated by using techniques that sort the acquired data
into near motion-free frames representing different positions within the cardiac and
respiratory cycles. External electrocardiogram (ECG) devices are widely used in
clinical settings to synchronise the data acquisition with the cardiac cycle, so that
data acquired over multiple cardiac cycles can be sorted into frames representing
different cardiac phases (e.g. systole or diastole), typically using the R-wave as a
reference. Similarly, the effect of respiratory motion can be reduced by aggregating
data acquired at similar respiratory positions over multiple breathing cycles. Sur-
rogate signals that are strongly correlated with the respiratory motion of the heart,
such as the motion of the chest wall or the position of the diaphragm, can be used
for sorting the data into respiratory phases (e.g. end-inspiration or end-expiration).
These techniques, widely known as gating techniques, can be used to acquire data
(or accept data for image reconstruction) only when both the respiratory and car-
diac signals are within a predefined phase, typically end-expiration and mid-diastole
respectively, rejecting all the other data being acquired. The main drawback of gat-
ing approaches is that long acquisition times are required in order to acquire enough
data in this acceptance window, i.e. with enough signal-to-noise ratio (SNR) for
PET and enough samples for a desired spatial resolution and coverage for MR.
Alternatively, the problem of cardiac and respiratory motion can be addressed
by obtaining information about the motion from all the acquired data and then
using it to produce motion-compensated images with improved image quality in a
shorter acquisition time. Although several motion compensation approaches have
been developed over the last decades separately for both PET and MR imaging,
the introduction of hybrid PET-MR scanners has allowed the development of novel
techniques to alleviate the problem of motion simultaneously for both modalities.
In the context of cardiac PET-MR imaging, most of the research efforts about
motion compensation have focused on improving PET image quality by acquiring
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MR images with high spatial resolution and superior soft-tissue contrast simultane-
ously with PET, so that motion information obtained from such MR images can be
used to correct the PET data [25]. Although this approach has been shown to pos-
itively impact PET image quality and quantification, in general the simultaneously
acquired MR data is being used only for motion estimation, limiting their use for
diagnosis purposes.
Therefore, whereas clinical application of simultaneous cardiac PET-MR imag-
ing for the diagnosis of CAD and other cardiovascular conditions would benefit from
the complementarity between the functional and morphological diagnostic informa-
tion provided by both modalities, in practice, state-of-the art approaches acquire
diagnostic information from each modality sequentially, leading to long acquisition
times and misaligned diagnostic PET and MR images.
In this thesis, a novel framework for truly simultaneous motion-compensated car-
diac PET-MR imaging is proposed, enabling visualisation of the coronary arteries by
CMRA and assessment of myocardial integrity by PET from a single examination.
An efficient and robust acquisition and reconstruction methodology was developed
so that the complex non-rigid deformation of the heart due to cardiac and respira-
tory motion is estimated from MR images and used to correct both the CMRA and
PET datasets to the same position. This approach is highly efficient since nearly all
acquired data is used for image reconstruction (100% scan efficiency), resulting in
shorter scan time than conventional gated acquisitions. Additionally, this framework
enables the acquisition of diagnostic MR and PET images simultaneously, signifi-
cantly reducing the total exam time compared to techniques that perform diagnostic
MR acquisitions after the PET acquisition, without sacrificing image quality.
The organisation of the rest of this document is described below. Chapter 2
gives a brief description of the human heart, focusing on the coronary arteries and
left ventricular anatomy and function. Chapter 3 gives an overview of cardiac
PET-MR imaging, describing the techniques traditionally used for acquisition of
CMRA and cardiac PET as well as conventional image reconstruction and motion
compensation techniques for each imaging modality. A brief discussion about state-
of-the-art approaches for cardiac PET-MR imaging, including research developments
for motion correction in PET-MR and clinical applications is also included.
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Chapter 4 describes the proposed approach for respiratory motion-corrected
CMRA-PET, including results from an initial validation of the motion correction
framework in healthy subjects and a proof-of-concept study in oncology patients.
A first clinical validation of this approach is described in Chapter 5, where the
framework is used for the simultaneous visualisation of coronary integrity by CMRA
and myocardial viability by 18F-FDG PET in patients with documented chronic total
occlusion of the coronary arteries.
Chapter 6 extends the framework presented in Chapter 4 to include cardiac
motion compensation, based on a dual-phase CMRA acquisition. This framework
allows visualisation of the coronary anatomy, estimation of left ventricular function
and cardiac and respiratory motion-corrected PET to be obtained from a single
examination. Results from a first study testing this approach in a small cohort of
healthy subjects and cardiac patients are also presented and discussed here.
Chapter 7 adapts the respiratory motion-corrected approach presented in Chap-
ter 4 for simultaneous water/fat CMRA imaging. The water/fat CMRA approach
allows for an improved contrast between the coronary arteries and surrounding epi-
cardial fat in the water CMRA image, and provides an additional image that contains
useful diagnostic information about the distribution of cardiac fat. Furthermore, as
it provides good-quality water/fat anatomical images throughout the respiratory
cycle, this approach potentially allows for an improved attenuation correction of
simultaneously acquired cardiac PET data. Preliminary results obtained from a
validation study in a cohort of healthy subjects are discussed in this Chapter.
A brief discussion about the contributions and findings of this thesis are included
in Chapter 8, which also presents some final remarks including areas of future work.
The work presented in this thesis resulted in several publications. An extended
version of the discussion about motion correction for cardiac PET-MR (Chapter
3, Section 3.5) was published as a review paper in PET Clinics [26]. Some of the
results presented in Chapters 4 and 6 have been published as peer-reviewed articles
appearing in Magnetic Resonance in Medicine [27,28], while the study in Chapter 5
has been published in EJNMMI [29]. Finally, the work presented in Chapter 7 has
been accepted for publication in Magnetic Resonance in Medicine (in press).
Chapter 2:
The Human Heart
The heart is a muscular organ located in the thoracic cavity, whose main function is
to pump blood through the arteries, veins and capillaries throughout the rest of the
body, in order to carry oxygen and nutrients required for metabolic activity of the
cells and assist in the removal of carbon dioxide and metabolic waste products. As
any other muscular tissue, the heart muscle (or myocardium) requires a reliable and
steady supply of oxygenated blood. This oxygen supply is delivered by the coronary
arteries, which together with the coronary veins form the extensive and complex
system of coronary circulation. As described in Chapter 1, when the coronary circu-
lation is impaired or interrupted, the pumping function of the heart is compromised,
with a sustained oxygen deprivation resulting in the death of myocardial cells.
This Chapter provides a brief description of cardiac anatomy and function, fo-
cusing on the coronary arteries and left ventricular function. Additionally, a brief
characterisation of the physiological motion of the heart is included, and some stan-
dard techniques for the visualisation of cardiac structures of interest for this thesis
are described.
2.1 Cardiac Anatomy and Function
The human heart consists of four chambers: two upper chambers, called atria,
whose purpose is to receive blood and push it towards the two lower chambers,
called ventricles, whose function is to pump blood out of the heart towards the
lungs or the rest of the body. In the heart circulation, depicted in Figure 2.1a,
the deoxygenated blood coming from the body is collected in the right atrium, and
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Figure 2.1: Anatomy of the heart. (a) Four chambers of the heart and major vessels
in the heart circulation system. Adapted from [30]. (b) Coronary arteries and
main branches. During most of their course, the coronary arteries are embedded in
epicardial fat (not depicted in the figure). Adapted from [31].
pumped into the lungs by the right ventricle through the pulmonary arteries. Then,
the oxygenated blood returns to the left atrium through the pulmonary veins, and
it is pumped towards the rest of the body by the left ventricle via the aorta.
The coronary arteries are small vessels (typically around 3 to 5 mm diameter in
the proximal segments and 1 to 2 mm in the distal section) that provide oxygenated
blood to the myocardium and other cardiac structures. They arise from the base of
the aorta and follow a tortuous path covering the heart, as depicted in Figure 2.1b,
and are embedded in epicardial adipose tissue during most of their course. While
the right coronary artery (RCA) distributes blood to the right atrium and portions
of both ventricles, the left coronary artery distributes blood to the left atrium,
left ventricle and the interventricular septum through its two main branches, the
left anterior descending (LAD) and left circumflex (LCX) arteries. The coronary
arteries give rise to several smaller branches that interconnect with each other in
order to provide a reliable blood supply to the myocardium, even in cases of partial
blockage of some of the branches.
In order to pump blood towards the rest of the body, the muscular cells of the
myocardium contract 50 to 80 times per minute in a healthy adult in rest state, trig-
gered by an electrical signal that travels from the atria down to the ventricles. The
sequence of mechanical events regulated by the electrical activity of the myocardium
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Figure 2.2: Schematic ECG signal during one cardiac cycle. The beginning of the
ventricular systole is given by the R wave, while ventricular diastole is produced
between the end of the T wave and beginning of the next QRS complex.
in one heartbeat is known as the cardiac cycle, and it comprises the contracting phase
that pumps blood to the body, known as systole, and the relaxation and refilling of
the ventricles, known as diastole. The electrical activity of the heart can be detected
by placing electrodes on the chest to produce an electrocardiogram (ECG) as shown
in Figure 2.2. The QRS complex represents the electrical depolarisation of the ven-
tricles as the electrical impulse travels through the myocardium, which indicates the
beginning of the systolic phase. The T wave represents the repolarisation of the
ventricles, and marks the beginning of the diastolic phase of the cycle. The length
of the cardiac cycle can be measured by detecting consecutive R waves, typically
known as the RR interval.
The pumping efficiency and the volume of blood pumped by the ventricles are
relevant clinical measures of how well the heart is meeting the demand of oxygenated
blood from the rest of the body. One such functional measurement is the cardiac
output, defined as the average volume of blood pumped by the heart per unit time.
The cardiac output is typically computed by multiplying the heart rate (usually
in beats per minute) and the stroke volume (SV), defined as the volume of blood
pumped by each of the ventricles in one cardiac cycle. The SV can be obtained by
subtracting the end systolic volume (ESV) from the end diastolic volume (EDV),
obtained from ECG-synchronised images acquired with a variety of imaging modal-
ities or by invasive procedures involving cardiac catheterisation. A conventional
measurement of the pumping efficiency of the heart is the ejection fraction (EF),
which represents the fraction of blood that is pumped by the ventricle in each con-
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traction. The EF is computed by dividing the SV by the EDV, and it is usually
expressed as a percentage. Equation 2.1 shows the formulas for computing these
two functional indices. In a healthy adult, the SV ranges from 55 to 100 ml, while
the EF ranges from 55 to 70%.
SV = EDV− ESV (2.1a)
EF = EDV− ESVEDV × 100% (2.1b)
2.2 Physiological Motion of Cardiac Structures
The heart is continually moving due to the cardiac and respiratory cycles. In MR
and PET imaging, such motion can induce blurring and artefacts in the images,
compromising their diagnostic quality. This section describes the main character-
istics of the cardiac and respiratory-induced motion of the heart, focusing on the
coronary arteries and the left ventricle.
2.2.1 Cardiac-Induced Motion
The heart moves periodically due to the contraction and relaxation of the atria and
ventricles. The frequency of such motion is given by the heart rate, which ranges
from 50 to 80 beats per minute in healthy adults, but can vary significantly more in
patients with cardiovascular disease. While the duration of the ventricular systolic
phase is approximately constant (around 400 ms) among a wide range of heart rates,
the length of ventricular diastole varies greatly, with a typical duration between 200
and 800 ms.
In order to estimate more accurately the duration of each of these cardiac phases
for a given heart rate, linear models have been proposed for adult healthy subjects
and patients with congestive heart failure [32, 33], with linear coefficients shown
in Table 2.1. However, the applicability of such models is limited in younger and
elderly patients, or patients with other cardiovascular conditions [34, 35].
Throughout the cardiac cycle, there is not an exact correspondence between the
Chapter 2. The Human Heart 28
a (ms) b (ms·bpm−1) Reference
Male 541 2.2 [33]
546 2.1 [32]
Female 540 2.0 [33]
549 2.0 [32]
Table 2.1: Linear coefficients proposed in the literature for defining the length of
ventricular systole as a function of the heart rate, so that systole = a−b×heart rate.
motion of the left ventricle and the motion of the coronary arteries. Although there
are periods of minimal motion in both systolic and diastolic cardiac phases for both
the left ventricle and each of the coronary arteries, the duration of such periods
varies greatly between structures.
The movement of the left ventricle between diastole and systole is the product
of three components: 1) inwards radial contraction, 2) longitudinal shortening and
3) twisting of the apex in relation to the base [36]. According to a review study
using MR imaging for estimating the amplitude of each component of the motion in
the left ventricle myocardium [37], the radial contraction ranges from 4.4± 1.0 mm
in the apex of the left ventricle to 5.4± 1.0 mm in the base, while the length of
the base-to-apex longitudinal contraction is 11.2± 2.2 mm, with most of the motion
resulting from the base of the ventricle and the apex remaining nearly stationary.
Finally, the twisting movement consists of a basal clockwise rotation of 4.4± 0.4◦
and an apical counter-clockwise rotation of 10.0± 2.3◦.
Different imaging techniques have been used to measure the cardiac-induced
motion of the coronary arteries both in free breathing and breath-holding conditions.
In [38], a study on 25 healthy subjects where MR images were acquired under free
breathing conditions showed that there are two periods of minimal motion of the
coronary arteries: a first one of ∼50 ms duration at end-systole, and a longer one
around mid-diastole. This study also showed that the mid-diastolic quiescent period
for the RCA is shorter and starts later than for the LAD artery, as summarised in
Table 2.2. This is consistent with the findings presented in [39], where CT images
were used to measure the motion of the RCA, LAD and LCX arteries in a cohort
of 70 patients. In this study, it was shown that in patients with heart rates below
80 beats per minute, the coronary arteries have two motion-free periods, the first of
them corresponding to end-systole (40%–50% of the RR interval), and the second
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RCA LAD
Onset 69± 11% 66± 10%
Duration 17± 9% 25± 10%
Table 2.2: Onset and duration of the mid-diastolic quiescent period for the RCA
and LAD as a percentage of the RR interval. Data from [38].
RL AP SI
LAD 6.8± 1.7 mm 7.9± 1.5 mm 6.8± 1.9 mm
LCX 9.3± 2.1 mm 12.7± 2.3 mm 10.5± 1.3 mm
RCA 9.0± 1.7 mm 10.6± 1.7 mm 11.3± 2.8 mm
Table 2.3: Maximum displacements of the RCA, LAD and LCX arteries during the
cardiac cycle in the right-left (RL), anterior-posterior (AP) and superior-inferior
(SI) directions. Data from [40].
one in mid-diastole (60%–80% of the RR interval). In patients with higher heart
rates, only the end-systolic rest period was observed.
The maximum displacement of each coronary artery during the cardiac cycle was
measured in [40] for a cohort of 8 healthy subjects using MR images acquired under
breath-hold conditions. Table 2.3 summarises the findings of this study, where it
can be observed that the amplitude of the motion of the RCA and LCX is larger
than the LAD in all directions.
2.2.2 Respiratory-Induced Motion
Breathing also induces motion of the heart, due to movement of both the diaphragm
and the chest wall. From these two sources, a dominant superior-inferior (SI) trans-
lation of the heart is produced, ranging from 10.5± 4.8 mm for the root of the RCA
(i.e. the point where the RCA arises from the aorta) to 18.1± 9.1 mm for the inferior
margin of the heart for an average diaphragm motion of 19.7± 11.9 mm, according
to a well-known study in healthy subjects [41]. This study used MR images acquired
under breath-hold conditions at seven different respiratory positions throughout the
breathing cycle.
In addition, this study found a linear relationship between the movement of
the different cardiac structures and the motion of the diaphragm. In particular, a
factor of 0.6 was found to correlate the SI displacement of the diaphragm and the
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displacement of the root of the RCA and LAD. It is worth noting that in [41], the
amplitude of SI motion was found to differ across the heart, with superior regions of
the heart experiencing about 40% less SI displacement compared to inferior regions.
Therefore, the height of the heart is reduced during the respiratory cycle as the
diaphragm moves upwards.
Furthermore, additional studies have shown that during free breathing there
are hysteretic loops in some subjects, so the relation between the motion of the
heart and the motion of the diaphragm follows different paths for expiration and
inspiration [42]. Thus, a given diaphragm position might correspond to different
heart positions for these different phases of the respiratory cycle. The extent of
the hysteresis effect is strongly subject dependant, as shown in Figure 2.3 for four
representative healthy subjects.
Displacements in the SI direction are not the only component of the respiratory-
induced motion of the cardiac structures. Smaller displacements have been observed
in the anterior-posterior (AP) and right-left (RL) directions, with 4.3± 3.7 mm and
2.0± 2.1 mm displacement on average, respectively, using MR images acquired in
a cohort of 8 healthy subjects and 10 patients with cardiovascular disease [43].
Furthermore, in agreement with [41], several studies have shown that the motion of
the heart due to the breathing cycle, and in particular that of the coronary arteries, is
not purely translational but a complex deformation. This motion has been modelled
as an affine transformation, and more generally, as a non-rigid deformation [43–45].
It is worth noting that due to time restrictions in MR image acquisition, some of
these early studies measured the motion using images acquired during breath-holds
at different respiratory positions. Studies using other imaging modalities, such as
X-ray angiography, have shown much smaller average displacements of the coronary
arteries during normal tidal breathing, with average translation in the SI, AP and
RL directions of 4.9± 1.9 mm, 1.3± 1.8 mm and 0.4± 2.0 mm, respectively, in a
cohort of 10 patients with cardiovascular disease [46].
Compared to cardiac-induced motion, the respiratory-induced motion of the
heart has more inter-subject variability. A healthy adult in rest state breathes
at a rate of 12–20 times per minute, with an inspiration length ranging 1–2 seconds,
and a slightly longer expiration period of 2–3 seconds. There are quiescent periods
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Figure 2.3: Histograms of SI respiratory-induced motion of the heart versus that of
the diaphragm in four healthy subjects. Darker squares indicate a higher occurrence
of the measurement; and straight lines correspond to linear fits to the data (cf
= correction factor, r = correlation coefficient). Reprinted with permission from
Nehrke K., et al. Free-breathing cardiac MR imaging: Study of implications of
respiratory motion—Initial results. Radiology 2001;220:810-815 [42].
within each of these respiratory phases. According to a study in healthy subjects,
the quiescent phase at end-expiration was observed to have a length of 1.1 ± 1.6
seconds, while a shorter quiescent period at end-inspiration of 0.4± 0.2 seconds was
observed, with an average respiratory period of 4.3± 1.1 seconds [47].
2.3 Visualising Cardiac Structures
As described in Chapter 1, different non-invasive imaging modalities have been used
for visualisation of the integrity of the coronary arteries and the left ventricle my-
ocardium. Due to the extensive differences in the cardiac anatomy and orientation
between subjects, but also due to the intrinsic characteristics of each imaging tech-
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nique, the resulting images greatly differ from each other. In order to prevent such
variability from hindering intra- and inter-modality comparisons, several approaches
have been introduced for standardising the visualisation of the coronary arteries and
the left ventricle myocardium. Conventional approaches for depicting both cardiac
structures are briefly described in this section.
2.3.1 Visualising the Coronary Arteries
The coronary arteries follow a tortuous path, as depicted in Figure 2.1b. Although
multi-planar reformatting (MPR) and maximum intensity projections (MIPs) tech-
niques have been used for improving visualisation and quantitative analysis of the
coronary arteries [48], these techniques assume that the vessel of interest is con-
tained in a thick plane. Therefore, these approaches only allow for the visualisation
of a segment of an individual vessel in one image. Furthermore, they do not allow
for a direct comparison of image quality between different imaging techniques.
Alternatively, approaches that use curved reformatting of the coronary arteries
have been proposed in the literature, which enable the simultaneous visualisation of
two or three vessels, covering from the proximal to the distal segments. In particular,
for MR angiography, a widely used tool for visualisation of the coronary arteries and
objective image quality assessment is the ‘Soap Bubble’ software [49]. This software
is extensively used throughout this thesis, so its main features are described here.
The ‘Soap Bubble’ approach assumes that the coronary tree is contained in a
smooth surface resembling a bubble, as shown in Figure 2.4. Once this smooth
surface is defined, a 2D image that depicts the whole coronary anatomy can be
created by projecting this smooth surface onto a plane.
Initially, the user manually selects a collection of points Pi in each of the vessels
of interest (depicted in red in Figure 2.4), that define a convex surface D′. Then,
the software creates a parallel projection in a direction normal to the surface at each
selected point. In this way, more than one vessel can be visualised in a single image
as shown in Figure 2.5a. It is worth noting that in this planar image, the distance
between voxels is not constant. Therefore, metrics such as vessel length, sharpness
or diameter are performed directly in the 3D volume, using the points selected by
the user. Figure 2.5b shows an example of the points selected by the user for a
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representative coronary MR angiography, indicated by yellow crosses. The software
includes tools for measuring the length of each vessel (Figure 2.5c) and the average
vessel sharpness, calculated from an edge image (Figure 2.5d) obtained by applying
the first-order derivative to the input image.
Figure 2.4: Curved reformatting using the ‘Soap Bubble’ software tool. The MR
angiography image is acquired in a Cartesian grid (x, y, z) within a volume V. The
user selects a series of points Pi that can be used to define a smooth surface D′.
By creating a MIP parallel to this surface, a planar coronary reformatting can be
obtained. Reprinted with permission from Etienne A., et al. “Soap-Bubble” visu-
alization and quantitative analysis of 3D coronary magnetic resonance angiograms.
Magnetic Resonance in Medicine 2002;48:658–66 [49].
Figure 2.5: Planar reformatting example from ‘Soap Bubble’. (a) The curved refor-
matting enables the visualisation of both the right (RCA) and left (LAD) coronary
arteries. (b) User-selected points (yellow crosses) produce the reformatted image.
(c) Measurement of the length of the vessel (LAD) by tracking the central line (in
red). (d) Vessel sharpness is measured in a collection of profiles (in red) perpendic-
ular to the central line of the vessel.
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2.3.2 Visualising the Left Ventricle
The American Heart Association (AHA) proposed a standardized segmentation and
nomenclature for left ventricular myocardial imaging that has been widely adopted
in the clinical practice [50]. In this approach, three orthogonal planes oriented with
respect to landmarks in the heart are defined. These planes are called 1) vertical
long axis, a two-chamber view that depicts the left ventricle and atria; 2) horizontal
long axis, a four-chamber view of the heart and 3) short axis slices, where the right
and left ventricle are visualised from the base to the apex. Figure 2.6 shows a
schematic with such planes, which can be observed for a real cardiac MR scan in
Figure 2.7.
Figure 2.6: Definition of orthogonal cardiac planes for 3D imaging modalities. RV:
right ventricle, LV: left ventricle. Reprinted with permission from Cerqueira M.D.,
et al. Standardized Myocardial Segmentation and Nomenclature for Tomographic
Imaging of the Heart. Circulation 2002;105:539–542. [50]
Figure 2.7: Example orthogonal cardiac planes for 3D MR imaging, showing (a) a
short axis slice, (b) vertical long axis and (c) horizontal long axis view.
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Figure 2.8: Left ventricular myocardial segmentation according to the AHA 17-
segment model. (a) The model divides the left ventricle into three short-axis slices:
apical, mid-cavity, and basal. The basal and mid-cavity slices are divided into 6
segments, while the apical slice is divided into 4 segments. The apex is added as an
additional segment, usually obtained from the vertical long-axis view. (b) Conven-
tional naming for the 17 segments. For perfusion or viability imaging, the segments
can be rearranged in polar plots, where the value in each segment is related to the
integrity of the myocardium in that specific section. (c) Each segment can be as-
signed to one or more coronary arteries; however, anatomical variations in the blood
supply in different subjects need to be taken into account. Reprinted with permis-
sion from Dilsizian V., et al. ASNC imaging guidelines/SNMMI procedure standard
for positron emission tomography (PET) nuclear cardiology procedures. Journal of
Nuclear Cardiology 2016;23:1187–1226 [51].
The short axis view is one of the most widely used planes for acquiring and
displaying MR and PET images of the left ventricle myocardium, as it enables the
visualisation of the integrity of the myocardial wall and the extent of perfusion
or viability defects in both the radial and circumferential directions. The short
axis view was therefore proposed as a reference for segmenting the left ventricle
myocardium, in the so-called 17-segment AHA model, depicted in Figure 2.8.
This model uses three thick short-axis slices, located at the basal, mid-cavity and
apical levels, to represent most of the left ventricle. The basal and mid-cavity slices
are divided in 6 segments each, while the apical slice is divided in four segments, as
depicted in Figure 2.8a. In order to assess the integrity of the apex, an additional
segment is obtained from the vertical long axis view. Although in general each
of the segments can be assigned to a particular coronary artery (Figure 2.8c), the
guidelines recommend a case-to-case evaluation, as anatomical variations in some




This chapter provides an overview of the techniques used for coronary MR angiog-
raphy (CMRA) and myocardial integrity imaging with PET. The physics of MR
and PET imaging are briefly summarised, including details about the data acqui-
sition protocols in both modalities. Standard approaches for motion compensated
MR and PET image reconstruction are then described. Finally, techniques that
have been recently proposed for MR-based motion compensation and novel clinical
applications for cardiac PET-MR imaging are described and discussed.
3.1 Cardiac MR Acquisition
MR is a non-invasive medical imaging modality that uses the nuclear magnetic reso-
nance (NMR) effect to obtain information about the intrinsic physical and chemical
properties of an object. According to the NMR effect, when placed in an external
static magnetic field, nuclei with a nonzero spin can be excited by applying a ra-
diofrequency (RF) pulse, inducing the emission of a subsequent detectable RF signal
after a short period of time. By using spatially variant gradient magnetic fields, this
signal can be localised in space, allowing for production of a multi-dimensional im-
age that reflects intrinsic characteristic of the object being scanned, such as nuclear
spin density, spin relaxation times, magnetic susceptibility, molecular diffusion and
perfusion, and chemical shift. By varying parameters such as the amplitude, shape
and timings of the RF pulses and gradients, different contrast between tissues can be
36
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obtained, making MRI a versatile modality that can produce anatomical and func-
tional images with high spatial resolution. This section describes the basic principles
of MR data acquisition following the approach proposed by Liang and Lauterbur
in [52], and then focuses on pulse sequences for CMRA, including mechanisms used
for enhancing tissue contrast and conventional motion compensation approaches.
3.1.1 Fundamentals of MR Imaging
Consider a population of nuclei with an odd number of protons or neutrons. Such
nuclei possess an intrinsic angular moment ~J , typically called spin, which can be con-
sidered analogous to a physical rotation about its axis. The charged and rotating
nuclei give rise to an intrinsic magnetic moment ~µ = γ ~J , where γ is a nucleus-
dependant constant known as the gyromagnetic ratio. According to quantum me-
chanics, the magnitude of this magnetic moment is given by
|~µ| = γ~
√
I(I + 1) (3.1)
where I is the nuclear spin quantum number and ~ is the reduced Planck constant.
Under normal conditions, the direction of ~µ is random due to thermal motion, result-
ing in a non-measurable magnetic field, i.e. a zero net magnetic field as illustrated
in Figure 3.1a. However, when placed in a magnetic field ~B0 = B0êz (where êx, êy, êz
correspond to the unitary vectors for a Cartesian coordinate system), each spin will
take one of a finite number of orientations in the direction of the magnetic field, so
that the z-component of ~µ becomes quantised into 2I levels, according to
µz = ~γmI (3.2)
where mI = −I,−I+1...I−1, I is the magnetic quantum number. Thus for I = 1/2
spin nuclei, such as hydrogen (1H), only two orientations are possible, giving rise
to two spin populations, usually called parallel and antiparallel spins (Figure 3.1b).
These two populations contain on average a different number of spins, resulting in
a net bulk magnetisation in the spin system, which can be derived as described
hereafter.
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Figure 3.1: Schematic of a I = 1/2 spin system. (a) In absence of an external
magnetic field, the spins are randomly oriented. (b) In presence of an external
magnetic field ~B0, spins will align parallel or antiparallel to the magnetic field.
The ratio between the number of spins in each population depends on the differ-
ence between their energy levels and the temperature of the nuclei system, T , and









where N↑ and N↓ represent the population of parallel and antiparallel spins, respec-
tively, ∆E is the difference between energy levels and k is the Boltzmann constant.
Using that the energy level of each spin is given by
E = −~µ · ~B0 (3.4)





where NS is the total number of spins in the system. For a conventional MR system
of B0 = 3 T operating at room temperature, the difference between both populations
is approximately 3 ppm.
So far, the z-component of the magnetic moment has been described, but the
other two components (x- and y-) have not yet been discussed. Following a classical
mechanical approach, when placed in an external magnetic field, magnetic moments
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Solving this equation, it can be obtained that
µxy = µxy(0)eiγB0t (3.7a)
µz = µz(0) (3.7b)
where µxy = µx + iµy represents the transverse component of the magnetic mo-
ment in complex notation (corresponding to the transverse magnetic moment vec-
tor ~µxy = µxêx + µyêy) and µxy(0) and µz(0) correspond to the initial value of the
transverse and longitudinal components of the magnetic moment, respectively. An
important implication of this result is that when placed in a static magnetic field,
spins will precess about the direction of the magnetic field with an angular frequency
ω0 = γB0, also known as the Larmor frequency. Moreover, given that spins are ini-
tially randomly oriented, the direction of the transverse component of the magnetic
moment remains random for each of the spins.
The net bulk magnetisation, ~M , can then be obtained by aggregating the mag-
















where µx,n, µy,n and µz,n are the components in the x-, y- and z-axes respectively
of the magnetic moment ~µn corresponding to the nth spin of the system. Ac-
cording to Equation 3.2, µz,n = ±12γ~, depending on whether the spin belongs
to the parallel or antiparallel population. Furthermore, given that the orienta-
tion of the transverse magnetisation of the magnetic moment remains random,











4kT NSB0êz = M0êz
(3.9)
The bulk magnetisation is therefore parallel to the external static magnetic field,
and its magnitude depends on intrinsic properties of the nuclei system, such as
γ and NS, which makes 1H very attractive as a target for MR, due to its strong
gyromagnetic ratio and high natural abundance.
In order to measure this bulk magnetisation, a second magnetic field ~B1 needs
to be applied, typically perpendicular to the static magnetic field. Using the same









Consider now a radiofrequency field ~B1, known as the RF excitation field, rotat-
ing at the Larmor frequency
~B1 = B1(t) (cos(ω0t)êx − sin(ω0t)êy) (3.11)
When ~B1 is applied during a short period of time Tp, and given that the initial
magnetisation is ~M(t=0) = M0êz, Equation 3.10 can be solved so that the magneti-
sation of the system is given by
~M = M0 sin(α) sin(ω0t)êx +M0 sin(α) cos(ω0t)êy +M0 cos(α)êz (3.12)





As can be observed in Equation 3.12, applying a RF magnetic field tips the
longitudinal magnetisation toward the transverse plane, and induces an oscillating
magnetisation (Figure 3.2a) that can then be detected by means of electromagnetic
induction as will be described shortly. The strength of the detected signal depends,
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Figure 3.2: Magnetisation evolution when an RF magnetic field pulse is applied.
(a-b) The RF field tips the magnetisation towards the transverse plane in an angle
α that depends on the shape and duration of the RF pulse. (c) After the RF pulse
is switched off the magnetisation returns to the equilibrium, in a process known
as relaxation. The longitudinal magnetisation Mz recovers while the transverse
magnetisation Mxy decays.
among others, on the flip angle used. In particular, for α = 90◦, the bulk magneti-
sation is fully tipped to the transverse plane; so that a maximum induced signal is
achieved.
After switching off ~B1, the magnetised spin system will return to the initial
equilibrium state over time, so that the longitudinal magnetisation recovers while the
induced transverse magnetisation disappears. This process is known as relaxation
and can be phenomenologically described by the Bloch equation
d ~M
dt





where Mx, My and Mz are the components in the x-, y- and z-axes respectively of the
magnetisation ~M , ~B is the magnetic field being applied, corresponding in this case to
~B0, and T1 and T2 correspond to intrinsic properties of the nuclei system that depend
on the interactions between the spins and their microenvironment. More precisely,
T1 is the spin-lattice relaxation time, also known as longitudinal relaxation, which
reflects the energy exchange between the spins and the static magnetic field. As
such, T1 depends on the value of B0, with values in the range of 100 to 2000 ms for
biological tissues of interest for conventional magnetic field strengths (B0 = 1.5 or
3.0 T). T2 is the spin-spin relaxation time, also known as transverse relaxation, that
reflects the energy exchange of spins with each other. Thus, T2 times are insensitive
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to changes in B0, with typical values for tissues in the range of 50 to 500 ms.
Solving Equation 3.14, it is possible to obtain that
















where Mxy(t) = Mx + iMy corresponds to the transverse magnetisation in com-
plex notation. From Equation 3.15, it can be observed that the longitudinal and
transverse relaxations occur at different rates (Figure 3.2c), and that the transverse
magnetisation decays rotating around the z-axis.
According to Faraday’s law, the voltage S(t) induced by the rotating magnetisa-
tion Mxy(t) in a nearby receiver coil is equal to the rate of change of the flux through
the coil, which in turn is proportional to the rate of change of the magnetisation, so









where v is the volume of magnetisation and M0(~r) is the equilibrium magnetisation
at location ~r. Since both ω0 and M0(~r) depend linearly on the strength of the static
magnetic field B0, S(t) ∝ B20 , making high magnetic fields attractive for enhancing
signal-to-noise ratio (SNR) in MR imaging.
It is worth noting that in Equation 3.16, the integral encompasses the entire
volume of magnetisation, so even though the whole magnetisation of the system
can now be measured, it is not possible to know its spatial distribution. In order
to measure M0(~r), additional magnetic fields that encode spatial information need
to be applied. These fields, commonly known as gradient fields, are parallel to
the main magnetic field, but their amplitude changes in space so that they can be
written as (~G(t) · ~r)êz. Solving Equation 3.14 for a total magnetic field given by
~B = B0êz + (~G(t) · ~r)êz results in
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Neglecting the effect of T2 (by assuming that the acquisition time is in general
much shorter than T2), it can be observed from Equation 3.19 that the relation
between the applied gradient fields, the spatial distribution of the magnetisation
and the induced signal can be mathematically described by the Fourier transform.
Therefore, the MR sampling space, widely known as k-space, contains the Fourier
transform of the object that is to be observed, and the problem of estimating M0(~r)
can be solved by collecting an appropriate number of samples of the signal S(~k) and
then using an appropriate mathematical mechanism for transforming the acquired
k-space data into the image domain. These mechanisms, referred to as MR image
reconstruction techniques, will be described in detail in Section 3.3.
As shown in Equation 3.19, the induced signal has to be localised in space in
order to produce an MR image, and three gradient fields are typically applied for
this purpose. When acquiring transversal two-dimensional images, the first of such
gradient fields, known as slice selection gradient, consists of a linear gradient along
the z-axis that is applied simultaneously during the RF excitation. The combination
of the slice selection gradient and RF excitation produces a linear change in the
resonance frequency of the spins in the volume, resulting in a spatially selective
excitation where only the spins belonging to a slice of the object will resonate with




where BW is the bandwidth of the RF excitation pulse, and Gz is the slope of the
slice selection gradient (i.e. the gradient field is given by ~G = Gzzêz).
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Figure 3.3: Slice selection gradient. When applied simultaneously with an RF ex-
citation pulse B1(t) of bandwidth BW , the slice selection gradient results in the
selective excitation of spins in a slice of thickness ∆z.
The second gradient field is known as frequency encoding, and consists of a linear
gradient typically varying along the x-axis. This gradient produces a linear change
in the resonance frequency of the magnetisation along the x-direction. Therefore,
samples acquired at different time points tn during the application of this gradient
correspond to different values of kx in the MR sampling space, with kx(n) = γGxtn
for a gradient field ~G = Gxxêz. As the data is acquired while applying this gradient
it is also known as readout gradient, and the x-axis is known as the readout direction.
Finally, the third gradient field, known as phase encoding, varies along a direction
perpendicular to the readout direction (typically the y-axis), and it is applied prior
to data acquisition. After this gradient is switched off, the spins have accumulated a
phase that varies linearly with the position of the spins on the y-axis, allowing for en-
coding the remaining spatial direction in the detected signal. It is worth noting that
this description can be generalised for two-dimensional imaging in any orientation.
Furthermore, a similar description can be obtained for three-dimensional imaging.
In this case, a slice selective gradient is not needed, and instead, two phase encoding
gradients are applied: one of them varying along the y-axis and a second one along
the z-axis.
Each combination of amplitude, shape and duration of the three gradient fields
defines a unique order in which the k-space is sampled, which is commonly known as
k-space trajectory. The case described above results in the data being collected line-
by-line in a Cartesian grid, and it is one of the most widely used k-space trajectories.
However, any arbitrary k-space trajectories is possible by changing the shape of these
gradients [53].
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Figure 3.4: (a) Schematic of a generic pulse sequence, showing RF excitation pulses,
slice encoding (SE), frequency encoding (FE) and phase encoding (PE) gradients,
and the signal acquired (Acq). The repetition time (TR) and echo time (TE) are
also indicated. (b) Corresponding k-space trajectory for the pulse sequence shown.
The sequence of RF and gradient fields used to acquire a MR image are collec-
tively known as pulse sequence. By changing parameters in the pulse sequence, such
as the shape and duration of the RF excitation pulse, or the timing between the
application of RF excitations, gradient fields and data acquisition, the information
content of the resulting image will change, producing a contrast that can be based,
among others, on the density of 1H, T1 and T2 times of the object being scanned or
a combination of any of these properties.
Pulse sequences are generally described by schematics similar to the one shown
in Figure 3.4a, indicating the flip-angle of the RF excitation pulses, and shape and
duration of the gradient fields in the slice encoding (SE), frequency encoding (FE)
and phase encoding (PE) directions. Parameters related to the timings of the pulse
sequence are also depicted, including the repetition time (TR), corresponding to the
time between consecutive RF excitations, and the echo time (TE), corresponding
to the time between the RF excitation and the appearance of the peak amplitude
of the induced signal, called the echo. As can be seen in Figure 3.4b, the pulse
sequence can also be used to describe the k-space trajectory being followed in each
particular MR acquisition protocol.
As described above, the MR data are acquired when the peak amplitude of
the induced signal is produced. This peak can be induced by using RF pulses
and/or by using readout gradients with opposed polarity. Pulse sequences that use
RF pulses to induce a signal echo are usually known as spin echo sequences, while
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Figure 3.5: Schematic of a spin echo sequence. A 90◦ RF pulse is used to tip the
magnetisation to the transverse plane, and a 180◦ RF pulse applied after TE/2 is
used to induce an echo by refocusing the spins at TE.
sequences that rely only on readout gradients to induce the signal echo are known as
gradient echo sequences. Typically, the spin echo sequences use a 90◦ RF excitation
pulse that completely tips the longitudinal magnetisation to the transverse plane.
After switching off the RF pulse, the spins start to dephase in the transverse plane
according to their T2 properties. Subsequently, a 180◦ RF pulse is applied after
TE/2, so that the dephasing is reversed and spins get refocused at a time TE. A
generic spin echo pulse sequence is depicted in Figure 3.5.
In gradient echo sequences a pre-phasing lobe is used in the readout gradient
to produce the signal echo (Figure 3.6). In this case, the RF excitation pulse uses
a flip angle α < 90◦, reducing the time required for the recovery of longitudinal
magnetisation and therefore allowing for faster acquisitions. For this reason, gradient
echo sequences are one of the most widely used pulse sequences for cardiac imaging.
When TR T2, the transverse magnetisation fully decays between consecutive
RF excitations, and the signal induced at the echo time is proportional to parameters
intrinsic to the object being scanned and extrinsic acquisition parameters, as shown
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Figure 3.6: Schematic of a gradient echo sequence showing multiple RF excitations.
In general TR is long enough for the transverse magnetisation to fully decay between
consecutive RF excitations. A pre-phasing lobe is used in the frequency-encoding












) sin(α)e−TET ∗2 (3.21)
where ρ(~r) is the density of 1H at location ~r, and T ∗2 (also known as T2 star) is
a parameter that depends on both the intrinsic parameter T2 and the local field






Note that in general, the parameters T1, T2 and ∆B are spatially dependent, so that
T1 = T1(~r) and so on. This notation has been omitted for simplicity.
MR acquisition time increases linearly with TR. Thus, shorter TRs are desirable
in order to accelerate the acquisition and reduce total scan time. However, reducing
TR changes the magnetisation relaxation processes. Indeed, when TR ≈ T2, the
transverse magnetisation Mxy does not fully decay between RF excitations, and
therefore the induced signal at echo time is influenced by both the residual Mxy
from previous RF excitations and the new longitudinal magnetisation Mz tipped
into the transverse plane. It can be shown that after several repetitions, both Mxy
and Mz reach a dynamic equilibrium, so that the induced signal reaches a steady
state. Alternatively, additional gradient fields can be used to null the residual Mxy
after data acquisition, using so-called magnetisation spoiling techniques, as shown
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Figure 3.7: Schematic of a spoiled gradient echo sequence showing multiple RF
excitations. Additional fields in the slice-encoding (SE) gradient (in blue) spoil the
residual transverse magnetisation, allowing for reduced repetition time (TR). Phase-
encoding (PE) re-winder gradients (in red), which allow returning to the centre of
k-space between consecutive acquisitions, are also shown.
in Figure 3.7. In this case, the induced signal behaves similarly to Equation 3.21,
and different image contrasts including T1, T2 and proton density weighting can be
obtained by appropriately choosing TR, TE and α.
So far we have assumed that all spins within the volume of interest experience
the same external static magnetic field B0 and as a consequence precess at a unique
Larmor frequency ω0 = γB0. In practice, however, the electrons surrounding nuclei
in different molecular structures produce weak local magnetic fields that shield the
main field B0. This effect, known as chemical shift, results in an environment-specific
local reduction of the magnetic field, so nuclei that belong to different molecules
precess at slightly different frequencies, as described in Equation 3.23.
ω̂0 = ω0(1− δ) (3.23)
where ω̂0 is the resonance frequency for a nucleus with a shielding constant δ that
reflects its local chemical environment.
A well-known case of chemical shift occurs between water and fat. The most
abundant chemical structure in fat is the methylene bridge (-CH2-), whose protons
have a δ = 3.35 ppm compared to protons in water (H2O), resulting in a difference
in the Larmor frequency of 440 Hz at 3 T. Since the spatial position of the MR
signal is encoded by the frequency encoding gradient in the readout direction, the
difference in the Larmor frequency between the two species will produce a misregis-
tration in the image, as the water and fat signal coming from the same location get
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erroneously assigned to different locations. In order to suppress this artefact, a va-
riety of techniques can be used, that either saturate the signal coming from the fat,
or excite only the protons in water. Alternatively, the chemical shift effect can be
used to produce images that reflect the water and the fat content of an object. Both
approaches will be described in the next section in the context of CMRA imaging.
3.1.2 Coronary MR Angiography Imaging
MR has proven to be a robust and reliable technique for cardiovascular imaging,
providing detailed information about cardiac anatomy and function and allowing for
characterisation of myocardial tissue. As such, it has progressively been incorporated
into the guidelines of several cardiology associations worldwide for the diagnosis
and management of a variety of cardiovascular pathologies [54, 55]. Cardiovascular
MR is mentioned in 78% of the American Heart Association, the American College
of Cardiology and the European Society of Cardiology guidelines, with a total of
128 specific recommendations, mainly focused on the diagnosis and management of
stable coronary artery disease, hypertrophic cardiomyopathies, aortic disease and
congenital heart disease.
For instance, anatomical MR imaging is recommended to show the size, extent,
and shape of aortic aneurysms in great-vessel disease, myocardial stress imaging is
recommended in scenarios of stable coronary artery disease for evaluating ischaemia
and planning myocardial revascularisation therapy, and techniques such as cine MR
can be used to study valvular morphology, wall motion abnormalities and cardiac
function [56]. More recently, whole-heart CMRA has shown promising results for the
accurate depiction of the coronary anatomy, allowing the identification of anomalies
and aneurysms in the coronary arteries and non-invasive depiction of stenoses in
patients with multi-vessel coronary artery disease, as indicated in [57].
The aim of CMRA is to provide a high-resolution image with sufficient volumet-
ric coverage that allows visualisation of the coronary arteries. The acquisition of
such images presents several technical challenges. The complex physiological mo-
tion of the heart produces artefacts and blurring of the images, so compensation for
respiratory and cardiac motion is fundamental. Additionally, contrast between the
coronary blood pool and the surrounding epicardial fat and myocardium needs to be
Chapter 3. Cardiac PET-MR Imaging: An Overview 50
enhanced in order to properly visualise the arteries. Finally, given the small diameter
of the coronary arteries, in the range of 2.8 to 4.2 mm for healthy subjects [58], 3D
high-resolution images are required in order to visualise both normal and pathologic
vessels, with a spatial resolution typically in the order of 1 mm isotropic [59].
Cardiac Motion in CMRA
The effect of cardiac motion is conventionally minimised in CMRA by synchro-
nising the data acquisition with the cardiac cycle using an external ECG device.
Assuming that cardiac motion is periodic, data can be grouped according to their
position within the cardiac cycle to produce images with minimal cardiac motion.
There are two main approaches for performing this task, as shown in Figure 3.8.
In the first approach (Figure 3.8a), data are acquired only during a short time
window within each heartbeat over multiple cardiac cycles, and then combined into
a single k-space to produce a ‘motion-free’ image [60]. The R-wave is used as a
reference for triggering the start of the acquisition, so that the data acquisition
window coincides with a period of minimal myocardial motion. As described in
Chapter 2, this period often corresponds to mid-diastole for adults, with a duration
of ∼100 ms, while in paediatric patients or patients with variable heart rates the
end-systolic period may be preferable [61–64], which has the disadvantage of being
a shorter quiescent period (∼50 ms). In this approach, known as ECG triggered
acquisition, two subject-specific parameters are set by the MR operator: the trigger
delay and the duration of the acquisition window. Usually, these parameters are
visually identified from a high-temporal resolution 2D cine scan performed shortly
before the CMRA acquisition [65].
In the second approach, known as “free-running” acquisition (Figure 3.8b), data
are continuously acquired during the cardiac cycle. Using the ECG signal as a
reference, the data are then retrospectively sorted in a number of cardiac phases,
assuming that within each of them there is minimal cardiac motion, so that ‘motion-
free’ images can be reconstructed at each of these phases. The free-running approach
is widely used for 2D cine imaging, and it has been demonstrated for whole-heart
CMRA in combination with advanced undersampled and motion-compensated re-
construction techniques [66, 67].
Compared to the ECG triggered approach, free-running approaches have the ad-
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Figure 3.8: Two conventional approaches for minimising cardiac motion in CMRA.
(a) ECG-triggered segmented acquisition. In each cardiac cycle a segment of k-space
is acquired during a period of minimal motion, typically mid-diastole, so that k-space
is filled in a series of n subsequent cardiac cycles. (b) Free-running acquisition. Data
are continuously acquired and retrospectively sorted into m cardiac phases, each of
them with minimal cardiac motion.
vantage of not needing to prospectively define the length of the acquisition window
and trigger delay, reducing operator dependency during data acquisition. Further-
more, the cardiac phase with minimal motion can be found retrospectively, and
information from different cardiac phases can be used to obtain clinically relevant
parameters, including ventricular function indices, such as stroke volume and ejec-
tion fraction. However, since data are acquired continuously, the longitudinal mag-
netisation does not recover between consecutive excitations, resulting in a loss of
SNR in the images. Another disadvantage of free-running approaches is that in or-
der to fill multiple k-spaces, larger amounts of data are required, so total acquisition
time tends to be longer than for ECG triggered acquisitions.
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Respiratory Motion in CMRA
An approach analogous to ECG triggering can be used for minimising the effect of
respiratory motion, by using a signal related to the breathing cycle to combine data
acquired at a similar respiratory position during multiple breathing cycles. External
devices such as respiratory bellows can be used for respiratory gating, assuming a
high correlation between the motion of the heart and the motion of the chest wall.
Alternatively, the respiratory cycle can be monitored directly by interleaving one-
dimensional (1D) navigator echoes during the MR acquisition.
A navigator echo consists of an image representing a thin column of tissue that
can be used to monitor the position of a high-contrast moving structure, such as the
liver-lung interface, as shown in Figure 3.9c (in blue). When this interface is within
a predefined window, usually placed at end-expiration with a width of 3–5 mm [68],
the acquired data is accepted for image reconstruction, as depicted in Figure 3.9d.
Otherwise, the data is rejected and reacquired in a later cardiac cycle. The infor-
mation provided by the navigator echoes can also be used to further reduce motion
artefacts by correcting for motion within the acceptance window. This approach,
known as gating and tracking, assumes that the motion of the heart due to breathing
is predominantly a translation in the superior-inferior (SI) or foot-head (FH) direc-
tion, and that this translation is directly proportional to the displacement of the
diaphragm [41]. The linear factor that relates the displacement of the diaphragm
and the motion of the heart, known as tracking factor, is typically set to 0.6 based
on the study by Wang et al. [41].
The navigator echoes can be obtained by either using a spin-echo technique, as
originally proposed in [69], where the excitation and refocusing planes are angulated
so that the measured signal only arises from the intersection of the two planes (Figure
3.9b), or by applying a spatially selective 2D excitation pulse oriented in the FH
direction (so-called pencil-beam navigators) [70,71] (Figure 3.9a).
Although this approach is widely used in clinical settings due to its robustness,
it has several limitations. Firstly, the motion of the heart is not measured directly,
but it is inferred from the motion of the diaphragm. The population-based track-
ing factor of 0.6 is not appropriate for all subjects [44], so techniques that estimate
subject-specific tracking factors have been proposed [72, 73]. However, even with
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Figure 3.9: Diaphragmatic 1D navigator. An image of a thin column of tissue is
acquired at each heartbeat to monitor the respiratory position of the heart; by using
either (a) a ‘pencil-beam’ excitation or (b) two obliquely aligned excitations. (c) The
resulting navigator signal can be used to track the lung-liver interface. (d) When
the position of this interface is within a predefined acceptance window (in green),
the acquired data is accepted (green dots), otherwise, data is rejected (red dots).
subject-specific tracking factors, the 1D navigator approach only accounts for trans-
lational motion in the FH direction, and is incapable of including corrections for
translational motion in the anterior-posterior (AP) or right-left (RL) directions.
Furthermore, this approach does not account for the hysteresis effect described in
Section 2.2, as it uses the underlying assumption that a given position of the di-
aphragm is associated to a unique position of the heart, and it does not consider the
complex non-rigid deformations of the heart during the breathing cycle. Finally, the
efficiency of the acquisition (i.e. the percentage of acquired data that is accepted for
image reconstruction) varies significantly between subjects, typically ranging from
20 to 60%, which leads to increased and unpredictable acquisition times.
Alternatively, self-navigation methods that estimate the respiratory motion of
the heart from the acquired data itself have been proposed in the literature. These
methods derive a respiratory signal from a repeated acquisition of either the centre of
k-space [74] or a central line in k-space [75–77], usually acquired in the FH direction.
Compared to diaphragmatic navigator approaches, self-navigation methods have the
advantage of removing the need for a correction factor. However, they also perform
motion correction in the FH direction only. Furthermore, their ability to estimate
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a respiratory signal is impaired by the presence of static tissue, as both the centre
of k-space and the central line of k-space are projections of the whole field of view.
In order to address these limitations, respiratory motion compensation tech-
niques that use image-based navigators (iNAVs) have been proposed more recently in
the CMRA literature. By acquiring low-resolution 2D [78–81] or 3D images [82–87]
instead of the traditional 1D navigator, motion can be directly measured in the heart
by tracking a region of interest (ROI). The measured motion can be then used to cor-
rect the acquired CMRA data either prospectively or retrospectively, incorporating
most of the acquired data for image reconstruction (i.e. they achieve near 100% scan
efficiency), which leads to predictable and significantly reduced acquisition times.
A detailed description of methods that have been proposed for retrospective motion
correction in CMRA using iNAVs can be found in Section 3.3.
Contrast Generation in CMRA
In order to properly visualise the coronary arteries, sufficient contrast between the
arterial blood pool and the surrounding epicardial fat and myocardium is required.
The contrast between blood pool and myocardium can be enhanced by exploiting
the intrinsic properties of the tissues and/or by using exogenous contrast agents.
Intravascular contrast agents that reduce the T1 relaxation time of the blood pool
can be used in combination with magnetisation preparation pulses, such as a train
of dummy RF pulses [88] or an inversion recovery pulse [89], so that the signal from
the myocardium is strongly attenuated or nulled during the acquisition, while the
coronary blood pool appears bright.
Alternatively, the difference in the T2 relaxation time between the arterial blood
pool and the surrounding tissues can be used as an endogenous contrast mechanism
by including a T2 preparatory pulse (T2-prep) before the acquisition of imaging
data [90, 91]. A T2-prep consists of a 90◦ RF pulse that flips the longitudinal
magnetisation to the transverse plane, an even number of 180◦ RF refocusing pulses,
and a final 90◦ tip-up pulse (Figure 3.10a). For tissues with long T2 relaxation times,
such as the arterial blood (250 ms), this pulse has minimal effect. But for tissues with
short T2, e.g. the myocardium (50 ms), cardiac venous blood (∼35 ms) or epicardial
fat (100 ms), the T2-prep will strongly attenuate the longitudinal magnetisation.
Thus, during data acquisition, most of the measured signal is obtained from the
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Figure 3.10: Schematic of T2-preparation pulses of duration TE. (a) Conventional
non-adiabatic T2-prep (b) Adiabatic T2-prep. (c) Effect of T2-preparation in CMRA
at 3 T, non-adiabatic T2-prep shows high sensitivity to field inhomogeneities (top
row, arrows) while using an adiabatic T2-prep improves signal homogeneity, reduc-
ing image artefacts (bottom row). *CMRA images adapted with permission from
Nezafat R., et al. B1-Insensitive T2 preparation for improved coronary magnetic res-
onance angiography at 3T. Magnetic Resonance in Medicine 2006;55:858–864 [92].
arterial blood pool.
The original formulation of the T2-prep module for 3D CMRA at 1.5 T consid-
ered four RF refocusing pulses [91], showing promising results in healthy subjects
and patients. The tolerance of the T2-prep module to B0 and B1 inhomogeneities
depends on the number of refocusing pulses used, so at higher magnetic fields a
longer train of 180◦ RF is desirable. However, increasing the number of 180◦ RF
pulses results in an increased energy deposition to the patient (known as the spe-
cific absorption rate, SAR) for the T2-prep pulse, which prevents its use at 3 T.
Alternatively, adiabatic 180◦ RF pulses that are intrinsically insensitive to field in-
homogeneities can be used, as proposed in [92] (Figure 3.10b). In this study, it was
shown that CMRA image quality at 3 T is improved by using two adiabatic 180◦
RF refocusing pulses instead of the conventional train of four non-adiabatic pulses
(Figure 3.10c). Further advances in T2-preparation at 3 T have been recently been
proposed in the literature [93], where by using water-selective RF excitation pulses
an additional suppression of the fat signal is achieved.
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Fat Suppression in CMRA
The coronary arteries are embedded in a layer of epicardial fat for most of their
course. Fat has a shorter T1 relaxation time than the arterial blood, so signal arising
from the epicardial fat in T1-weighted CMRA sequences can obscure the visualisa-
tion of the coronary arteries if not adequately suppressed (Figure 3.11). The most
common approach for fat suppression in CMRA is based on the use of a spectrally
selective RF pulse before data acquisition [91, 94, 95], which relies on the chemical
shift and relaxation time differences between water and fat to null or minimise the
fat signal. This approach, known as SPIR, selectively saturates the signal arising
from protons by applying a frequency selective RF pulse, typically centred in the
resonance frequency of the methylene bridge, that partially or completely inverts the
fat magnetisation. After applying this inversion RF pulse, the signal arising from
the fat will start recovering due to longitudinal relaxation, reaching a null longitu-
dinal magnetisation after a short time. Then, by selecting an appropriate waiting
time, CMRA data can be acquired when the fat signal is nulled.
Although this technique has been shown to be robust at 1.5 T, adequately sup-
pressing the fat signal, its intrinsic sensitivity to field inhomogeneities can result
in incomplete fat suppression at higher magnetic fields [96]. Shimming techniques
that improve field homogeneity in a volume of interest can alleviate this problem,
producing good quality images as shown in [97,98].
Alternatively, the chemical shift between water and fat can be used to separate
the two species into images that reflect the water and fat content of each voxel in the
image, using so-called water/fat separation methods. The transverse magnetisation
Figure 3.11: Effect of fat suppression on CMRA imaging. (a) Appropriate fat
suppression allows for good depiction of the coronary arteries while in (b) incomplete
fat suppression (red arrows) obscures the visualisation of the vessels.
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in a voxel that contains water and fat can be written as
Mxy(t) = MWxy +MFxyexp(iδω0t) (3.24)
where MWxy and MFxy correspond to the transverse magnetisation arising from the
water and fat protons, respectively. In the original formulation of the water/fat
separation approach, proposed by Dixon in 1984 [99], data are acquired at two
different times: a first dataset is acquired when δω0t = 2nπ (in-phase echo) and a
second dataset is acquired at δω0t = (2n + 1)π (out-of-phase echo). By using such
times in Equation 3.24, it can be shown that the resulting magnetisation can be
written as
MIP = MWxy +MFxy (3.25a)
MOP = MWxy −MFxy (3.25b)
where MIP and MOP are the in-phase and out-of-phase transverse magnetisation,
respectively. From these two acquisitions, it is possible to obtain the signal arising
from the fat and water by adding and subtracting the two acquired signals, as shown
in Equation 3.26
2MWxy = MIP +MOP (3.26a)
2MFxy = MIP −MOP (3.26b)
This method, known as two-point Dixon, does not take into account the presence of
field inhomogeneities, which introduce an additional phase in the acquired data. In
order to solve the ambiguity produced by this additional phase, additional echoes can
be acquired, using so-called multi-echo or multi-point Dixon approaches [100, 101].
Alternatively, algorithms that estimate the field inhomogeneities from the two-point
data itself have been proposed in the literature [102, 103]. Furthermore, methods
that do not require exact in-phase and out-of-phase echoes have been proposed [104],
allowing for flexible echo times. The water/fat separation approach has been applied
to CMRA imaging, and it has been shown to improve image quality at 1.5 T [105]
and 3 T [106] compared to conventional spectrally selective fat saturation, increasing
SNR of the arterial blood and improving blood-to-fat contrast-to-noise (CNR) ratio
in the water images.
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Figure 3.12 shows a generic CMRA acquisition sequence, including the most
widely used mechanisms for compensating for cardiac and respiratory motion, and
for producing enough contrast between arterial blood and surrounding tissues.
Figure 3.12: Generic ECG-triggered CMRA sequence. Preparation pulses (PP)
to improve the contrast between blood and surrounding tissues are applied before
data acquisition: T2 preparation (T2-prep) improves the contrast between blood
and myocardium while fat saturation (Fat Sat) minimises the signal arising from
epicardial fat. A subject-specific trigger delay and a short acquisition window are
used to minimise cardiac motion, while different navigators (NAV) can be used
to compensate for respiratory motion, including diaphragmatic navigators (dNAV)
or image-based navigators (iNAV). 3D CMRA data are generally acquired with
a gradient echo sequence, or with a balanced steady-state free precession (SSFP)
sequence, depending on the strength of the magnetic field.
3.2 Cardiac PET Acquisition
PET is a non-invasive imaging technique that allows measurement of the spatial
distribution of the concentration of a positron-emitting radiopharmaceutical, ad-
ministered to a patient via injection or inhalation, in order to provide functional
information about a physiological process. Within the body, an emitted positron
annihilates with a nearby electron producing two photons travelling in opposite
directions, which can be subsequently detected by an array of detectors that con-
stitute the PET scanner. When two photons are simultaneously detected, using
so-called coincidence detection mechanisms, it is assumed that they originated from
the annihilation of a positron located somewhere along the line between the de-
tectors. By collecting enough such coincidences from sufficient angles around the
patient, and using some tomographic image reconstruction technique, the spatial
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distribution of the radiopharmaceutical concentration can be estimated, resulting in
a multi-dimensional PET image.
Due to the high sensitivity of radiation detectors, PET scanners can detect
even nanomolar concentrations of the radiopharmaceutical [107]. Therefore, trace
amounts of these compounds, also referred to as radiotracers or simply tracers, are
sufficient to produce PET images where the presence or absence of the radiopharma-
ceutical can be observed without disturbing the biological process being observed.
Furthermore, PET systems allow for absolute quantification of the concentration
of the radiotracer, providing objective measurements that can be used for accurate
monitoring of disease progression or evaluating response to therapy. This section
describes the basic principles of PET data acquisition, following the methodology
and terminology presented in Cherry et al [107], and then focuses on cardiac PET
imaging, including a brief description of the radiopharmaceuticals commonly used
for cardiac applications, acquisition protocols and conventional mechanisms used for
motion compensation.
3.2.1 Fundamentals of PET Imaging
Consider a positron-emitting radionuclide positioned within a PET scanner, as
shown in the schematic in Figure 3.13a. The radionuclide decays by emitting a
positron that undergoes mutual annihilation with an ordinary electron from the
surrounding atoms, after travelling some distance from the site of emission depend-
ing on its energy. This annihilation produces two 511 keV annihilation photons
travelling in approximately opposite directions.
These annihilation photons can be detected, typically by using scintillation-based
radiation detectors arranged in one or more rings, which register each detected pho-
ton as an event. When a pair of such events are recorded within certain coincidence
timing window (ranging from 6 to 12 ns for traditional PET systems, to 500 to 600 ps
for scanners with time of flight capabilities), it can be assumed that they resulted
from the same annihilation, and that the positron that originated them is located
somewhere on the line between the detectors. This annihilation coincidence detec-
tion (ACD) mechanism constitutes the basis of the PET measurement system. It
is worth noting that due to Compton scattering of the annihilation photons within
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Figure 3.13: (a) A positron-emitting radionuclide decays by emitting a positron (e+)
that annihilates with a neighbouring electron (e−) after following a tortuous path,
producing two annihilation photons (γ) travelling in opposite directions. (b) Resid-
ual momentum of the positron before annihilation slightly deflects the annihilation
photons, resulting in a noncolinearity effect. (c) The width of the detectors impacts
the spatial resolution of the system, as it is not possible to spatially distinguish
annihilations within certain distance. Note that in (b,c) the scale of the effects has
been exaggerated for illustration purposes.
the detector crystals, the ACD mechanism requires a wide energy window that not
only records 511 keV photons but also photons of lower energy. This energy window
typically ranges from 400 to 600 keV in conventional PET systems.
The spatial resolution of ACD systems is limited mainly by three factors. The
first of them, known as positron range, is related to the distance that positrons
travel before annihilation. After emission, the positron will follow a tortuous path
before annihilation, as depicted in Figure 3.13a, and the distribution of the effective
length of such paths, or effective positron range (i.e. the perpendicular distance
between the location of the positron emission and the line formed by the annihilation
photons) depends on the energy of the radionuclide involved, the electron density of
the medium surrounding the radionuclide, and the presence or absence of a strong
static magnetic field. Figure 3.14(a) shows the root-mean-square effective positron
range, Re+ , for radionuclides commonly used for in vivo PET imaging as a function of
their maximum energy measured in water, while Figure 3.14(b) shows the differences
in mean positron range for three of these radiotracers in absence of a surrounding
magnetic field and in presence of a 3 T magnetic field, for both water and lung tissue.
It is worth noting that the positron range decreases when the object being
scanned is placed in a strong magnetic field (such as the case of clinical 3 T PET-MR
systems). This reduction occurs in the plane perpendicular to the static magnetic
field of the scanner, resulting in a non-isotropic spatial resolution [108]. However,
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Figure 3.14: (a) Effective root-mean-square (rms) positron range as a function of
the positron energy, which ranges from a few hundred microns to a few millimetres.
Modified from [107], including data from [110,111]. (b) Mean positron range in both
water and lung tissue in absence of a magnetic field and at 3 T. Data from [108].
the effects of this anisotropic positron range are negligible for 18F-based radionu-
clides compared to the other factors that affect spatial resolution in conventional
clinical scanners [109].
The second factor that affects spatial resolution is the noncolinearity of the
annihilation photons. Due to a residual momentum of the positron at the end of
the path travelled after emission, the resulting annihilation photons get slightly
deflected, so that the line connecting the detectors is actually displaced from the
location of the annihilation, as illustrated in Figure 3.13b. The noncolinearity effect
can be modelled as a point-spread function, whose width increases linearly with
the distance between detectors, so that if a distance D separates the detectors, the
full-width at half-maximum (FWHM) of this function is given by
Rnonc = 0.0022D (3.27)
The third factor that plays a role in spatial resolution is the width of the detec-
tors, as shown in Figure 3.13c. For a radionuclide located in the middle of the line
that connects two detectors of width d, the contribution of this effect in terms of




Finally, the spatial resolution of the system, Rsys can be obtained by combining
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the three factors described above, as shown in Equation 3.29. This value represents
the FWHM of the overall point-spread function of the detector system.
Rsys =
√
R2e+ +R2nonc +R2size (3.29)
Depending on the configuration of the system, some of the three described fac-
tors are negligible compared to others. For instance, in whole-body PET scanners
(D = 60 cm, d = 4 mm) using 18F based radiotracers; the dominant factor defining
the detector system resolution is the detector size, resulting in an overall Rsys of
∼2.4 mm. It is worth noting that although the effects described here only refer to
the intrinsic spatial resolution of the ACD system, the spatial resolution of resulting
PET images is affected by additional factors, including the location of the radionu-
clide within the field of view, the level of activity within the field of view, and the
algorithm used for image reconstruction, among others.
The limited spatial resolution of the ACD system is not the only factor that af-
fects PET image quality. So far, it has been assumed that the detected coincidences
arise exclusively from the emission of two annihilation photons travelling directly to
the detectors, as shown in Figure 3.15a. However, unwanted coincidences may occur
when photons from unrelated annihilations are detected within the coincidence tim-
ing window, as depicted in Figure 3.15b. These coincidences are known as random
coincidences, and their spatial distribution depends on the area of the body being
imaged and the radiotracer distribution. For thoracic and abdominal imaging, it is
generally assumed that they occur approximately uniformly across the field of view
of the scanner. Additionally, one or both annihilation photons may scatter with-
out a significant loss of energy due to Compton scattering, producing an erroneous
coincidence detection (Figure 3.15c).
Whereas the rate of random coincidences increases linearly with the duration of
the coincidence timing window and with the square of the administered radioactiv-
ity, both true and scatter coincidences increase linearly with the activity and are
roughly independent of the length of the coincidence timing window. Both ran-
dom and scatter coincidences raise the background noise, degrading the PET image
contrast, so mechanisms to correct for their effect are required to produce accurate
quantitative PET images.
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Figure 3.15: Types of coincidence in PET imaging. (a) True coincidences, (b) ran-
dom coincidences, arising from near simultaneous detection of photons from unre-
lated annihilations, and (c) scatter coincidences, occurring when one or both photons
scatter with minimal loss of energy.
Two methods are conventionally used for estimating random coincidences: the
delayed coincidence window and the singles method. In the first method, the ACD
mechanism is slightly modified so that the coincidence timing window is delayed by a
time much longer than its duration. Such a delay ensures that no true or scatter, but
only random coincidences are recorded, and by using the assumption that the rate of
random occurrences in the undelayed and delayed coincidence timing window is the
same, the rate of random coincidences can be estimated. Alternatively, if knowledge
about the rate of single photon detections is available for each detector, the rate of
random coincidences for a pair of detectors r(i, j) can be estimated by
r(i, j) = 2rirj∆T (3.30)
where ri is the rate of single photon detections in detector i and ∆T is the duration
of the coincidence timing window.
The rate of scatter coincidences depends on several factors, including the den-
sity and geometry of the object being scanned, the density of the photon detector
material, the amount of radioactivity administered, and the width of the energy
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acquisition window of the PET scanner. Several methods have been proposed to
estimate scatter coincidences, including approaches based on using multiple energy
acquisition windows and methods that directly simulate the scatter distribution us-
ing analytic models or Monte Carlo simulations of the photon-matter interactions.
A detailed description of such methods can be found in the comprehensive reviews
by Zaidi and colleagues [112,113].
Considering the described ACD mechanism and neglecting for a moment the ran-
dom coincidences and scattering effects, the total number of coincidences registered
for a particular pair of detectors corresponds to the line integral of the radiotracer
distribution along the line defined by the centre of both detectors, L, the so called
line of response (LOR). For 2D PET imaging the LORs can be parameterised by
their angle θL and the distance dL to the centre of the detector ring, as shown in
Figure 3.16. Usually, measured PET data is stored in an array, known as sinogram,
where each row represents one projected view of the radiopharmaceutical distribu-
tion at an angle θL across a range of distances dL. For 3D PET imaging, each LOR
can be described by adding a third parameter that corresponds to the angle of the
LOR relative to the long axis of the scanner, so that a set of sinograms parameterised
by this angle is obtained. Alternatively, PET raw data can be stored as a list-mode
file, where each coincidence is recorded indicating the time of the coincidence event
and the corresponding pair of detectors.
Considering the 2D case illustrated in Figure 3.16, the relationship between the




δ(x cos(θL) + y sin(θL)− dL)ρ(x, y)dxdy (3.31)
It can be observed from Equation 3.31 that when using a purely geometric model
for the PET data acquisition, the measured PET data corresponds to the Radon
transform of the spatial distribution of the radiotracer concentration. Therefore,
the problem of estimating such a distribution could be solved by collecting enough
projected views and then using some mathematical transformation for inverting
Equation 3.31. These techniques, referred to as PET image reconstruction, will be
described in detail in Section 3.4.
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Figure 3.16: Example of lines of response (LORs) for a 2D PET system. Each LOR
can be parameterised by the angle θL (L = 1, 2 in this example) and distance dL.
It is worth noting that the simple model presented in Equation 3.31 does not
account for all the physical effects that characterise the PET acquisition process.
For instance, the effect of random and scattered coincidences is not considered. Fur-
thermore, this model assumes that each pair of detectors has an identical sensitivity
so that the rate of coincidences only depends on the spatial distribution of the radio-
tracer. In practice, however, the sensitivity of the individual photon detectors of the
PET scanner will affect the number of coincidences registered in each LOR. In order
to take this effect into account, a known radiation source can be used, so that the
sensitivity of each pair of detectors can be estimated from the corresponding number
of coincidences acquired in the phantom scan. This information can be then used
to normalise the number of coincidences recorded by each pair of detectors before
PET image reconstruction.
Additionally, some of the photons will be absorbed before reaching the detectors,
reducing the number of coincidences registered for most of the LORs. The well-
known Beer-Lambert law states that the probability that both annihilation photons
reach a pair of detectors is given by









where µ(x) are the linear attenuation coefficients of the tissues in the path L that
photons travel in their way to the corresponding detectors.
These attenuation coefficients depend on the objects within the gantry of the
scanner, including the subject being scanned, and as such are patient-specific. They
are commonly obtained by properly scaling a simultaneously acquired computed
tomographic (CT) image for PET-CT systems [114, 115] or can be inferred from
anatomical MR images in hybrid PET-MR systems [116].
While CT-based attenuation correction is based on using CT images in Hounsfield
units to estimate the density of tissue, and therefore estimate linear attenuation co-
efficients at 511 keV, MR imaging does not provide a direct measurement of tissue
density. Since MR images have a superior tissue contrast, MR-based attenuation
correction are typically based on segmenting the acquired MR image into a number
of tissue classes, so that known attenuation values are assigned to each class. Al-
though several methods for MR-based attenuation correction have been proposed in
the literature in recent years, only a handful of them have been approved by reg-
ulatory agencies for routine clinical use. Indeed, commercially available PET-MR
systems use either a 3-class (air, soft-tissue and lungs) or a 4-class (air, fat, soft-tissue
and lungs) segmentation-based method for creating attenuation maps [117].
Nonetheless, the segmentation-based approach has several limitations. First, in
most cases it does not account for bone tissue, introducing bias particularly when
imaging areas of the body with abundant presence of bones, such as in brain PET
imaging. Second, the assumption that there is a unique attenuation coefficient for
each tissue class further limits the accuracy of this approach. For instance, lung
tissue has a high variability across different patient populations, within each pa-
tient, and even throughout the breathing cycle due to the changes on the air volume
within the lungs [118,119]. Several studies have shown that the use of fixed attenu-
ation values for lung tissue in MR-based attenuation correction results in bias in the
quantification of lung lesions [120] and volumes of interest within the lungs [121].
Although the bias induced by assuming a fixed attenuation value of the lung tissue
affects the whole PET image, this effect has been shown to be less significant in
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cardiac structures. For instance, a recent study focused on cardiac imaging showed
no statistically significant differences in average myocardial uptake when compar-
ing PET-CT and PET-MR using MR-based attenuation correction [122]. Finally,
additional challenges for MR-based attenuation correction in the context of car-
diac PET-MR imaging result from the extensive use of Gadolinium-based contrast
agents. Changes of up to 1.3% in linear attenuation coefficients due to varying
concentrations of contrast agent have been reported in [123]. Furthermore, if the
contrast agent is injected before the acquisition of the MR-based attenuation map,
potential errors in the segmentation can be produced due to tissue misclassification
arising from T1 shortening [124].
3.2.2 Cardiac PET Imaging
In cardiac imaging, PET has been established as the reference modality for assess-
ing myocardial integrity through the use of different radiotracers including 13N-NH3
(13N-ammonia), 82Rb, 15O-H2O and 18F-fluorodeoxyglucose (18F-FDG). A summary
of the main characteristics of these radiotracers is presented in Table 3.1 (modified
from [22,125]). The first three radiotracers are commonly used to quantify myocar-
dial perfusion, as hypoperfused areas may indicate the presence of obstructive coro-
nary artery disease. While both 13N-NH3 and 82Rb accumulate in the myocardium,
15O-H2O diffuses freely across cell membranes and capillaries, requiring post pro-
cessing of the images in order to subtract the signal arising from the blood pool.
For this reason, 13N-NH3 and 82Rb are more commonly used in clinical practice [15].
Furthermore, their relatively short physical half-life allows imaging of myocardial
perfusion in both rest and stress during a single scanning session, including a wait-
ing period for full decay of the radiotracer between both scans, with a total duration
from 30 to 120 minutes depending on the radiotracer used [22].
As mentioned before, myocardial perfusion PET imaging allows for a highly
accurate diagnosis of CAD, with 93% sensitivity and 92% specificity, according to a
review of studies including ∼800 patients [22]. However, perfusion imaging does not
allow regions of infarcted myocardium to be distinguished from those of hibernating
myocardium that have a potentially reversible dysfunction. Given that hibernating
myocardium exhibits an active glucose metabolism, 18F-FDG (a glucose analogue)











0.7 mm 10 min Cyclotron 10–20
82Rb Na/K-ATPase
(perfusion)
2.6 mm 78 s Generator 8
15O-H2O Free diffusion
(perfusion)
1.1 mm 2 min Cyclotron 5
18F-FDG Glucose transport
(viability)
0.2 mm 110 min Cyclotron up to 45
Table 3.1: Characteristics of commonly used radiotracers for cardiac PET imaging.
can be used to distinguish hibernating from infarcted myocardium, highlighting
areas that could benefit from revascularisation therapy [126].
The acquisition of 18F-FDG PET images that reflect the glucose uptake in the
myocardium is challenging because under normal conditions this muscle derives its
energy from a variety of sources [127], leading to a very heterogeneous pattern of
radiotracer uptake. Different preparation strategies have been proposed in order to
standardise the metabolic conditions for 18F-FDG myocardial viability imaging, en-
hancing radiotracer uptake and improving image homogeneity. These preparation
strategies include instructing the patient to fast for up to 12 hours before exam-
ination, use of oral glucose loading for stimulating insulin secretion, hyperinsuli-
naemic clamping for enhancement of glucose/18F-FDG utilisation, or a combination
or them [128,129].
Alternatively, if the normal physiological glucose metabolism is suppressed, 18F-
FDG can be used for imaging inflammatory response in the myocardium, reflecting
only the increased glucose uptake by macrophages and other inflammatory cells.
This suppression can be achieved by prolonged fasting (more than 12 hours), by pre-
scribing a high-fat low-carbohydrate and protein-permitted diet for approximately
24 hours before examination, by intravenous administration of unfractionated hep-
arin, or a combination of the latter two [51]. Such patient preparation has allowed
the use of 18F-FDG for the diagnosis and characterisation of several conditions,
including cardiac sarcoidosis [130] and myocarditis [131].
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82Rb, 13N-NH3 and 18F-FDG are the most widely used radiotracers for cardiac
PET imaging in clinical practice. However, the flexibility of PET to target spe-
cific molecular processes has stimulated the development of novel radiotracers for
targeting different mechanisms of cardiovascular disease, as shown in Table 3.2 [132].
Radiotracers Target Disease/Condition













18F-MISO Tissue hypoxia Atherosclerotic plaque
18F-galacto-RGD Angiogenesis Atherosclerotic plaque





11C based 11C-hydroxyephedrine Denervation in
the myocardium
Ischaemic heart disease and
heart failure








Macrophages Vascular inflammation in
atherosclerosis
68Ga-NOTA-RGD Angiogenesis Atherosclerotic plaque
64Cu-ATSM [134] Tissue hypoxia Myocardial ischaemia
Table 3.2: Novel radiotracers for cardiac PET imaging, modified from [132].
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Of particular interest for CAD are the promising results obtained by using 18F-
sodium fluoride (18F-NaF) for identifying high-risk and ruptured atherosclerotic
plaque [8, 135, 136]. Further studies in larger cohorts of patients are required for
assessing the clinical impact of this new radiotracer in terms of improving risk strat-
ification and monitoring of disease progression.
Independently of the radiotracer used, the acquisition of cardiac PET images is
much slower than physiological motion, typically 8 min for 82Rb, 20 min for 13N-NH3
and up to 45 min for 18F-based radiotracers [15,137]. Therefore, motion compensa-
tion techniques are required to reduce image quality degradation due to the effects
of cardiac and respiratory motion. Similarly to MR, the most common approach to
minimise the effect of cardiac motion in PET is the use of an external ECG device
to synchronise the acquisition with the cardiac cycle and sort the acquired data into
time frames of 50 to 100 ms, representing different cardiac phases.
For respiratory motion compensation, devices such as respiratory bellows, pa-
tients’ airflow thermometers and visual tracking systems, can be used to obtain a
surrogate signal for respiratory gating [138]. By using a dual-gating approach, i.e.
sorting the data according to both the cardiac and respiratory position where it was
acquired, a set of nearly motion-free datasets can be obtained. However, since only
a fraction of the total detected counts is used for image reconstruction, the SNR of
each of these datasets is highly reduced. In static PET imaging, a sufficient number
of detected counts can be obtained in each motion-free dataset by increasing the
acquisition time. However, for dynamic PET studies this approach is not suitable;
since the aim of such studies is to obtain temporal information about the radiophar-
maceutical distribution, increasing the total acquisition time would not improve the
SNR of the individual gated datasets.
Alternatively, when information about the motion during the acquisition is avail-
able, such information can be used to correct the acquired PET data retrospectively
by incorporating the motion in the image reconstruction process, as will be described
in Section 3.4. The cardiac and respiratory motion information can be obtained from
the PET data itself, when the radiotracer distribution provides sufficient informa-
tion, or from simultaneously acquired MR anatomical images in hybrid PET-MR
systems.
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3.3 MR Image Reconstruction
MR image reconstruction refers to the mechanisms used for obtaining an image that
reflects the spatial distribution of the magnetisation and/or tissue properties from
the induced signal that constitutes the measured MR data. This section describes
conventional MR image reconstruction algorithms, first describing reconstruction as
an inverse problem, and then focusing on widely used algorithms for fully sampled,
undersampled and motion-corrected reconstruction.
As described in Section 3.1, MR data is measured in the spatial frequency do-
main, which is related to the spatial distribution of the magnetisation M0(~r) by the







where S(~k) represents the signal measured in k-space and F{·} represents the Fourier
transform. Although Equation 3.33 provides a continuous description of MR data
acquisition, in practice, MR systems acquire a discretised and quantised signal,
resulting in a finite number of discrete samples of k-space being acquired. The
sampling process can be written as a multiplication of Equation 3.33 by a train of
Dirac delta functions, as shown in Equation 3.34a, where ~kn is the discrete frequency
space position where the nth sample of k-space was acquired and ~∆k is the spacing
between samples. Using the convolution theorem, it can be shown that sampling in
k-space results in replicating the image periodically, with each replica separated by
1/~∆k as shown in Equation 3.34b. In order to avoid overlapping replicas that would
distort the reconstructed image, a given sampling density in k-space imposes a limit
on the size of the object being imaged. Conversely, for a finite image of width ~rw,
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The effect of acquiring a finite number of samples Ns in each dimension of k-space
can be written as a multiplication in k-space by a box function of width Ns~∆k, which
















From Equation 3.35 it can be observed that, given a fixed ~∆k, limiting the
number of acquired samples limits the spatial resolution of the image, as the image
of a point source will be spread according to the width of the sinc function. The
spatial resolution of the image is thus given by ~∆r = 1/Ns~∆k. A further effect of the
limited sampling in k-space is the so-called Gibbs ringing artefact, which appears
as an oscillating over- and undershoot in areas of the image with sharp transitions
due to the convolution with a sinc function.
The described relations between k-space and image space are both instances of
the Nyquist’s sampling theorem, where the extension of k-space (i.e. the maximum
frequency sampled) defines the resolution of the reconstructed image, and the density
of samples in frequency space defines the extension of the image. Thus, for a desired
field of view (FOV) and image resolution, a defined number of samples with a specific
spacing are to be acquired, as depicted in Figure 3.17
When all of the required samples are acquired, the k-space is said to be fully
sampled, and image reconstruction can be performed by using the inverse discrete
Fourier transform. An underlying assumption when obtaining an image using this






where φj(~r) are a collection of non-overlapping basis functions, most commonly
voxels, and xj is the value in the jth voxel, namely the intensity value that in MR
can be represented in general as a complex number.
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Figure 3.17: Relationship between the extension and resolution in k-space and image
space. The spacing between the samples acquired in k-space defines the extension
of the field of view (FOV) in the image space, while the extension of k-space defines
the resolution in image space.
Thus, Equation 3.33 can be re-written as a matrix vector product, as shown in
Equation 3.37, where k represents the sampled k-space, F is the discrete Fourier
transform operator, and x is a J-dimensional vector containing the voxel intensities
of the discretely sampled image. Using this representation, the MR acquisition
model can be written as a system of linear equations, and therefore, MR image
reconstruction can be studied as a linear inverse problem.
k = Fx (3.37)
In general, any mathematical problem can be classified as being correctly posed
or incorrectly posed, and this will have implications on how difficult it is to solve
such a problem. According to Hadamard [139], a problem is said to be correctly or
well-posed when it meets the following three requirements
1. A solution exists
2. The solution is unique
3. The solution is stable
In the context of MR imaging, the first condition is generally true, because
the data is acquired from a real object. However, noisy measurements can lead to
Chapter 3. Cardiac PET-MR Imaging: An Overview 74
inconsistencies in Equation 3.37. This issue can be solved by reformulating MR
image reconstruction as a minimisation problem
xLS = arg min
x
‖Fx− k‖22 (3.38)
where xLS is the least squares solution. This minimisation has a closed form solution
given by
xLS = (FHF)−1FHk (3.39)
where (·)H denotes the Hermitian transpose of a matrix.
The second of Hadamard’s conditions is rarely met in MR imaging. As de-
scribed above, the discrete sampling in k-space results in replicas of the object
in image space. Therefore, there are multiple images that will produce the same
data measurements. Similarly, given the characteristics of the Fourier transform,
small perturbations in the measured k-space, result in errors across the whole re-
constructed image, particularly in low SNR cases. Therefore, the third condition
is also usually unmet, so that in general MR image reconstruction is an ill-posed
problem.
In order to improve the posedness of the MR reconstruction problem, prior knowl-
edge or prior assumptions about the object being imaged can be incorporated into
the minimisation problem described in Equation 3.38. This approach is widely
known as regularisation, and it has been successfully used in MR image reconstruc-
tion in a variety of contexts, particularly for highly undersampled acquisitions. Some
of the most widely used assumptions for regularised MR image reconstruction are
that images have minimum energy, which can be expressed as the L2 norm of the
image, or that the images are sparse in some domain, which can be expressed as the
L1 norm of the transformed image. Both of these approaches result in more stable
solutions than the un-regularised problem, however, they require finding an appro-
priate balance between how well the reconstructed image matches the acquired data
(known as data consistency) and how well the image meets the defined assumption.
Since regularisation methods were not used in this thesis, they are not described in
further detail here, but relevant applications to cardiac MR imaging can be found
in [140–144].
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It is worth noting that for the fully sampled case under normal SNR conditions,
the solution in Equation 3.38 provides a good estimate of the acquired MR image.
However, the inversion of the matrix FHF in Equation 3.39 is computationally ex-
pensive. Alternatively, iterative methods to find xLS can be used. One such method
is the well-known conjugate gradient (CG) approach [145], that will be briefly de-
scribed here.
Considering a general linear problem
Qx = b (3.40)
with Q ∈ Rn×n a positive definite matrix. The CG method will converge to xLS in
a finite number of steps by successively minimising the residual r = b −Qx along
an optimal set of directions p. At each iteration, the algorithm moves towards
xLS along a new direction, orthogonal to all previous search directions. The steps





x(it+1) = x(it) + λ(it)p(it) (3.41b)
r(it+1) = r(it) − λ(it)Qp(it) (3.41c)




It is worth noting that the CG algorithm can use any arbitrary initial guess for
x(0). Therefore, in general, the first residual and direction for minimisation, r(0) and
p(0) respectively, can be written as
r(0) = b−Qx(0) (3.42a)
p(0) = r(0) (3.42b)
In the context of MR image reconstruction, the CG algorithm is generally
stopped when the norm of the residual is less than a certain threshold or after
a pre-defined number of iterations.
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3.3.1 Iterative SENSE for Undersampled MR Reconstruction
Despite its potential to produce high-resolution images, MR performance is limited
by acquisition time, as a limited number of k-space samples can be acquired within a
reasonable scan time. In order to overcome this limitation, undersampled acquisition
schemes and specialised reconstruction techniques have been proposed to reduce
scan time without degrading image quality or to improve image resolution without
significantly increasing acquisition time.
Techniques such as SMASH [146], SENSE [147] and GRAPPA [148] pioneered
the field of parallel imaging undersampled MR reconstruction, by using spatial in-
formation obtained from the sensitivity of multiple receiver coils to partially recover
samples not acquired in k-space. The basic concept behind the SENSE method is
depicted in Figure 3.18, where information from the sensitivity of the receiver coils,
known as coil sensitivity maps, is used to unfold aliased images acquired with a
regular undersampling pattern, i.e. an MR acquisition scheme where k-space lines
are skipped at regular intervals.
The SENSE approach can be generalised to other undersampling schemes, in a
method known as iterative SENSE. The iterative SENSE method, originally pro-
posed in [150], is discussed here in more detail as it is used for MR image recon-
struction throughout this thesis. The acquisition model described by Equation 3.37
assumes a unique receiver coil with a uniform sensitivity over all the acquired field
of view. In practice, multiple receiver coils with spatially dependant sensitivities
detect the MR signal, thus, for a system with NC receiver coils (also called chan-
nels), NC measurements of k-space are acquired simultaneously. Each of them can
be described as
kn = FCnx ∀n = 1...NC (3.43)
Knowledge about the coil sensitivities Cn can be obtained by acquiring additional
MR measurements with a so-called body coil and information from images recon-
structed for each channel [147], or estimating them from the MR data itself [151,152].
Once knowledge about the coil sensitivities is available, images reconstructed sepa-
rately for each channel can be combined by weighting them appropriately, maximis-
ing the signal to noise ratio of the resulting combined image [153]. Alternatively, as
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Figure 3.18: SENSE reconstruction method for undersampled MR imaging. Under-
sampled data are acquired, resulting in aliased images with a reduced field of view
(b). By using information from acquired coil sensitivity maps (a), an unfolded im-
age with full field of view can be obtained (c). Reprinted from Griswold M.A. Basic
Reconstruction Algorithms for Parallel Imaging. In: Schoenberg S.O., Dietrich O.,
and Reiser M.F., editors. Parallel Imaging in Clinical MR Applications. Springer
Berlin Heidelberg 2007 [149].
proposed in the iterative SENSE method, the additional information provided by
the multiple coils can be used to reduce the required number of samples. By apply-
ing a sampling mask S that defines which samples of k-space are to be acquired, the
MR acquisition can be modelled as
k = SFCx (3.44)
where k is now a vector that contains the NC undersampled k-spaces concatenated,
and similarly C contains the corresponding sensitivities for the NC receiver coils.
Although in some cases direct inversion of Equation 3.44 can be used to compute
an estimated image x, this is even more computationally expensive than in the
single coil case, with a number of operations on the order of N6 for reconstructing
a N ×N 2D image [150]. Alternatively, x can be iteratively estimated by using the
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CG method described above. In order to apply the CG method, Equation 3.44 has
to be rewritten as
(QHEHDEQ)x′ = k′ (3.45)
with x′ = QHx, k′ = QHEHDk. E = SFC is known as the encoding matrix, and
includes the coil sensitivities, the Fourier operator and the sampling mask used,
Q is a matrix compensating for the coil sensitivities and D takes into account the
inhomogeneous sampling density in k-space.
3.3.2 Motion-Compensated MR Reconstruction
The iterative SENSE method, as well as the MR acquisition model presented so
far, assumes that the object being scanned remains static during the acquisition. In
practice, for many MR applications such as cardiac imaging, physiological motion
occurs during data acquisition. Respiratory and cardiac motion during MR acqui-
sition results in image artefacts whose effect depends on the region of k-space being
sampled. For example, if motion occurs when the outer region of k-space is being
sampled (i.e. when sampling higher spatial frequencies), the artefacts will appear as
blurred edges of the moving object, and the severity of the artefact will depend on
the amplitude of the motion. On the other hand, if motion occurs during the acqui-
sition of the central region of k-space, the whole image is affected, and in extreme
cases this could result in ghosting and severe image degradation.
As described in Section 3.1, effects of motion can be minimised in CMRA imaging
by acquiring data only in a predefined cardiac and respiratory phase. Alternatively, if
knowledge about the motion that occurs during the MR data acquisition is available,
its effect can be compensated for during image reconstruction.
Depending on the nature of the motion, there are different approaches that can
be used for motion correction in MR reconstruction. For instance, if the motion
can be represented by a translation of the object, so that the moved image can be
written as
xb(~r) = x(~r −∆~rb) (3.46)
where x is the object in a reference position and ∆~rb is the translation vector that
moves the object from the reference position to a motion state b, then by using
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the definition of the Fourier transform it can be shown that the sampled k-space at
motion space b, kb, is related to the Fourier transform of the object at the reference
position, k, by
kb = Sbk exp(−2πi~u∆~rb) (3.47)
where ~u contains the spatial frequency coordinates of the sampled point in k-space,
and Sb is a sampling matrix containing the information of which samples were ac-
quired at each motion state b. From Equation 3.47 it can be observed that it is
possible to correct each motion state to the reference position by applying an ap-
propriate linear phase shift. Then, by aggregating all of the motion states together,











FCx = SFCx (3.49)
It is worth noting that once the phase corrections in k-space have been ap-
plied, solving Equation 3.49 does not require knowledge about the motion, and any
conventional reconstruction technique, such as the CG iterative SENSE technique
described above, can be used to estimate the motion-corrected image.
A similar formulation can be used for correcting rotation, shearing and scaling
in k-space, allowing for this k-space motion correction technique to compensate for
3D affine motion. This approach has been successfully applied to free-breathing
CMRA for respiratory motion compensation, where 2D and 3D iNAVs acquired at
each heartbeat have been used to estimate translational or affine motion and correct
each segment of k-space acquired, in a beat-to-beat fashion [78, 80, 83, 154]. In this
approach, each heartbeat is in principle considered as a different motion state, so
the total number of motion parameters to estimate scales linearly with the total
number of heartbeats and subsequently, with the length of the acquisition.
Other approaches have used 1D diaphragmatic navigators [155] or self-navigation
[156] for sorting the data into a number of respiratory bins, and estimating affine
motion from images reconstructed at each respiratory position. These approaches
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apply the motion correction in a bin-to-bin fashion, reducing the total number of
motion states to ∼3 to 6. However, depending on the size of the respiratory bins,
this approach can result in residual intra-bin motion, that can affect the estimation
of the motion parameters and the subsequent correction. More recently, approaches
based on 2D iNAVs for a combined beat-to-beat 2D translational motion correction
with bin-to-bin 3D affine motion correction have been proposed for CMRA [157].
The k-space correction approach is limited to a motion model where the entire
object contained in the field of view is affected by a unique affine transformation.
In practice, however, different tissues and organs move differently during MR data
acquisition. In particular for 3D CMRA, there are some regions of the image that re-
main mostly static during the acquisition, such as the spine, arms and subcutaneous
fat; and different organs, such as the stomach, the liver and the heart, are affected
differently by the expansion and contraction of the lungs during the breathing cycle.
Therefore, applying a global k-space correction using motion parameters estimated
by tracking the heart will induce ghosting and artefacts arising from an erroneous
correction of the surrounding organs and tissues.
This issue can be alleviated by using a more general motion model, where each
voxel in the field of view is allowed to move freely between different motion states.
This motion model then allows for local arbitrary deformations of any magnitude
and orientation, including for some regions to remain static (i.e. without any mo-
tion). Such motion model, known as non-rigid motion, does not have an equivalent
description in k-space, and therefore it cannot be corrected using the approach de-
scribed above.
Alternatively, non-rigid motion can be included directly in the image acquisition
model, as described by Batchelor et al. [158], using a General Matrix Description
(GMD) formulation. This approach assumes: 1) that k-space data are acquired in
a number of shots, 2) that the motion within each shot is negligible, and 3) that
information about the motion of the object relative to a reference position is known
for each shot. Using these assumptions, the static MR acquisition model presented
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where kc represents the motion-corrupted acquired data, Sb represents the sampling
mask containing the shots acquired in motion state b, and Ub is a motion operator
that transforms the object in the reference position to the motion state b. A motion-
corrected image xMC can then be directly estimated by solving
xMC = arg min
x
‖Ex− kc‖22 (3.51)





Using a formulation similar to Equation 3.45, Equation 3.51 can be solved with
the previously described conjugate gradient approach. The GMD approach has been
successfully applied to ECG-triggered CMRA imaging in a conventional 1.5 T MR
system [159], and that work constitutes the starting point for the MR reconstruction
approach used in this thesis.
3.4 PET Image Reconstruction
PET image reconstruction refers to the mechanisms used for obtaining an image that
reflects the spatial distribution of the radiotracer concentration from the measured
projections that constitutes the measured PET data. This section describes con-
ventional PET image reconstruction algorithms, including a brief description of the
PET acquisition model, and then focusing on iterative reconstruction and options
for motion compensated PET image reconstruction.
Considering the measurement model presented in Equation 3.31 as starting point,
and using a discrete object approximation for the radiotracer spatial distribution
similar to the one presented in Equation 3.36, the acquisition model can be written
as a matrix-vector product
m = Pρ (3.53)
where the matrix P, usually called the system matrix, contains in each of its elements
pi,j information about the contribution of positrons emitted at the spatial location
j to the LOR i, m is a column vector of length I that contains the total number of
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coincidences detected for each LOR, and ρ is a vector of length J that represents
a discretised version of the spatial distribution of the radiopharmaceutical, also
known as the emission map. This model is widely known as forward projection or
the forward model.
This simple model can be extended to include the physical processes that occur
during PET acquisition as described in Section 3.2. For instance, a diagonal matrix
N, known as the normalisation matrix, can be included in the forward model in order
to account for the variations in the sensitivity of the individual photon detectors
of the PET scanner. Similarly, the effect of attenuation coefficients in each LOR
can be arranged in a diagonal matrix A to be included in the model. Finally, as
described in Section 3.2, background coincidences may occur due to scattering of one
or both annihilation photons or due to random detection of photons from unrelated
positron annihilations. These effects can be accounted for in the measurement model
by including an additive term b. Including all these effects, a more complete and
realistic forward model can be obtained (Equation 3.54).
m = NAPρ + b (3.54)
The image reconstruction problem consists then in estimating ρ given m and
knowledge of the physical model (N, A, P, b). Similarly to Equation 3.39, a
straightforward method to do this is to use an analytical reconstruction approach
so that
ρ̂ = (PTP)−1PT(NA)−1(m− b) (3.55)
It is worth noting that the matrix P is not necessarily square, as the number
of image voxels J is in general smaller than the number of measurements I for
3D PET imaging, and thus a direct inversion of the system matrix is not possible.
Moreover, given that for modern PET systems both I and J are in the order of
1× 104 to 1× 106, the inversion of (PTP) is computationally expensive, and in
most cases not possible, as the system matrix P is rarely full rank. Finally, this
reconstruction approach might produce physically unrealistic negative values in the
radiopharmaceutical distribution due to the subtraction of estimated background
coincidences in regions of low or null radioactivity.
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Alternatively, statistical iterative PET reconstruction can be performed by mod-
elling the acquisition process using Equation 3.54 and using a series of forward-
projection (P) and back-projection (PT) operations that result in a reliable and
realistic estimate of ρ.
3.4.1 Statistical PET Reconstruction
The nature of PET data acquisition, based on counting inherently random occur-
rences of positron annihilations, results in randomness in the measured data, which
can be statistically modelled as a collection of conditionally independent random
Poisson processes. The conditional probability of observing mi coincidences in sino-





Considering that every qi is a function of the radiotracer distribution ρ, as shown
in the forward model in Equation 3.54, the likelihood of ρ given the set of measure-







A reasonable choice for estimating ρ in this context is to maximise O(ρ|m),
i.e. to estimate the most likely radiotracer spatial distribution given the acquired
projections. In order to make the function easier to maximise, the log-likelihood
can be used instead; since ln(·) is a monotonically increasing function, any estimate
that maximises ln(O(ρ|m)) will maximise O(ρ|m). Thus, the maximum-likelihood
estimator for ρ can be written as




(mi ln(qi(ρ))− qi(ρ)) (3.58)
Equation 3.58 does not have an analytical solution. Instead, iterative methods
that seek to converge to the maximum likelihood estimate have been commonly
used in the PET reconstruction literature. The most widely known of such methods
is the maximum-likelihood expectation-maximisation (MLEM) algorithm, first pro-
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posed by Shepp and Vardi [160], that converges to ρ after a relatively large number
of iterations of a two-step algorithm. In the first step, the forward model of the
acquisition (Equation 3.54) is applied to the current estimate of the radiopharma-
ceutical distribution, and the estimated projections are compared with the measured
projections by taking the ratio. In the second step, this ratio is back-projected and
used to update the estimation of the activity distribution. The update equation of





NAPρ(it) + b (3.59)
where ρ(it) is a column vector that contains the PET voxel values at iteration (it)
and 1I is a column vector of ones of length I. All vector multiplications and divisions
are taken element-by-element.
This algorithm requires an initial estimation of the radiotracer distribution. Most
conventionally a blank image is used to initialise the algorithm (i.e. ρ(0) = 1J). The
multiplicative nature of the update equation of the MLEM algorithm implies that
it is not possible to produce negative or zero voxel values, resulting in a bias in
high-noise low-activity regions.
As mentioned above, the MLEM algorithm requires a relative large number of it-
erations to produce a good image, which has prevented its widespread use in clinical
settings. In order to alleviate this problem, an accelerated version of the MLEM al-
gorithm, called ordered-subsets expectation-maximisation (OSEM) is typically used
instead [161]. The OSEM algorithm groups the acquired projections into a number
of subsets, and applies the MLEM algorithm to each subset in turns, using the es-
timated activity distribution obtained with one of the subsets as starting point for
the next one. As the system matrix for each of the subsets is smaller, the forward
and back-projection process for updating the activity estimation is faster than in
traditional MLEM. OSEM is nowadays the most widely used PET reconstruction
algorithm in clinical systems [162].
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3.4.2 Motion Compensation in PET
The PET acquisition model described so far assumes that the object being scanned
remains static during the whole acquisition. In cardiac PET imaging, however,
physiological (cardiac and respiratory) motion occurs during the scan, resulting in
image quality degradation if the motion is not compensated for. A moving emission
map will produce image blurring around the moving organs, due to the assignment of
coincidences from moving tissues to the wrong LORs. Furthermore, motion can pro-
duce mismatches between the moving emission map and the static attenuation map,
which is conventionally acquired during a breath-hold, inducing artificial voids or
enhancements in the PET signal. These artefacts are particularly severe in regions of
abrupt change in the attenuation values, such as the heart-lung boundaries. Indeed,
some studies have shown that motion-induced emission-attenuation mismatches can
appear as false myocardial perfusion defects [163].
Although such artefacts can be minimised by rejecting data acquired outside a
pre-defined respiratory and cardiac phase, as described in Section 3.2, this approach
reduces the amount of data available for PET image reconstruction, increasing image
noise. Alternatively, if motion information throughout the PET acquisition is avail-
able, e.g. it can be estimated from the PET data itself, or from simultaneously ac-
quired CT or MR data, two different approaches can be used to compensate for mo-
tion in PET images: reconstruct transform average (RTA) and motion-compensated
image reconstruction (MCIR).
In RTA approaches, also known as reconstruct register average (RRA) or post
reconstruction registration (PRR) [164], the acquired data is first binned into a
number of near motion-free datasets that are to be reconstructed independently,
using any standard algorithm, most typically OSEM.
In order to avoid mismatches between emission and attenuation maps, an at-
tenuation map Ab is created for each motion-free dataset, by using the motion
information to transform the attenuation map acquired at the reference position to
the corresponding motion state b. Thus, omitting the subsets notation for simplicity,
each bin is reconstructed according to












where ρ(it)b is the vector representation for the PET image at motion state b after
(it) iterations of the reconstruction algorithm, and mb is a vector that contains the
fraction of the data acquired in motion state b. In this model, background coinci-
dences are assumed to vary slowly compared to changes in the activity distribution
ρ, so the effect of motion on them is typically neglected.
Once all frames have been reconstructed, they are transformed back to a reference
frame using inverse motion operators, and ultimately aggregated so that one motion
compensated image is obtained using all measured data, as depicted in Figure 3.19.
The reference frame for cardiac PET imaging is usually end-expiration and end-
diastole. Instead of using a simple average, an alternative approach has been recently
proposed in [165], where images are weighted before being combined according to
the estimated intra-frame motion amplitude. Thus, better quality images acquired
at quiescent phases of the cardiac and respiratory cycles have more influence in the
final motion compensated image.
Figure 3.19: Reconstruct Transform Average (RTA) approach for motion compen-
sated PET imaging. Acquired data is binned into near motion-free datasets that
are independently reconstructed. These reconstructed images are transformed to
a reference frame using inverse motion operators, and aggregated to produce the
motion-corrected PET image.
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Figure 3.20: Motion Compensated Image Reconstruction (MCIR) approach for PET
imaging. Acquired data is binned into near motion-free datasets and information
about the motion between such frames is included in an iterative reconstruction
algorithm, directly resulting in a motion-corrected PET image.
In MCIR approaches [166], the motion information is incorporated as an addi-
tional term in the forward projection model, so that a motion-corrected image is
directly obtained by modelling the motion during the image reconstruction process.
Theoretically, if continuous motion information is available throughout the PET
acquisition, PET data could be corrected in a coincidence-by-coincidence fashion,
by incorporating the transformation between the current position and a reference
position into the forward model of any iterative reconstruction algorithm.
This approach would lead to increased and impractical reconstruction times, so in
practice PET data is also binned into near motion-free frames in MCIR approaches
and the motion information is also used in a frame-to-frame fashion (Figure 3.20).
For instance, the MLEM algorithm can be modified to include motion as part of the










where Ub is a motion operator that transforms an image at the reference position to a
motion state b and Ab is a diagonal matrix containing the effect of the attenuation at
position b. In this case, ρ corresponds to the motion-corrected image reconstructed
at the reference position. Also in this case the background coincidences are assumed
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to vary slowly compared to the activity distribution, so the effect of motion on them
is neglected.
The performance of the RTA and MCIR approaches for motion compensation has
been compared in a number of abdominal and thoracic simulation studies, including
respiratory motion only. A study based on pseudo-PET images simulated from
healthy volunteer abdominal and thoracic MR data [168] concluded that RTA and
MCIR reconstructions result in comparable global measures of similarity compared
with a motion-free reference, but RTA produces greater resolution loss than MCIR.
Additional studies [169,170] have shown that MCIR achieves better contrast and
smaller bias in low-activity regions compared to RTA at the expense of reduced SNR
in the final motion compensated image. These studies also showed that MCIR has
a smaller mean squared error (MSE) only for a small number of OSEM iterations
(i.e. 1–2). As the number of iterations increases, RTA has significantly less MSE
than MCIR, suggesting that MCIR may provide better overall performance only
when SNR is high. For low SNR cases, MCIR can be applied in conjunction with
regularisation methods to control noise levels. For instance, a regularised MCIR
based on a maximum a posteriori one-step-late algorithm with median-root-prior
has been proposed in [171]. This study concluded that regularised MCIR achieves
less bias and MSE, and similar contrast and SNR compared to regularised RTA.
3.5 Cardiac PET-MR: State-of-the-Art
Since the development of simultaneous PET-MR scanners, cardiovascular imaging
has been proposed as one of the clinical applications that could benefit the most from
this new technology. The complementary anatomical and functional information
offered by both imaging modalities, and the ability to simultaneously produce high-
resolution MR images with superior tissue contrast and quantitative PET images
has shown promise for improving the diagnosis of different cardiac conditions from a
single scan session. This section describes some of the clinical applications that have
been proposed for cardiac PET-MR imaging, and briefly reviews the state-of-the art
techniques for motion correction in the context of cardiac PET-MR.
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3.5.1 Clinical Applications
The recently published joint statement by the European Society of Cardiovascu-
lar Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)
suggests that including hybrid PET-MR examinations in the routine clinical prac-
tice could enhance the diagnosis and aid decisions in the management of a variety
of cardiac conditions, including stable coronary artery disease, acute coronary syn-
drome, ischaemic cardiomyopathies and cardiac inflammation [24]. The potential of
PET-MR for each of these applications is briefly discussed hereafter.
As mentioned before, PET has been established as the reference modality for my-
ocardial perfusion imaging, allowing for an accurate diagnosis of obstructive CAD
through the assessment of myocardial perfusion defects. Recent studies using simul-
taneous PET-MR scanners have shown a good correspondence between myocardial
perfusion quantified by PET and by dynamic contrast enhanced (DCE) MRI imag-
ing [172]; however, the capabilities of the PET-MR system in this study were mostly
used to provide a gold-standard for cross validation between imaging modalities. A
different approach for perfusion imaging is proposed in [173], where MR images
are used for MR-based cardiac motion correction of simultaneously acquired 18F-
Flurpiridaz (a novel perfusion radiotracer), showing improvements in image quality
in a pre-clinical study.
In the context of CAD, the feasibility of imaging atherosclerotic plaque by 18F-
NaF using a PET-MR system has been recently demonstrated in a cohort of 12
patients with either documented CAD or documented risk factors for developing
the disease [174]. This approach, in combination with simultaneously acquired MR
anatomical images that provide information about the plaque location and integrity
of the artery lumen, in addition to novel MR sequences that allow for characterisa-
tion of intraplaque haemorrhage [175,176], could potentially allow for a comprehen-
sive non-invasive assessment of vulnerable plaque.
A more conventional approach for PET-MR in CAD has been the use of 18F-FDG
in combination with conventional late Gadolinium enhancement (LGE) imaging by
MR. Whereas LGE allows detection of both transmural and non-transmural scar in
the myocardium, 18F-FDG allows identification of areas of viable myocardium. By
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combining both modalities, an improved stratification of patients that could benefit
from revascularisation therapy can be achieved [177]. The simultaneous 18F-FDG
PET–LGE MRI imaging approach has been also demonstrated in patients after
acute myocardial infarction [178–180]. In [178], good correlation was found between
the area of reduced 18F-FDG uptake (defined as > 40% reduction compared to the
remote myocardium) and the area-at-risk (AAR) as estimated by delineating the
endocardial surface area, although 18F-FDG overestimated the size of the AAR.
Similarly, in [179] a very good correlation was found between the size of AAR as
defined by a reduction of > 50% in 18F-FDG uptake and as defined by delineation
in MR T2-mapping. In both studies, the AAR estimated by reduced 18F-FDG
uptake was larger than the infarct size delineated in the LGE images, suggesting
that reduced 18F-FDG uptake can accurately estimate myocardial viability early
after infarct. Furthermore, the presence of viable myocardium as estimated by
residual 18F-FDG uptake was shown to predict segmental wall motion recovery in
follow-up examinations [179,180].
Finally, the simultaneous 18F-FDG PET–LGE MRI approach has been used to
improve the differential diagnosis in myocardial inflammation. Recent clinical ex-
perience has been reported in [181], including cases of myocarditis, congestive heart
failure and cardiac sarcoidosis. In particular, the latter has received a lot of attention
in the cardiac PET-MR community, as early reports suggest that the complementary
information obtained by PET and MR improves the diagnostic accuracy of cardiac
sarcoidosis compared to using each modality alone [182–184]. Therefore, cardiac
PET-MR could potentially become the reference modality for a non-invasive tool
for the detection and monitoring of cardiac involvement in patients with known or
suspected sarcoidosis.
3.5.2 Motion Correction for Cardiac PET-MR
As mentioned in Chapter 1, simultaneous PET-MR systems have made possible the
use of MR-measured motion fields to correct the motion-degraded PET data using
either of the techniques for motion-compensated PET imaging described in Section
3.4.2. In the early days of MR-based PET motion compensation, several simulation
studies showed improved lesion detectability and reduced noise levels in motion
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Figure 3.21: Conventional approaches for MR-based motion correction of PET data
in PET-MR imaging. (a) Pre-calibrated motion models estimate a motion model
before or during the first part of the PET-MR examination. (b) Simultaneous motion
models estimate motion information by using MR images acquired throughout the
whole PET data acquisition.
compensated images compared to gated images, in addition to reduced blurring and
improved contrast compared with uncorrected images for a variety of cardiac [167,
185] and abdominal and thoracic [168,169,171,186–189] applications. Phantom [190–
193] and preliminary patient studies [165, 193–197] later confirmed those findings.
It is worth noting that while the phantom studies included cardiac applications
showing promising results, the patient studies focused mainly on respiratory motion
correction for thoracic and abdominal 18F-FDG PET-MR imaging in oncology.
Most of the current approaches for MR-based PET motion compensation esti-
mate the motion-induced deformation of the organs within the field of view by using
one of the following techniques: 1) pre-calibrated motion modelling, where MR im-
ages are acquired before or during the first few minutes of the PET acquisition
to form a motion model that is then used to correct for motion during the whole
PET acquisition, or 2) simultaneous motion modelling techniques, where motion is
estimated by applying image-based registration algorithms to MR images acquired
throughout the whole PET data acquisition (Figure 3.21). Both of these approaches
have been used to estimate cardiac, respiratory, or cardiac and respiratory motion
for motion-compensation in PET-MR, using a variety of MR acquisition sequences,
as described hereafter.
The most widely used acquisition techniques in MR imaging to estimate cardiac
motion are cine MR and tagged MR imaging [198]. As described in Section 3.1, for
cine MR imaging, data are continuously acquired throughout several cardiac cycles
and retrospectively binned into several motion-free cardiac phases using a simulta-
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neously acquired ECG signal. In terms of motion estimation for PET-MR, cine MR
has been used as a simultaneous motion model technique. For instance, stacks of 2D
cine MR images have been used to estimate cardiac motion in a phantom PET-MR
study, using B-spline non-rigid registration of 25 cardiac phases with respect to an
arbitrary reference phase [191]. An important drawback of this approach is that no
information about 3D motion is available, so errors due to misalignment between
slices can be produced. In order to measure 3D motion accurately, in [185] simu-
lated 3D T1-weighted images were used to estimate motion between eight cardiac
phases and the end-diastolic phase using an optical flow framework. Although such
an approach could potentially be extended to in vivo studies, cardiac motion can be
difficult to track in regions with uniform contrast such as the myocardium.
In tagged MR, radiofrequency prepulses are used to generate a pattern of alter-
nating bright and dark stripes over the image being acquired, allowing for tracking
deformation even in areas of uniform contrast. The most commonly used tagged
MR techniques are based on SPAMM (SPAtial Modulation of Magnetisation), pro-
posed by Axel and Dougherty in [199], where the deformation of a sinusoidal pattern
superimposed on 2D images can be used to visualise and estimate motion. The pat-
tern fades after the tagging preparation pulse due to spin relaxation, so multiple
acquisitions are required in order to characterise the entire cardiac cycle. Further-
more, in order to track the 3D motion of the heart, multiple orthogonal image planes
(i.e. coronal, sagittal, transverse) or orthogonally motion-encoded volumes need to
be acquired [200]. For this reason, tagged MR images are simultaneously acquired
with an external ECG signal that allows for the triggering of the tagging preparation
pulse and gating of the data in different cardiac phases. Once the tagged MR images
have been reconstructed for each cardiac phase, different approaches can be used
to estimate motion. B-spline non-rigid registration of SPAMM-tagged images has
successfully been applied to track myocardial motion in PET-MR phantom stud-
ies [163, 192], and more recently in a proof-of-concept clinical study [193] dividing
the cardiac cycle into 9 phases.
One of the main disadvantages of tagged MR is the extended time required to
obtain a complete description of the motion during the cardiac cycle, so it is typically
used as a simultaneous motion model technique. As reported in [193], the acquisition
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time of fully sampled tagged MR images for motion estimation in a patient exper-
iment was more than 8 min, preventing the application of other clinically relevant
sequences to assess cardiac anatomy and function. Half k-space acquisition [192],
and compressed sensing and parallel imaging reconstruction techniques [193] have
been employed to accelerate the acquisition of tagged MR images and move towards
a pre-calibrated motion model approach. For instance, in [193] it was demonstrated
that by combining tagged MR with conventional compressed sensing techniques, it
was possible to accelerate the acquisition 8 times, and still provide accurate cardiac
motion estimation, yielding motion-corrected PET images of a similar quality to
those corrected with motion estimated from fully sampled tagged MRI. This was
demonstrated both in phantom studies and in one patient, using myocardial defect
contrast as measurement of image quality.
Unlike the case of cardiac motion, pre-calibrated motion model techniques have
been widely used for estimating respiratory motion. These techniques aim to create
a patient-specific motion model from the MR imaging data, usually by acquiring a
surrogate signal simultaneously with the imaging data, so that the created model
approximates the relationship between the surrogate and the motion [201].
In the context of PET-MR imaging, pre-calibrated motion models are based on
near real-time MR images acquired prior to, or during a fraction of the simultaneous
PET-MR acquisition. The first approach has been applied in MR-based PET simu-
lation studies [169,186,188,202–205] using MR data acquired from healthy subjects.
3D T1-weighted turbo field echo (TFE) MR images were acquired using parallel
imaging (SENSE) with an acceleration factor of 8, so that each whole-thorax vol-
ume was acquired in 0.7 s. Motion displacements estimated from hierarchical local
affine registration of these fast acquired 3D MR volumes are modelled as functions
of a 1D surrogate signal, so that during the subsequent simultaneous PET-MR
acquisition only information from the position of a 1D navigator echo is required
for motion estimation. In [187], 2D images were used as surrogate for a statistical
motion model, and more robust results were obtained compared with 1D surrogates.
A different pre-calibrated model-based approach was proposed in [197], and
tested in thoracic images of four patients. Here, a motion model is generated during
a one-minute PET-MR acquisition by acquiring multiple high-resolution 2D sagittal
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spoiled gradient echo MR images, with a temporal resolution of 0.3 s. During the
remainder of the acquisition, a respiratory surrogate extracted from the list-mode
PET data itself is used to perform MR-based motion correction, so no additional 1D
surrogate is required. One of the limitations of this approach is that given the 2D
nature of the MR acquisition, the left-right component of the motion is neglected. A
similar approach that addresses this issue is proposed in [194], where high-resolution
2D sagittal acquired during a 3 minute scan are retrospectively reordered to form
four 3D volumes representing different respiratory positions. These 3D volumes
are then used for estimating non-rigid motion fields via image registration, using
end-expiration as reference position. While in both studies the authors stated that
reducing the time required for motion estimation was desirable in order to provide
time for diagnostic MR sequences to be acquired simultaneously with PET, there
is no discussion about the impact of changing the time allocated for generating the
motion model.
Simultaneous motion model approaches have also been used for estimating respi-
ratory motion, typically by applying non-rigid registration to images reconstructed
at different respiratory bins (so called bin-to-bin respiratory motion estimation).
Thanks to the capability that MR offers for monitoring respiratory motion, most
of these techniques rely on 1D navigator echoes or self-gating approaches instead of
external devices for binning the acquired MR data. The 1D navigator approach has
been used in two PET-MR patient studies. In [206], data acquired using a golden-
angle radial spoiled gradient echo pulse sequence is retrospectively binned into eight
respiratory bins for thoracic imaging, while in [195] data acquired using a navigated
steady-state free-precession MR acquisition protocol was binned into seven bins for
abdominal imaging.
A self-gating approach for respiratory motion estimation in PET-MR was pro-
posed in [165, 207] and evaluated in abdominal and thoracic images of 15 patients.
MR data was acquired using a 3D T1-weighted golden-radial stack-of-stars spoiled
gradient echo with fat suppression sequence. The stack-of-stars trajectory allows the
estimation of a respiratory surrogate from the centre of the k-space (kx = ky = 0)
for each line acquired in the central slice of the volume (kz = 0). Based on this
signal, the MR data was retrospectively binned into 2 to 15 uniform respiratory
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bins. The authors concluded that up to 10 bins are required to recover the full res-
piratory amplitude depending on the respiratory pattern of the patient. However,
when analysing the average binning error, with only 5 bins the 95th percentile fell
below 2 mm, suggesting that increasing the number of bins over 5 does not have a
significant impact in the accuracy of the estimated motion.
A study comparing the performance of a simultaneous motion model using five
different 1D respiratory surrogates for retrospective binning of MR data was pre-
sented in [196], including respiratory bellows, an MR-based self-gated signal, and
three PET-based navigators, finding high correlation between the different respi-
ratory signals. This study was performed in 20 patients, who were referred for
diagnosis of malignant diseases in the abdomen (11 patients), heart (1 patient) and
thorax (8 patients).
A different bin-to-bin-based simultaneous motion model approach involves the
acquisition of near real-time MR images that are subsequently classified in different
respiratory phases. In [191], an image-based navigator is used to select 6 respiratory
phases from a set of 35 acquired 3D TFE images of a phantom capable of both
cardiac and respiratory motion.
Tagged MR imaging has also been used to estimate respiratory motion to improve
accuracy in regions with uniform contrast such as the liver. B-spline non-rigid
registration of tagged MR images using two different similarity measures (i.e. sum
of squared differences and negative mutual information) has been applied to PET-
MR abdominal imaging of rabbits and non-human primates [208]. The authors
found no statistically significant difference in the detectability of lesions in motion-
corrected PET images using either similarity measure. In [190], respiratory motion
is estimated through regularised phase-tracking of multi-slice tagged MR images.
The proposed approach was demonstrated to be robust against noise in a numerical
simulation study, but its applicability to in vivo data has not been tested. As
discussed by the authors, a severe limitation of tagged MR approaches for respiratory
motion estimation is the lack of signal in the lungs.
Finally, in order to address both cardiac and respiratory motion simultaneously,
dual-gating approaches have been proposed in the literature for both pre-calibrated
and simultaneous model techniques. In [185], respiratory motion was assumed to be
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rigid within each cardiac phase, so rotation and translation parameters that charac-
terise motion between respiratory phases were estimated using least squares minimi-
sation. Using these parameters, respiratory corrected MR images were reconstructed
for each cardiac phase and afterwards, non-rigid cardiac motion was estimated using
optical flow. A more general framework, where non-rigid registration of dual gated
images into a reference cardiac and respiratory phase is performed assuming the exis-
tence of 1D surrogates for both the cardiac-induced and respiratory-induced motion
of the heart, has been shown in simulation studies [167, 209] and more recently in
preliminary patient studies [210,211].
While pre-calibrated motion model approaches allow for real-time motion esti-
mation, they do not measure motion directly during PET data acquisition, so they
are susceptible to changes in the cardiac and respiratory pattern of the patient dur-
ing long examinations. This limitation is alleviated when using simultaneous motion
modelling approaches, which capture the motion throughout the whole data acqui-
sition process. However, the main drawback of these approaches is that the MR
images acquired simultaneously with PET are in general designed only for motion
estimation purposes, so they have limited or no diagnostic value.
Furthermore, in the context of cardiac PET-MR applications, both pre-calibrated
and simultaneous motion modelling techniques have focused on improving only PET
image quality using motion information estimated from MR. Clinically useful MR
images are in general acquired after the simultaneous PET-MR examination, leading
to long acquisition times and misaligned diagnostic PET and MR images.
More recently, a novel approach where the motion estimated from MR is used to
simultaneously correct both PET and MR images has been proposed [212]; however,
MR images showed reduced contrast between blood and myocardium due to the
absence of preparation pulses and limited spatial resolution for visualisation of the
coronary arteries, impairing the diagnostic use of such MR images.
In the following chapters, the novel approach for motion-corrected cardiac PET-
MR imaging developed in this thesis will be described, where respiratory and cardiac
motion information estimated from MR is used to correct for non-rigid motion in si-
multaneously acquired CMRA and 18F-FDG PET data, allowing for the visualisation




Respiratory motion is a major source of image degradation in both PET and MR
imaging. In particular, within the context of cardiac PET-MR imaging, respiratory
motion can result in image blurring and ghosting artefacts in MR, and image blurring
and artefacts due to mismatches between attenuation maps and emission maps in
PET. As described in Chapter 3, the development of simultaneous hybrid PET-MR
scanners has stimulated the development of novel approaches to address the problem
of respiratory motion in cardiac PET-MR imaging. Most of such approaches rely
on acquiring MR images with sufficient contrast, spatial and temporal resolution to
produce motion estimates for improving PET image quality. In other words, such
MR images are designed to provide motion information only, hindering their use for
diagnostic purposes.
In this Chapter a novel framework for efficient free-breathing simultaneous whole-
heart CMRA-PET is introduced. An acquisition that enables non-rigid respiratory
motion correction of simultaneously acquired CMRA and cardiac PET data was
developed, allowing for the visualisation of the coronary arteries and assessment of
myocardial integrity from a single examination. This was achieved by including a
2D image navigator (iNAV) in the MR acquisition sequence, which allows estimation
of the position of the heart within the respiratory cycle at each heartbeat. Then, by
combining a beat-to-beat 2D translational motion correction with a bin-to-bin 3D
non-rigid motion correction approach for CMRA, the MR-derived non-rigid motion
fields can be used to correct for both the CMRA and the simultaneously acquired
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PET data to the same respiratory position.
The beat-to-beat 2D translational motion correction compensates for the main
components of intra-bin motion, while 3D non-rigid deformations of the heart dur-
ing the breathing cycle are captured by the bin-to-bin motion correction. This
approach is highly efficient since nearly all acquired MR data is used for recon-
struction (∼100% scan efficiency after respiratory outlier rejection), resulting in a
shorter scan time than conventional 1D diaphragmatic gated MR acquisitions, as
has recently been demonstrated for coronary and vessel wall balanced steady-state
free precession (bSSFP) MR imaging at 1.5 T [159]. Additionally, it enables the
acquisition of diagnostic MR and PET images simultaneously, significantly reducing
the total exam time compared to techniques that perform diagnostic MR acquisi-
tions after the simultaneous PET-MR scan. The framework for motion-corrected
CMRA reconstruction was tested in ten healthy subjects and compared to a reference
scan with 1D diaphragmatic navigator gating and tracking. The motion-corrected
PET-CMRA approach was then tested in five oncology patients (without known or
suspected cardiac disease) that exhibited 18F-FDG uptake in the myocardium. Some
of the results presented in this chapter have been published as a journal article [27].
4.1 Methods
4.1.1 Image Acquisition
The proposed PET-MR acquisition protocol consists of an ECG-triggered free-
breathing CMRA acquisition simultaneously acquired with list-mode PET data
on a 3 T hybrid PET-MR system. Before the simultaneous PET-MR acquisition,
a 2D cine acquisition is performed to determine a subject-dependent trigger de-
lay and acquisition window for CMRA, with both estimated visually targeting the
mid-diastolic quiescent period of the cardiac cycle. Following this, a Dixon-based
attenuation map (called µ-map hereafter) is acquired during a breath-hold at end-
expiration [117]. This approach uses a conventional two-point Dixon acquisition
in combination with a water/fat separation algorithm, so that each voxel within
the image is classified as belonging to one of four categories: background, lung,
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Figure 4.1: Cardiac PET-MR acquisition scheme. Before the simultaneous CMRA-
PET acquisition a µ-map is acquired for attenuation correction of the PET data,
and a 2D CINE image is acquired to define a subject-dependent trigger delay and
acquisition window for the CMRA acquisition. 3D CMRA data is acquired using
a golden-step Cartesian spiral profile order sampling trajectory (one spiral interleaf
per heartbeat) and a low-resolution 2D iNAV is acquired at each cardiac cycle using
spatially-encoded low flip angle echoes at the beginning of the CMRA acquisition.
T2 preparation (T2 prep) and fat saturation (Fat Sat) prepulses are applied before
the 3D CMRA acquisition to improve contrast between the coronary arteries and
the surrounding tissues. List-mode PET data is acquired during the whole CMRA
acquisition.
fat, or soft-tissue. Each tissue class is then assigned a known attenuation value,
background: 0 cm−1, lung: 0.018 cm−1, fat: 0.086 cm−1, and soft-tissue: 0.1 cm−1.
Finally, the patient-specific µ-map is added to a previously acquired µ-map of the
bed and scanner hardware to produce a complete µ-map for attenuation correction
during PET image reconstruction. The whole image acquisition scheme is shown in
Figure 4.1.
The CMRA data is acquired using a 3D spoiled gradient echo sequence with a
fully sampled golden-step Cartesian spiral profile order sampling trajectory [155].
This trajectory samples the phase-encoding plane in k-space following approximate
spiral interleaves on a Cartesian grid. In each cardiac cycle a predefined number
of profiles following a spiral-like shape is acquired. At the following heartbeat, a
new spiral rotated by the golden angle (θGR = 111.24◦) is acquired, as shown in
the schematic k-space sampling in Figure 4.1. This acquisition trajectory leads to
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a homogeneous filling of k-space over time, and allows retrospective binning of the
acquired data according to a respiratory signal, ensuring a quasi-uniform distribution
of k-space samples in each of the respiratory bins.
A low-resolution 2D iNAV is acquired at each cardiac cycle by adding spatially-
encoded low flip-angle lines at the beginning of each interleaf of the spoiled gradient
echo 3D CMRA acquisition, in contrast to previously published approaches where
the start-up echoes of a bSSFP acquisition were spatially-encoded to obtain the
iNAVs [78]. An adiabatic T2 preparation pulse is performed before data acquisition
at each heartbeat to improve contrast between blood and myocardium without the
use of exogenous contrast agents [91], and a conventional spectrally selective fat
saturation preparation pulse is performed to minimise the signal arising from the
epicardial, visceral and subcutaneous fat.
4.1.2 Motion Estimation and Motion-Corrected CMRA Im-
age Reconstruction
MR motion estimation and correction is performed in a beat-to-beat and bin-to-bin
fashion for gradient echo acquisition at 3 T PET-MR scanner, similarly to what has
previously been introduced for bSSFP CMRA at 1.5 T [159]. First, beat-to-beat 2D
translational motion in the foot-head (FH) and right-left (RL) directions is estimated
from the iNAVs using normalised cross correlation of a template covering the apex of
the heart, using the first acquired 2D iNAV as a reference frame. In order to produce
an accurate estimation of FH and RL motion, the iNAVs are interpolated to a 10×
resolution, and a search window around the template used for tracking the heart
is defined. Thus, normalised cross correlation is calculated between the reference
template and the subsequent iNAVs by shifting the template over the search area, so
that the 2D translation for a given heartbeat corresponds to the shift that resulted
in the highest cross correlation.
The estimated FH motion is then used to assign the acquired 3D CMRA data
to Nbins different respiratory bins according to their position in the breathing cycle,
as shown in Figure 4.2. Outlier data due to deep breaths are removed, so that only
data acquired within two standard deviations from the mean FH translation is used
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Figure 4.2: Respiratory binning for CMRA. Foot-head motion estimated from the
2D iNAVs (in red) is used to define a number of respiratory bins, three in this
example. 3D CMRA data acquired at each heartbeat are translationally corrected
to the centre of the corresponding bin (green arrows). At the end of the binning
process, an undersampled k-space is obtained for each respiratory bin.
for image reconstruction. MR data assigned to each respiratory bin is corrected for
2D translational motion to the centre of the bin by applying a phase shift in k-space
according to the estimated FH and RL motion, as described in Equation 3.48.
It is worth noting that although the CMRA acquisition is fully sampled, the
binning process results in undersampled respiratory bins. In order to reduce the
artefacts introduced by the undersampling, the image reconstruction problem is
modified to allow the partial inclusion of data acquired outside each bin. This ap-
proach, usually known as soft-binning, introduces a set of weights for the acquired
data that varies according to the FH distance to the centre of each bin. The de-
gree of undersampling is then reduced, and each soft-bin can be then reconstructed
independently by using, for instance, the iterative SENSE approach introduced in
Section 3.3.1 [150].
The image reconstruction problem for each bin can be formulated as
x̂b = arg min
xb
‖Wb (Exb − kb)‖22 (4.1)
where x̂b are the reconstructed bin images, Wb is a diagonal matrix containing the
data weights for respiratory bin b, E is the encoding matrix, including the discrete
Fourier transform operator and coil sensitivities, and kb is the k-space data acquired
at each respiratory bin after 2D translational motion correction.
The diagonal elements of Wb are defined as a function of the respiratory position
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where the data was acquired, so that samples acquired within the bin have a unitary
weight, and samples acquired outside have a weight that decreases linearly to zero
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where wbk are the diagonal weights for data k at bin b, dFH(b) is the FH distance
from the bin centre to the edge of the bin, tbFH(k) is the FH distance between the
centre of bin b and the respiratory position when the k-space sample k was acquired
and δ is a parameter defining the amplitude of the soft-bin.
After each bin has been reconstructed, bin-to-bin 3D non-rigid motion can be
estimated via image registration based on free-form deformations with normalised
mutual information as the similarity metric [213], using one of the respiratory bins
(typically end-expiration) as the reference, as shown in Figure 4.3. The free-form
deformations algorithm outputs direct and inverse deformation fields that transform
an image at the reference position to any given respiratory position and vice versa,
respectively. These deformation fields represent the movement in each dimension
for each voxel in the images, and can be re-written as sparse matrix operators using
trilinear interpolation.
Then, the estimated 3D non-rigid motion operators can be incorporated directly
into a GMD motion-corrected reconstruction framework [155,158,159], as described
in Equation 3.51. Considering xMF as the motion-free image, the motion-corrupted





where Sb is the sampling matrix that selects the k-space points acquired at bin b,
E is the encoding matrix and Ub are the non-rigid motion operators that transform
the object in the reference position to a respiratory state b. The motion-free image
xMF can be then reconstructed by solving Equation 4.3 using the conjugate gradient
method [145].
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Figure 4.3: Motion-corrected PET-MR reconstruction scheme. The foot-head mo-
tion estimated from iNAVs acquired at each cardiac cycle is used to bin both the MR
and PET data into a number of respiratory windows. Reconstructed MR images
at each respiratory position are used to estimate 3D non-rigid respiratory deforma-
tion fields that are then used to correct both PET (emission and attenuation) and
CMRA data to the same respiratory position.
4.1.3 Motion-Corrected PET Image Reconstruction
List-mode PET data are assigned to different respiratory bins according to their
position in the breathing cycle, in the same manner as previously described for the
CMRA data. The same bins are used for both PET and MR, as shown in Figure 4.3,
using the ECG signal to accurately synchronise the PET and MR data acquisition.
Using the motion information estimated from the MR respiratory bins, motion-
corrected PET reconstruction can be performed using the reconstruct-transform-
average (RTA) approach [164]. Each respiratory bin can be reconstructed indepen-
dently using any conventional statistical iterative reconstruction algorithm, such as
OSEM [161], including random and scatter as well as attenuation and normalisa-
tion effects. As described in Section 3.4.1, OSEM is a widely used iterative PET
reconstruction algorithm that divides the acquired data into a number of subsets,
and calculates image updates for each subset in turn. One full iteration of the algo-
rithm comprises one loop over all the subsets. The 3D non-rigid motion operators
provided by the simultaneously acquired CMRA data are used to compute one µ-
map for each respiratory bin position by transforming the static attenuation map
acquired at end-expiration to each respiratory motion state. Therefore, each bin is
reconstructed according to Equation 3.60, repeated here for completeness.










NAbPρ(it)b + r + s
(4.4)
where ρ(it)b is a vector that contains the PET image for respiratory bin b after
(it) full iterations of the OSEM algorithm, P is a matrix that models the geometric
aspect of the system forward-projection, N and Ab are diagonal matrices with entries
down the diagonal equal to the reciprocal of the normalisation and attenuation
correction factors for respiratory bin b, respectively, mb is a vector that contains the
fraction of the data acquired in respiratory bin b and r and s represent estimations
of random and scattered coincidences, respectively. Once again, the subsets division
was omitted in Equation 4.4 for simplicity. It is worth noting that in general,
random and scatter coincidences are assumed to vary slowly compared to the activity
distribution, so the effect of motion on them is neglected.
Once all respiratory bin PET images have been reconstructed, they are trans-
formed back to the reference end-expiration bin using inverse deformation fields
and ultimately added so that one motion compensated image is obtained using all





As can be observed in Equation 4.5, the motion operators are applied to the data
in PET image space. As the MR motion fields are estimated at a higher spatial
resolution, they are resampled prior to PET reconstruction.
4.2 Experiments
For this study two in vivo experiments were performed. The first experiment aimed
to validate the non-rigid motion correction CMRA framework at 3 T, and was per-
formed in a cohort of ten healthy subjects, using only the MR capabilities of a hy-
brid PET-MR scanner (Biograph mMR, Siemens Healthcare, Erlangen, Germany).
Then, the whole motion-corrected PET-CMRA framework was tested in a small co-
hort of five oncology patients without known or suspected CAD. Written informed
consent was obtained from all subjects according to institutional guidelines and the
institutional ethics committee approved the study.
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4.2.1 Healthy Subject Data Acquisition
Ten healthy subjects (age 30.0±3.7 years, 4 males) were scanned during free breath-
ing using a prototype implementation of the proposed 3D CMRA sequence. The
following MR image acquisition parameters were used: coronal slices, RL phase en-
coding, 1 × 1 mm2 in-plane resolution, 304 × 304 in-plane matrix size, 2 mm slice
thickness, subject-specific number of slices covering the whole heart, ranging from 40
to 48 slices, TR/TE = 3.7/1.7 ms, flip angle = 15◦, readout bandwidth = 685 Hz/px.
A subject-specific trigger delay was set targeting the mid-diastolic rest period and
an acquisition window ranging from 89 to 119 ms (corresponding to 24-32 k-space
lines forming the spiral interleaves acquired at each heartbeat) was used depending
on the length of the quiescent diastolic period of the subject. In order to improve the
contrast between the coronary arteries and the surrounding tissue, an adiabatic T2
preparation pulse of 50 ms was implemented in the scanner software (not available
in the standard vendor product), and a vendor-provided spectrally selective fat
saturation preparation pulse was used.
For the 2D iNAV data acquisition, the following parameters were used: high-low
linear Cartesian trajectory, coronal orientation, RL phase encoding, flip angle = 3◦,
14 lines [78] with the same field of view of CMRA acquisition (304 mm× 304 mm),
obtaining a 1 mm× 21.7 mm acquired in-plane resolution, interpolated to 1× 1 mm2
reconstructed resolution, with a slice thickness ranging from 80 to 96 mm, depending
on the coverage of the CMRA acquisition.
An additional conventional Cartesian ECG-triggered CMRA scan with a 1D
diaphragmatic respiratory gating and tracking with the same image acquisition pa-
rameters was performed for comparison purposes, using a 6 mm gating window and
a tracking factor of 0.6, in line with the population-based factor proposed in [41]. As
discussed in Chapter 3, 1D gating approaches lead to prolonged and unpredictable
scan times. In order to avoid long scan times, the 1D-gated acquisition was per-
formed using GRAPPA parallel imaging [148] with an undersampling factor of 2
and 24 calibration lines. It is worth noting that such differences in the acquisition
protocol result in slight differences in image SNR and contrast compared to the
proposed iNAV-based CMRA.
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4.2.2 Patient Data Acquisition
Five oncology patients (ages 53.4±10.4 years, 3 males) that had received an 18F-FDG
injection of 334.82 ± 24.35 MBq were scanned 2.3 ± 0.5 hours after injection using
the proposed PET-CMRA approach. Before the CMRA acquisition, a µ-map was
acquired during a ∼19 s breath-hold at end-expiration using the vendor’s standard
2-point Dixon acquisition. By default, these data are acquired with the following
imaging parameters: coronal orientation, FH phase encoding, 328× 500× 399 mm3
field of view, 2.6×2.6×3.12 mm3 voxel size, TR/TE1/TE2 = 3.60/1.23/2.46 ms. The
segmentation of the water/fat images into four tissue classes and generation of the
µ-map for PET reconstruction was performed automatically by the vendor-provided
software. Following this, the subjects were scanned during free-breathing using the
proposed CMRA sequence with the same MR imaging parameters described for
the healthy subjects. List-mode PET data was acquired during the whole CMRA
acquisition, resulting in a subject-specific PET acquisition duration of 10.8 ± 0.7
minutes on average.
4.2.3 PET-CMRA Image Reconstruction
CMRA image reconstruction was performed inline in the scanner software for 2D
translational motion correction only (i.e. using only the FH and RL motion es-
timated to produce one translationally motion-corrected image). The proposed
combined 2D translational and 3D non-rigid motion correction approach was im-
plemented offline in MATLAB (Mathworks, Natick, Massachusetts, USA).
The CMRA data acquired with the proposed approach was reconstructed with
(a) the proposed non-rigid motion-corrected approach (TC+GMD), (b) 2D trans-
lational motion correction only (TC) and (c) without motion correction (NMC) for
comparison purposes. The TC+GMD method used between three and six respira-
tory bins, automatically defined such that the maximum bin size was set to 4.5 mm
and each bin contained approximately the same amount of data [155]. This ensures
that the respiratory bin images have a similar quality, improving the robustness of
the free form deformations image registration algorithm. The soft-gate amplitude
(δ) was empirically determined and set to 1 mm.
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The TC+GMD CMRA image reconstruction required 2D translational motion-
corrected soft-binned iterative SENSE reconstructions (reconstruction time of∼250 s
per bin), followed by 3D bin-to-bin non-rigid registration (registration time of ∼50 s
per bin) and finally the GMD reconstruction (reconstruction time of ∼2200s), for a
total reconstruction time of ∼3700 s. The CMRA data acquired with 1D diaphrag-
matic respiratory gating and tracking (called Gated hereafter) was also reconstructed
inline in the scanner software for comparison purposes.
List-mode PET data was binned using the MR-derived respiratory signal and
bins, so that one 3D set of span 11 sinograms was created per each respiratory
bin. Non-rigid motion operators estimated from the MR bins were used to deform
the µ-map acquired at end-expiration to each respiratory bin position. PET im-
age reconstruction was performed separately for each respiratory bin in Siemens
e7 Tools (Siemens Healthcare, Knoxville, USA) using the OSEM algorithm with
3 iterations and 21 subsets, including point spread function modelling. Images
were reconstructed with a voxel size of 2.08 × 2.08 × 2.03 mm3 and a matrix size
of 344 × 344 × 127. Once all PET bins were reconstructed, they were transformed
to the reference respiratory position and aggregated in MATLAB to produce one
motion-corrected (MC) image.
The MC PET image reconstruction required a set of OSEM reconstructions
(∼240 s per bin), followed by 3D non-rigid deformation (∼10 s per bin) and finally
summation, for a total reconstruction time of ∼1250 s. Additionally, a) an uncor-
rected reconstruction including all the acquired PET data (NMC) and b) a gated
reconstruction at end-expiration (Gated) were performed with Siemens e7 Tools for
comparison purposes.
4.2.4 Image Analysis
In order to evaluate the quality of the non-rigid motion correction, each recon-
structed CMRA image was reformatted onto a 2D plane containing both the right
coronary artery (RCA) and left anterior descending (LAD) artery using the ‘Soap
Bubble’ software described in Section 2.3.1 [49]. Image quality metrics were ob-
tained separately for each coronary artery, including visible vessel length and vessel
sharpness for the first 4 cm and for the whole visible length of the vessel. Vessel
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sharpness values were normalised to the signal intensity of the centre line of each
vessel, so that 100% sharpness refers to a maximum signal intensity change at the
vessel edge. For the healthy subjects, the difference between the image quality met-
rics (vessel length and sharpness) for each reconstructed image was evaluated with
a paired t-test with a p-value of 0.01 considered statistically significant, including
corrections for multiple comparisons.
Reconstructed PET images were visually assessed with line profiles across the
left ventricle. Additionally the mean and coefficient of variation (CV) of the recon-
structed image intensity (a.u.) in a region of interest (ROI) within the myocardium
were analysed for all reconstructed PET images. The ROI was defined as a 10 mm
diameter sphere inside the myocardium. As the ROI is close to the edge of the my-
ocardium, the mean value reflects the sharpness of images, as blurring will induce a
decrease in image intensity. On the other hand, the CV (standard deviation/mean)
is conventionally used to measure noise levels in PET imaging [214]. When high
levels of noise are present in reconstructed PET images, a post-processing Gaussian
filter is typically applied to reduce the noise level at the expense of introducing
some blurring. In order to evaluate the improvement achieved by the motion cor-
rection, analysis was performed here in the original unsmoothed images and in the
post-processed images smoothed with a 4 mm Gaussian filter.
4.3 Results
4.3.1 Healthy Subjects
Scans were completed successfully in all subjects. The average acquisition time for
the proposed CMRA acquisition was 12.3 ± 1.7 minutes compared to 17.0 ± 3.2
minutes for the 2× accelerated acquisition with 1D navigator gating and tracking.
The minimum, maximum and average (and standard deviation) efficiency of the
latter was 39%, 65% and 52.3 ± 8.9% respectively for a 6 mm gating window. For
the proposed non-rigid motion correction approach, 3 to 5 (4.3±0.9 bins on average)
respiratory bins were used with bin sizes of 2.84± 1.20 mm on average.
Figure 4.4 shows a slice of five reconstructed respiratory bins for two represen-
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Figure 4.4: Reconstructed MR images at five respiratory positions (bins) for two
representative healthy subjects. A red line drawn at the level of the diaphragm in
end-inspiration is included for reference purposes. Despite residual undersampling
artefacts, the respiratory bins allow for estimation of non-rigid motion fields.
tative subjects. A red line placed at the level of the diaphragm in end-inspiration
shows the magnitude of respiratory motion in free breathing. Although each respi-
ratory bin is undersampled, the soft binning approach allows the reconstruction of
images with sufficient image quality for non-rigid motion estimation.
Figure 4.5 shows the reformatted images for the non-motion-corrected (NMC),
translational motion-corrected (TC), and non-rigid motion-corrected (TC+GMD)
reconstructions for five representative subjects. Gated images are displayed next to
the TC+GMD images for comparison purposes. Improvements in the visualisation
of the distal part of the LAD and RCA can be observed for all subjects when
applying TC in comparison with NMC, and further improvements can be observed
with TC+GMD in the visualisation of the vessels. Similar image quality can be seen
for TC+GMD and Gated approaches for both LAD and RCA coronary arteries. Loss
in vessel definition and sharpness can be observed in the proximal LAD for subject
3 with TC. This is because TC correction depends on the position of the template
for motion tracking (as the motion of the heart is not purely translational), which
in this work was located near the apex of the heart (Figure 4.1, in red over iNAV).
The TC+GMD approach overcomes this limitation by correcting for the complex
non-rigid motion of the heart.
Image quality metrics for the RCA and LAD are displayed in Figure 4.6. It can be
observed in Figures 4.6(a,d) that measured vessel lengths were similar for TC+GMD
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Figure 4.5: Reformatted CMRA images for five representative healthy subjects
(rows) showing non-motion-corrected (NMC), translational motion-corrected (TC),
translational plus non-rigid motion-corrected (TC+GMD) and gated and tracked
(Gated) images. Improvements in the visualisation of the distal part of the RCA
and LAD can be observed when applying TC and TC+GMD in comparison to NMC.
As the motion is tracked near the apex of the heart (Figure 4.1, in red over iNAV),
TC produces a loss in definition of the proximal LAD for subject 3. The TC+GMD
approach produces images of quality comparable to the Gated images.
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Figure 4.6: Image quality metrics for the RCA and LAD arteries for ten healthy
subjects, for NMC, TC, TC+GMD and Gated images. The metrics included: visible
vessel length along the (a) RCA and (d) LAD, where each measure is normalised to
the length observed in the corresponding Gated image; vessel sharpness for the (b,c)
RCA and (e,f) LAD, for both the first 4 cm and full length of each vessel. *denotes
a statistically significant difference with p < 0.01 compared to the Gated images.
and Gated, reaching 101.0±6.9% and 95.4±8.7% of the visible length of the Gated
images for the RCA and LAD respectively on average. Lower values were obtained
for TC and NMC, with an average of 85.7± 14.9 and 78.3± 14.2% for the RCA and
73.7± 14.7 and 72.0± 15.6% for the LAD, respectively. Significant differences were
found between Gated and NMC for both coronaries, and between Gated and TC for
the LAD. Similar results were obtained for vessel sharpness, as can be observed in
Figure 4.6(b,c) for the RCA and Figure 4.6(e,f) for the LAD. Significant differences
between Gated and NMC and between Gated and TC were obtained for both the
LAD and RCA coronaries, when analysing either the proximal segment (first 4 cm)
or the full length of each vessel. No statistically significant differences were observed
between the Gated and the TC+GMD approach for any of the measurements.
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4.3.2 Patients
Scans were completed successfully in all subjects. The average acquisition time for
the proposed PET-CMRA acquisition was 10.8 ± 0.7 minutes. For the TC+GMD
reconstruction, and subsequently for the motion-compensated PET image recon-
struction, 3 to 6 respiratory bins (4.4 ± 1.5 bins on average) were used, with bin
sizes of 2.77±1.06 mm on average. This binning scheme resulted in PET respiratory
bins with 47.28± 24.92 million counts on average.
Figure 4.7: Reformatted CMRA images for three representative oncology patients
(rows) showing NMC, TC and TC+GMD images. Extreme respiratory motion pre-
vents visualisation of the left anterior descending artery in patient 2. Improvements
in the visualisation of the vessels are observed when applying TC and further im-
provements are observed with TC+GMD.
Figure 4.7 shows the reformatted CMRA images along the RCA and LAD for
the NMC, TC and TC+GMD reconstructions three representative oncology patients.
Pronounced blurring is observed in all cases when no motion correction is applied,
and extreme blurring prevents the visualisation of the proximal LAD artery for
patient 2. TC reconstructed images allow visualisation of the proximal segments
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Figure 4.8: Image quality metrics for the RCA and LAD arteries for five oncology
patients for NMC, TC, and TC+GMD. (a,d) Vessel length along the RCA (a) and
LAD (d). (b,c) Vessel sharpness for the first 4 cm (b), and full length (c) of the
RCA. (e,f) Vessel sharpness for the first 4 cm (e), and full length (f) of the LAD.
of the vessel in all the cases, however important residual aliasing due to non-rigid
motion can still be observed. A consistent improvement in the visualisation of the
distal segment of the coronary arteries can be observed for all subjects when applying
TC+GMD.
Image quality metrics confirm the observed improvements in vessel sharpness for
both the RCA and the LAD for all the patients (P1-P5), as shown in Figure 4.8(b-c,
e-f). The visible length of both coronaries also increases when applying TC+GMD
compared to TC and NMC, as can be observed in Figure 4.8(a,d). On average, visible
length of the RCA and LAD increased by 45.53% and 75.45%, respectively, when
applying TC+GMD compared to uncorrected images. Similarly, vessel sharpness
for the full visible length of the vessels increased by 56.44% and 51.11% on average
for the RCA and LAD, respectively.
Reconstructed PET images with no motion correction (NMC), Gated (only con-
sidering the end-expiration respiratory bin, containing 27.6 ± 8.4% of the acquired
data) and MR-based motion correction (MC) for patients 1–5 are shown in Fig-
ure 4.9. Profiles across the myocardium for each patient are displayed alongside
the images. It can be observed that MC improves sharpness of the left ventricle
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myocardium compared to NMC while reducing noise levels compared to the Gated
reconstruction. From the shown profiles it can be observed that small features, such
as the papillary muscles, cannot be identified in the NMC images in all cases. In the
Gated images, sharpness is improved at the expense of an increased noise, and small
features become apparent. On the other hand, profiles across MC images show the
same sharpness as the Gated images while keeping signal to noise levels comparable
to NMC.
Figure 4.9: Coronal slice for the five acquired oncology patients (rows) showing
NMC, Gated and MC PET images, alongside with profiles across the left ventricle
myocardium. MC improves the sharpness of the myocardium and papillary muscles
compared to NMC and reduces noise levels compared to Gated.
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Figure 4.10: Mean and coefficient of variation of the image intensity for NMC,
Gated and MC PET images in a spherical ROI within the myocardium of 10 mm
diameter. Each reconstructed image was smoothed after reconstruction with a 4 mm
Gaussian filter, and both the unsmoothed and smoothed images were analysed. For
all patients, MC outperforms Gated and NMC in terms of noise (i.e. lower coefficient
of variation), and outperforms NMC in terms of mean image intensity, suggesting
an increased sharpness.
Figure 4.10 shows the mean image intensity and the CV for a ROI within the
myocardium in each patient, for unsmoothed and smoothed images. It can be ob-
served than when no smoothing is applied, the mean intensity in the ROI for NMC
is lower than in the Gated images, suggesting that NMC is underestimating the real
uptake value due to blurring. When MC is used, the mean increases for three of
the patients, and it remains nearly constant for the other two patients. MC images
also have a lower CV compared to Gated images for all the subjects. When images
are smoothed with a 4 mm Gaussian filter, it can be observed that the CV is signif-
icantly reduced for Gated images, but the minimum CV is still achieved by the MC
images.
Finally, Figure 4.11 shows example slices for two representative patients of the
fused motion compensated PET-CMRA image. It can be observed that the mo-
tion compensation scheme produces co-registered images at the same respiratory
position, and the left ventricle myocardium matches in both modalities.
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Figure 4.11: Example coronal, sagittal and transverse views of fused motion-
compensated cardiac PET-CMRA images for (a) patient 3 and (b) patient 5.
4.4 Discussion
In this Chapter, a respiratory motion-corrected approach for simultaneous whole-
heart coronary MR angiography and cardiac PET imaging has been proposed and
implemented for visualisation of the coronary lumen and myocardial viability imag-
ing. The proposed method estimates FH and RL translational motion with a high
temporal resolution in a beat-to-beat fashion, and uses the FH motion to bin both
the acquired CMRA and PET data in several respiratory bins and to correct the
CMRA data for intra-bin motion. MR images reconstructed for each bin are used to
estimate 3D non-rigid bin-to-bin respiratory motion, which is then used to correct
both the CMRA and PET data. The motion-corrected MR reconstruction approach
has been previously introduced for coronary and vessel wall imaging at 1.5 T for a
balanced steady state free precession sequence with a radial-like Cartesian trajec-
tory [159], and here it is extended to a 3 T hybrid PET-MR system using a 3D
spoiled gradient echo sequence with a golden-step Cartesian trajectory with spiral
profile order sampling without the use of exogenous contrast agents.
The CMRA acquisition and reconstruction approach was tested in a cohort of 10
healthy subjects and compared against a 6 mm gated and tracked acquisition. An
intermediate TC approach was implemented on the scanner, showing improvements
in image quality compared to NMC reconstruction, especially in the visualisation of
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the distal RCA and LAD. However, as the motion of the heart during the breathing
cycle is not purely translational, the TC might produce a loss of definition in the
proximal segment (or distal segment, depending on the location of the template to
estimate the translational motion) of the vessels for subjects with a more complex
non-rigid motion of the heart. The TC+GMD approach overcomes this limitation,
showing further improvements compared to TC and recovering both the proximal
and distal segments of the coronary arteries.
When quantifying vessel length and sharpness for both the RCA and the LAD,
no statistically significant differences were observed between the Gated and the
TC+GMD approach. The proposed approach had a shorter and predictable scan
time of ∼12 minutes (fully sampled acquisition) compared to ∼17 minutes for the
2× undersampled 1D gated and tracked, while simultaneously providing non-rigid
motion fields for correcting PET data. It is worth noting that the fully sampled
CASPR trajectory produces an elliptical sampling mask in the phase encoding
plane [155, 215], further reducing scan time compared to traditional fully sampled
Cartesian acquisitions.
The full PET-CMRA acquisition and reconstruction approach was then tested in
a small cohort of five oncology patients that exhibited radiotracer (18F-FDG) uptake
in the myocardium. For the CMRA data, extreme blurring was observed when no
motion correction was applied, in some cases completely obscuring the visualisation
of the vessels. TC images allowed visualisation of the arteries in all cases, and a
further improvement in visible length and sharpness of the coronary arteries was
observed when using TC+GMD approach.
Non-rigid motion fields obtained from CMRA data were also used to correct PET
data for respiratory motion. Increased sharpness of the myocardium and improved
visualisation of small features such as the papillary muscles can be observed for all
the subjects compared to non-motion-corrected PET images. In addition, reduced
noise levels compared to gated PET reconstruction were observed, as a greater
number of counts are used to produce the motion compensated images.
For reconstructed images without smoothing, an increased mean image intensity
in a ROI within the myocardium was observed for three of the subjects when apply-
ing motion correction compared to non-motion-corrected images, due to a significant
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reduction in blurring. For the other two subjects, the value remained approximately
constant, because the ROI was located in a region with less motion. When images
are smoothed, it can be observed that noise levels are significantly reduced for all
the images, however, minimum noise is achieved by the motion-corrected images for
all patients. Motion-corrected images also present a larger mean image intensity in
the ROI compared to non-motion-corrected, suggesting an increased sharpness in
the image.
In this work, each PET respiratory bin was reconstructed independently, and
motion fields were then used to warp all the images to a common reference position.
This motion compensation approach has been shown to produce an increased bias in
the standardised uptake values due the reduced number of counts in each respiratory
bin in simulation studies [169]. Including the motion directly in the system model
of the PET reconstruction algorithm can alleviate this problem, so that a motion
compensated image reconstruction can be performed instead, however this approach
requires a longer reconstruction time.
The validation and proof-of-concept study presented in this Chapter included
only healthy subjects and oncology patients without a history of cardiac disease.
However, respiratory breathing patterns in patients with cardiac disease are more
irregular. A first validation of the proposed method in patients with coronary artery
disease is presented in Chapter 5.
Furthermore, the method introduced in this Chapter only allows respiratory
motion correction to be performed for PET data. An extension of this approach for
acquiring an additional cardiac phase so that both respiratory and cardiac motion
correction can be performed is presented in Chapter 6, which further reduces blurring
of the myocardium in the PET images.
Finally, in this Chapter, the attenuation correction map is acquired using a
∼19 s breath-hold 2-point Dixon protocol. While this breath-hold time is feasible
for most healthy subjects, it becomes challenging for patients with respiratory or
cardiac disease. Incomplete breath-holds might produce tissue misclassification, re-
sulting in errors in the attenuation map. Chapter 7 investigates a potential solution
for the acquisition of free-breathing 2-point Dixon based attenuation maps, while
simultaneously acquiring diagnostic CMRA images.
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4.5 Summary
A framework for simultaneous coronary MR angiography and cardiac PET has been
introduced. This approach allows the correction of both the CMRA and PET data
for respiratory motion, producing potentially diagnostic images that allow simul-
taneous visualisation of the coronary arteries, myocardial viability and potentially
myocardial perfusion. The motion-corrected CMRA reconstruction framework was
validated in healthy subjects. No statistically significant differences were found
when comparing the proposed approach with a standard 1D diaphragmatic 2× un-
dersampled gated and tracked acquisition. However, the proposed approach has a
predictable scan time, was 30% faster on average, and provides non-rigid respira-
tory deformation fields for PET motion correction. The PET-CMRA framework was
tested in oncology patients, and results show improvements in sharpness and reduc-






The promising results obtained in initial patient studies have promoted an increasing
role of PET-MR imaging as a non-invasive technique for the comprehensive assess-
ment of several cardiac conditions [24,177,181,216–218]. For instance, an increased
accuracy for the diagnosis of active cardiac sarcoidosis was observed by combining
18F-FDG PET and cardiovascular MR in [184], while promising results of increased
sensitivity for the detection of borderline myocarditis using hybrid 18F-FDG PET
and cardiovascular MR scans are shown in [131]. A significant PET-MR intermodal-
ity agreement was observed in acute myocardial infarction [180] and more recently
cardiovascular MR in combination with 18F-FDG and 18F-NaF was successfully used
for imaging of inflammation and calcification in the coronary arteries [174].
Most of the currently used cardiac PET-MR imaging clinical workflows consist
of the acquisition of several MR images with differing contrasts and geometry, while
simultaneously acquiring list-mode PET data throughout the whole or most of the
scanning session. Cardiac MR images acquired in these protocols typically include
a stack of 2D cine images, 2D LGE images, CMRA and T1 and T2 mapping, leading
to scanning sessions that range between 30 to 90 minutes in duration [174, 180,
184]. During this prolonged examination time, physiological motion occurs due to
breathing and cardiac motion, thus requiring motion compensation techniques to
minimise ghosting, blurring and associated image artefacts in both modalities.
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As described in Chapter 3, the effect of cardiac motion in MR images is conven-
tionally minimised in the clinical routine by synchronising the acquisition with an
ECG device, and the effect of respiratory motion by using diaphragmatic navigation
techniques for 3D imaging or a series of breath-hold for 2D imaging. In both the
cardiac and respiratory cases, these techniques result in a significant reduction in
the effective data acquisition time, limiting the usability of similar techniques in
PET, as this reduction of available data would produce images with increased noise.
Therefore, in practice, most of cardiac PET-MR clinical studies still aggregate all
the PET data acquired throughout the cardiac and respiratory cycle into a single
static time frame blurred by both respiratory and cardiac motion [180,184].
Several approaches for MR-based motion correction of cardiac PET data have
been recently proposed in the literature, as reviewed in Chapter 3, where the MR
images acquired simultaneously with PET are usually designed for motion estima-
tion purposes only [197, 211, 212]. The lack of appropriate tissue contrast and/or
sufficient spatial resolution of these MR images might prevent their use for diagnos-
tic purposes. Therefore, such approaches generally lead to prolonged examination
times, as the diagnostic MR images are acquired afterwards, hindering their inte-
gration in the clinical practice.
In Chapter 4, a novel approach for respiratory motion-corrected cardiac PET-
MR imaging was introduced. With this approach motion estimated from MR images
is used to correct both 18F-FDG PET and CMRA datasets, enabling visualisation
of myocardial viability and coronary anatomy in a single efficient examination. The
feasibility of this PET-CMRA framework was initially shown in a small cohort of
oncology patients without known or suspected heart disease, however its feasibility in
patients with cardiovascular disease presents unique challenges in terms of robustness
and reliability of the technique in cases of more irregular breathing patterns.
This Chapter presents an initial clinical validation of the proposed method for the
simultaneous visualisation of myocardial integrity by 18F-FDG PET and coronary
lumen integrity by CMRA. The study was performed in a cohort of patients with
known coronary artery disease, in particular, patients with chronic total occlusion
of at least one of the coronary arteries. Some of the results presented in this chapter
have been published as a journal article [29].




5.1.1 PET-CMRA Image Acquisition
The whole-heart PET-CMRA acquisition consists of a free-breathing ECG-triggered
CMRA sequence simultaneously acquired with list-mode cardiac PET data, as de-
scribed in Chapter 4 [27]. The main characteristics of such acquisition are briefly
summarised here for completeness. CMRA data is acquired using a 3D spoiled gra-
dient echo sequence following a fully sampled golden-step Cartesian trajectory with
spiral profile ordering, so that one spiral interleaf is acquired at each heartbeat [155].
A 2D iNAV [78] is acquired at the beginning of each interleaf by spatially encoding
low flip angle k-space lines, and fat saturation and T2 preparation [91] pulses are
performed immediately prior to CMRA data acquisition to improve the contrast
between arterial blood and the surrounding myocardium and epicardial fat.
As part of the cardiac PET-CMRA acquisition protocol, a standard Dixon-based
attenuation map (µ-map hereafter) is acquired in breath-hold at end-expiration for
MR-based attenuation correction of the PET data, with missing tissue due to the
limited field of view of the MR (as compared to PET) estimated using the MLAA
(maximum likelihood reconstruction of attenuation and activity) approach [219].
Following the same approach presented in Chapter 4, a conventional 2D cine image
is acquired for defining the trigger delay and length of the acquisition window of the
3D CMRA.
5.1.2 PET-CMRA Image Reconstruction
Motion compensated PET-CMRA image reconstruction is performed as in Chapter
4, following a method that can be briefly summarised in four steps. In the first step,
foot-head (FH) and right-left (RL) translational respiratory motion is estimated
from the 2D iNAVs by using rigid image registration of a template covering the
apex of the heart. In the second step, FH motion is used to bin the acquired PET
and CMRA data in a number of respiratory windows ranging from end-expiration to
end-inspiration, each containing approximately the same amount of data. Outlier re-
jection is performed in this step, by excluding CMRA data acquired in deep breaths.
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In a third step, 3D MR images are reconstructed at each respiratory position using it-
erative SENSE with a soft-binning approach, and bin-to-bin respiratory deformation
fields are estimated by non-rigid image registration, using the end-expiration bin as
reference. Finally, the non-rigid deformation fields are used in a generalised matrix
description formulation for motion-compensated CMRA reconstruction. Moreover,
the non-rigid motion fields are also used to move the attenuation maps to each respi-
ratory position and perform a motion-compensated PET reconstruction. Therefore,
at the end of the reconstruction process, co-registered respiratory motion-corrected
CMRA and cardiac PET images are obtained.
5.2 Experiments
Fourteen patients with symptomatic CAD (angina or angina equivalent, excluding
acute ST-elevation myocardial infarction patients), chronic total occlusion (CTO)
of a relevant coronary artery (segment 1, 2, 6, 7, 11 or 13, diameter >2.5 mm),
and echocardiographic or angiographic evidence of a wall motion abnormality in the
corresponding area were recruited for this study between 12.10.2016 and 26.06.2017
(Figure 5.1). In order to improve risk stratification before elective percutaneous
coronary intervention (PCI) of the CTO, all patients underwent a hybrid 18F-FDG
PET-MR examination in a Biograph mMR scanner (Siemens Healthcare, Erlangen,
Germany). Relevant patient characteristics include: age 66.1 ± 9.5 years, 9 males,
left-ventricle ejection fraction (LVEF) 49±12%, and previous PCI stenting of at least
one of the coronary arteries. Written informed consent with respect to participation
was obtained from all subjects, and the study was performed in concordance with
the Declaration of Helsinki and approved by the institutional ethics committee.
5.2.1 Data Acquisition
The clinical PET-MR examination protocol included a scan of 40 to 50 minutes
with a list-mode PET acquisition for the assessment of myocardial viability under
insulin-clamped conditions 60 minutes after injection of 326± 29 MBq of 18F-FDG,
and a multi-slice 2D phase-sensitive inversion recovery (PSIR) LGE acquisition
(1.4–2.2 mm in-plane resolution, 8 mm slice thickness). During the 10–15 minutes




 Symptomatic CAD, CTO,
wall motion abnormality.














- No MR contrast agent (n = 1)
- No PET-CMRA overlap (n = 2)
Figure 5.1: Flow chart of patients included in the study. 14 patients with symp-
tomatic coronary artery disease (CAD), chronic total occlusion (CTO) of a coronary
artery and evidence of wall motion abnormality were recruited for this study.
waiting time required for optimal contrast in LGE images, an acquisition with the
proposed PET-CMRA sequence was performed.
For the CMRA acquisition, relevant imaging parameters included: coronal ori-
entation, resolution = 1 × 1 × 2 mm3 (interpolated to 1 mm3 isotropic resolution
during MR image reconstruction), field of view = 304× 304× 88–112 mm3 covering
the whole heart, TR/TE = 3.72/1.70 ms, flip angle = 15◦. A subject-specific trigger
delay was defined targeting the mid-diastolic quiescent period of the cardiac cycle,
and an acquisition window of 89 to 119 ms (corresponding to 24 to 32 lines per spiral
interleaf) was selected depending on the length of the mid-diastolic period. The 2D
iNAVs were acquired using the following imaging parameters: same field of view as
the 3D CMRA acquisition, flip-angle = 3◦, 14 acquired lines with a centric-in Carte-
sian trajectory, corresponding to a 1× 21.7 mm2 acquired resolution interpolated to
1 mm2 before FH and RL motion estimation. The vendor-provided fat saturation
preparation pulse was used, and an adiabatic T2-prep (50 ms duration) was imple-
mented to improve tissue contrast. µ-maps were acquired for each patient during a
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19 s breath-hold at end-expiration using the vendor’s standard 2-point Dixon proto-
col (acquisition parameters: coronal orientation, resolution = 2.6 × 2.6 × 3.1 mm3,
field of view = 328 × 500 × 399 mm3, TR/TE1/TE2 = 3.60/1.23/2.46 ms). All
patients underwent interventional X-ray angiography the day after the PET-MR
examination, for elective CTO revascularisation.
CMRA and PET datasets were reconstructed with the described motion correc-
tion scheme (MC) and without motion correction (NMC) for comparison purposes.
For each patient, the fraction of list-mode PET data acquired simultaneously with
the CMRA sequence was selected for PET image reconstruction. Due to variations
in planning time, the overlap between CMRA and list-mode PET acquisition varied
between patients, with an average overlap of 80.3 ± 20.9% of the duration of the
CMRA acquisition.
MR image reconstruction was performed offline in MATLAB (Mathworks, Nat-
ick, Massachusetts, USA) using custom developed software. PET image reconstruc-
tion was performed offline using RTA motion correction. For this, the µ-map ac-
quired at end-expiration was moved to each respiratory position in MATLAB using
the deformation fields estimated from MR images. Each respiratory bin was inde-
pendently reconstructed offline with e7 Tools (Siemens Healthcare, Knoxville, USA)
using the OSEM algorithm, with 3 iterations and 21 subsets, point spread function
modelling, voxel size = 2.03× 2.08× 2.08 mm3, matrix size = 127× 344× 344. Fi-
nally, images reconstructed at each respiratory position were combined in MATLAB
to produce a motion-corrected PET image.
5.2.2 Image Analysis
Reconstructed CMRA images were reformatted to simultaneously visualise the left
anterior descending (LAD) artery and right coronary artery (RCA) using the ‘Soap
Bubble’ software [49]. Metrics of visible vessel length and sharpness were obtained
for vessels without stents in the proximal artery. Vessel sharpness values were nor-
malised to the signal intensity of the centre line of each vessel, so that 100% sharp-
ness refers to a maximum signal intensity change at the vessel edge. Additionally,
motion-corrected CMRA images were reformatted following the anatomy observed
in the X-ray angiography in order to compare both of them visually.
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Reconstructed 18F-FDG PET images were analysed by automatically applying
the 17-segment model according to the American Heart Association [50] (see Section
2.3.2) to the left ventricular myocardium using dedicated software (MunichHeart
[220]). The relative increase in 18F-FDG signal of motion-corrected images over
uncorrected images was computed for each of the 17 segments for each patient.
Additionally, NMC and MC PET images were reoriented in short axis to visually
compare them with the LGE images acquired in the same scan session.
5.3 Results
Scans were successfully completed in all subjects. The average acquisition time
for the proposed PET-CMRA framework was 11.2 ± 2.4 minutes. Due to differ-
ences in planning time, in two of the patients there was no overlap between the
PET and the CMRA acquisition, so that motion correction of the PET data could
not be performed. Additionally, one of the patients was not able to receive the
gadolinium-based contrast agent. These three patients were excluded from the fol-
lowing analysis. For the rest of the patients (N = 11), the average overlap between
PET and CMRA acquisition was 8.8±1.2 minutes, corresponding to list-mode PET
data being acquired during 80.3± 20.9% of the duration of the CMRA acquisition.
For the motion-compensated PET-CMRA image reconstruction, 3 to 5 respiratory
bins (4.1± 0.9 bins on average) were used, resulting in PET bins with 62.93± 30.40
million counts.
Reformatted CMRA images showing non-stented RCA and LAD for three of the
patients are shown in Figure 5.2. Improvements in the delineation of the RCA and
LAD were observed in the CMRA images after applying MC, allowing depiction
of non-stented vessels, even in cases where severe respiratory motion prevented the
visualisation of both the left and right proximal coronary arteries in the NMC image,
as observed for Patient 1. Figure 5.3 shows example coronal slices of the 18F-
FDG PET images reconstructed for three representative patients. MC increased
the sharpness of the left ventricle myocardium and improved visualisation of small
features such as the papillary muscles (blue arrows) and delineation of viability
defects (red arrow) compared to NMC.
Chapter 5. Respiratory Motion-Corrected CMRA-PET: Initial Clinical
Validation
127
Figure 5.2: Reformatted images for 3 representative patients (columns) showing
uncorrected (NMC) and motion-corrected (MC) CMRA images. Improvements in
the visualisation of the vessels are observed when applying MC (green arrows) for
all cases, particularly in the distal segments of the arteries.
Figure 5.3: Coronal slice for 3 representative patients (columns) showing uncorrected
(NMC) and motion-corrected (MC) viability 18F-FDG PET images. Improvements
in image quality can be observed when applying MC, particularly in small structures
(blue and red arrows), compared to NMC.
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A visual comparison between the reformatted MC CMRA and the corresponding
invasive X-ray angiogram is shown in Figure 5.4 for two patients. Adequate spatial
resolution and contrast in CMRA images allowed for a depiction of the proximal
arteries comparable to the X-ray angiogram for both cases. In Patient 6, a stenosis
observed in the mid segment of the RCA in CMRA was confirmed in the angiogram
(Figure 5.4, red arrows), while in Patient 7 an aneurysm in the proximal RCA was
seen in both modalities (Figure 5.4, green arrows).
Figure 5.4: Reformatted CMRA and corresponding X-ray angiogram for two repre-
sentative patients. In Patient 6, a stenosis in the mid segment of the right coronary
artery (RCA) can be observed in both modalities (red arrows), while in Patient 7
an aneurysm can be observed in the proximal segment of the RCA (green arrows).
Figure 5.5 shows a short axis view of the 18F-FDG PET both for NMC and
MC reconstructions and corresponding slice of the 2D LGE scan for two patients.
It can be observed that MC PET images have an improved correspondence to the
anatomy as observed in the LGE images and reduced noise compared to NMC
images. In particular, improvements in delineation of viability defects are apparent:
for Patient 6, the transmural viability defect observed in the infero-lateral wall was
better depicted after motion correction (Figure 5.5, blue arrows), while in Patient 8,
motion correction allowed for the identification of viable myocardium in a defect that
appeared misleadingly as transmural in the NMC image (Figure 5.5, green arrows).
MC also enabled the depiction of thinner structures, such as the right ventricular
myocardium (Figure 5.5, pink arrow).
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Figure 5.5: Short axis view for 2 representative patients (rows) showing uncorrected
(NMC) and motion-corrected (MC) viability 18F-FDG PET images, and correspond-
ing conventional 2D LGE-MR scans. MC improves the correspondence of the PET
images to the anatomy as observed in the LGE images, particularly in the delin-
eation of viability defects (green and blue arrows) and right ventricle myocardium
(pink arrow).
Image quality metrics for uncorrected and motion-corrected CMRA images are
shown in Figure 5.6. Tracking of the vessels was possible in 14 out of 15 non-stented
vessels (8 RCA, 6 LAD). In one of the patients, significant cardiac motion prevented
the visualisation of the coronary arteries. For the rest of the vessels, increased visible
length of the vessels were observed after motion correction for both the RCA (49.9%
increase on average) and the LAD (32.6% increase on average), as shown in Figure
5.6(a,c). Similarly, vessel sharpness increased by 12.3% and 18.9% on average for
the proximal RCA and LAD respectively when using motion correction, as shown
in Figure 5.6(b,d).
Polar maps showing the relative increase in 18F-FDG PET signal in the left ven-
tricular myocardium after motion correction are displayed in Figure 5.7, for two
patients with distinct respiratory patterns alongside the average across the whole
cohort. For the patient with significant respiratory motion, the average signal in-
creased across all segments was 33%, with a maximum of ∼ 50% increase in the
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anterior wall. For the patient with moderate respiratory motion, an average of 3%
signal increase was observed across all segments. When considering the cohort av-
erage for each myocardial segment, signal increased most towards the inferior and
inferolateral regions, i.e. by an average of 8% across the six corresponding sectors
of the myocardium.
Figure 5.6: Image quality analysis for uncorrected (NMC) and motion-corrected
(MC) CMRA images in eleven patients, including: visible vessel length for (a) RCA
and (c) LAD, for each of the patients (green/blue lines) and average (red line); and
vessel sharpness for (b) RCA and (d) LAD. Visible vessel length and sharpness im-
prove after motion correction for all cases. Note that image analysis was performed
only in vessels without stents in the proximal segment of the coronary arteries.
Figure 5.7: 17-segment polar maps of the relative increase in 18F-FDG PET signal
after motion correction for the left ventricular myocardium. Two representative
patients with high amplitude respiratory motion and moderate respiratory motion
are shown, alongside the average across the cohort.
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Figure 5.8: Example fused PET-CMRA image (Patient 4) showing uncorrected
(NMC) and motion-corrected (MC) images. The motion correction framework pro-
duces co-registered diagnostic PET and MR images where an improved correspon-
dence between both modalities can be observed.
Finally, Figure 5.8 shows an example fused PET-CMRA dataset before and af-
ter motion correction. The framework produces co-registered diagnostic PET and
CMRA images, improving the correspondence between modalities compared to un-
corrected images.
5.4 Discussion
In this Chapter the proposed approach for respiratory motion-corrected cardiac
PET-MR for the simultaneous visualisation of coronary anatomy by CMRA and
myocardial viability by 18F-FDG PET was tested in a cohort of patients with
coronary artery disease. In contrast to most proposed MR-based motion correc-
tion approaches for cardiac PET data that utilise MR images mainly for improving
PET image quality [197,211,212], this approach produces diagnostic images in both
modalities, potentially reducing total PET-MR examination time. Furthermore, the
proposed PET-CMRA acquisition and reconstruction scheme has a short and pre-
dictable scan time of approximately 11 minutes, which makes it suitable for clinical
practice. Indeed, for this study the proposed PET-CMRA acquisition was included
into a standard clinical PET-MR protocol during the waiting time required for con-
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ventional LGE MR imaging.
Although the motion correction framework for CMRA data had been previously
shown and validated for healthy subjects [27, 159], this study focused on demon-
strating the feasibility of applying such framework to patients with documented
cardiovascular disease. For the cohort of patients in this study, improvement in
image quality after motion correction is apparent, allowing the visualisation of 14
out of 15 non-stented vessels and increasing visible length and sharpness of the coro-
nary arteries. Furthermore, visual comparison showed good agreement between the
motion-corrected CMRA and gold standard invasive X-ray angiograms, including vi-
sualisation of stenosis and aneurysm in the proximal segment of the arteries (Figure
5.4).
For the 18F-FDG myocardial viability PET images, the proposed motion correc-
tion approach improved the depiction of small structures such as the right ventricle
myocardium and papillary muscles, and enhanced the visualisation of transmural
and non-transmural viability defects in the left ventricle myocardium. In general,
motion correction produced an increased PET signal in each of the myocardial seg-
ments, with an average of 8% relative increase for the inferolateral wall. When
analysing the relative signal increase for each dataset, it was observed that im-
provements were strongly related to the respiratory pattern of each subject: modest
increase in signal was obtained in patients with shallow breathing, while regional in-
creases of up to 33% were observed in patients with significant respiratory motion.
Such increases come both from a reduction in the blurring and from appropriate
alignment between attenuation maps and emission data in the motion-corrected re-
construction framework. This is particularly significant in the anterior wall (Figure
5.7), located closer to the heart-lung interface. The results obtained are consistent
with findings in recent studies [221], where respiratory-induced mismatches between
emission and attenuation maps resulted in an average 6 ± 7% relative change in
18F-FDG uptake in the myocardium, compared to the 18F-FDG uptake obtained
with corrected attenuation maps, in a cohort of 20 patients.
The results obtained in this study suggest that respiratory motion compensa-
tion is fundamental for avoiding misinterpretation of non-viable segments in the
myocardium by 18F-FDG PET. An improved correspondence to the anatomy and
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delineation of transmural and non-transmural myocardial viability defects was ob-
served when comparing LGE-MRI with the motion-corrected PET images. Recent
studies have compared conventional LGE-MRI and 18F-FDG PET for the assess-
ment of myocardial viability [179, 180], finding good agreement between the two
imaging modalities. However, both studies report some mismatches between 18F-
FDG PET and LGE. It is worth noting that in these studies LGE-MR images were
acquired during breath-hold using 2D ECG-triggered sequences, as conventionally
done in clinical practice, to minimise cardiac and respiratory motion. On the con-
trary, in both studies, PET images did not include any motion compensation tech-
nique, which could partially explain the mismatches between the two modalities.
Further simultaneous 18F-FDG PET and LGE-MRI studies with 3D MR acquisi-
tion sequences that allow for motion compensation in both modalities, such as the
recently proposed MR BOOST sequence [222], could allow for a fairer comparison.
The study presented in this Chapter had a number of limitations. First, the pres-
ence of stents in at least one of the coronary arteries for each of the patients limited
the number of MR visible vessels available for analysis. A larger cohort would be re-
quired to provide a sufficient number of vessels for a more robust statistical analysis
of improvements in image quality after motion correction. Second, variations in the
overlap between the CMRA and PET acquisitions resulted in high variability in the
fraction of PET data that could be motion-corrected and therefore in the quality of
the PET images. An acquisition protocol with an extended PET list-mode acquisi-
tion that guarantees full overlap between the two acquisitions would allow the use of
the full capabilities of the motion correction approach. Third, patients with known
chronic total occlusion were recruited for this study. In order to assess the diagnos-
tic performance of the proposed simultaneous visualisation of myocardial viability
and coronary anatomy a similar study would need to be performed in subjects with
suspected coronary artery disease.
The proposed PET-CMRA protocol includes the acquisition of a Dixon-based
attenuation correction map, which segments the image into four tissue classes and
assigns a fixed attenuation value to each of them, as proposed in [117]. Studies
have shown that assigning a fixed attenuation value to the lung tissue can affect
accuracy of the PET images in the thoracic region, inducing bias in quantification
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of lung lesions [120] and volumes of interest within the lungs [121]. However, this
effect was shown to be less significant in cardiac structures. Moreover, a recent
study focused on cardiac imaging showed no statistically significant differences in
average myocardial uptake when comparing PET-CT and PET-MR using Dixon-
based attenuation correction [122].
While the presence of stents in the coronary arteries has been shown to produce
additional artefacts in MR-based attenuation correction due to misclassification of
voxels in stented arteries as air [221], such artefacts were not observed in this study.
Indeed, in this cohort of patients, voxels belonging to stented vessels were classified
as soft-tissue. It is worth noting that the impact of the stents themselves in the
accuracy of MR-based attenuation correction is challenging to assess, as such devices
usually produce artefacts in CT images [223], making gold-standard measurements
difficult to obtain.
As discussed in Chapter 4, the proposed motion compensation technique only
addresses the problem of respiratory motion. In CMRA, the problem of cardiac
motion was addressed by acquiring data only during the quiescent mid-diastolic
period of the cardiac cycle. A similar approach could be used for the PET data by
rejecting the fraction of data that falls outside the diastolic period, however, this
would impact image quality by increasing the noise in the PET images. Chapter
6 describes a novel approach for compensating for the effect of both cardiac and
respiratory motion on the PET images.
Finally, the proposed approach does not include a mechanism for compensating
for unpredictable bulk motion of the patient during the PET-CMRA examination.
Although this problem is alleviated when reducing total acquisition time, techniques
such as the one proposed in [224] for detection and correction of whole-body motion
in both PET and MR could be adapted to be used with the proposed framework
for improved robustness.
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PET radiotracer Clinical Indication Patient Gender Age (y)
13N-ammonia Healthy subject P1 M 51
P2 M 59




18F-choline† Coronary inflammation P7 M 67
P8 M 62
18F-NaF‡ Coronary plaque calcification P9 ∗ ∗
P10 ∗ ∗
Table 5.1: Summary of patient characteristics, including gender, age, cardiac PET
protocol and clinical indication. ∗ according to Institutional Ethics, this information
can not be disclosed. †Data acquired in collaboration with Rob Holtackers, Rik
Moonen and Eline Kooi (Maastricht UMC+). ‡Data acquired in collaboration with
Bas Bekkers, Bas Streukens and Eline Kooi (Maastricht UMC+).
5.5 Additional Clinical Experience
In order to demonstrate the benefits of the proposed respiratory motion correction
framework for simultaneous coronary MR angiography and cardiac PET in different
clinical contexts and with different PET radiotracers, preliminary tests have been
performed in 10 patients. Table 5.1 summarises the patient characteristics, clinical
indication and cardiac PET radiotracer used in each case.
All subjects were scanned in a 3 T Biograph mMR scanner (Siemens Health-
care, Erlangen, Germany). The CMRA-PET data was acquired after injection of a
Gadolinium-based MR contrast agent with the following CMRA parameters: voxel
size = 1× 1× 2 mm, field of view = 304× 304× 96−104 mm, TR/TE= 3.7/1.7 ms,
flip angle = 15◦, T2-prep = 50 ms and spectrally selective fat saturation.
A variety of PET radiotracers was used, depending on the clinical indication,
including 18F-FDG for myocardial inflammation, 13N-ammonia for myocardial per-
fusion, 18F-choline for vascular inflammation, and 18F-NaF for plaque calcification
PET imaging. Motion-corrected (MC) and uncorrected (NMC) images were recon-
structed in each case, for comparison purposes.
Scans were successfully completed in all subjects. The average acquisition time
for the PET-CMRA scan was 12.85 ± 2.50 minutes. Improvements in the delin-
eation of the left anterior descending and right coronary arteries were observed after
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Figure 5.9: Uncorrected (NMC) and motion-corrected (MC) (a) reformatted CMRA
images and (b) cardiac PET images for 3 representative patients. Fused PET-CMRA
is displayed for P9, due to the nature of the 18F-NaF uptake.
applying motion correction to the CMRA images in all cases, as can be observed
in Figure 5.9. In P3, an inadequate suppression of physiological myocardial uptake
can be observed, so myocardial inflammation could not be assessed. In P9, fused
cardiac PET-CMRA images are displayed, as the focal nature of the 18F-NaF uptake
requires an anatomical reference for localisation purposes. Overall, motion-corrected
CMRA shows sufficient image quality for depicting the proximal coronary anatomy,
while in the cardiac PET images, motion correction increases the sharpness of large
structures such as the liver or the myocardium, and enhances depiction of small
structures such as the papillary muscles.




A first clinical validation of the introduced respiratory motion-corrected whole-heart
PET-CMRA framework for simultaneous visualisation of coronary anatomy and
myocardial integrity in 11 patients with coronary artery disease has been described.
The reported results have shown that motion correction consistently improves image
quality compared to the uncorrected images for both imaging modalities. A good
agreement between coronary anatomy depicted by motion-corrected CMRA and X-
ray angiography was observed. In addition, motion-corrected 18F-FDG PET images
were in good agreement with LGE-MRI, showing more accurate depiction of both
transmural and non-transmural viability defects.
Results obtained from the cohort of patients with coronary artery disease and
from additional preliminary tests in patients with a variety of cardiac conditions
have shown that the PET-CMRA framework approach is robust and can be applied
in combination with different PET radiotracers. Furthermore, the results suggest
that the PET-CMRA framework allows the acquisition of diagnostic images with
both modalities in a short and time-efficient examination, showing promise for its
integration in clinical practice.
Chapter 6:
Respiratory and Cardiac Motion-
Corrected Simultaneous
Dual-Phase CMRA-PET
The approach for simultaneous CMRA-PET introduced in Chapters 4 and 5 only
enables correction of the effect of the respiratory-induced motion of the heart in
both imaging modalities. Whereas in the proposed approach for CMRA the effect
of cardiac motion is minimised by acquiring data only during the mid-diastolic
quiescent period of the cardiac cycle, no cardiac motion compensation was considered
for the PET data, which was simply aggregated over each heartbeat.
In order to assess the effect of cardiac motion correction in myocardial integrity
PET imaging, a preliminary simulation study was performed. In this study, the
impact of varying the spatial resolution and temporal resolution (i.e. number of
cardiac phases) of the cardiac motion fields was analysed, and results suggested that
using two cardiac phases, representing systole and diastole, and a spatial resolution
of 2 mm allows for an accurate estimation of the extent and degree of transmurality
of simulated viability defects. The methods and results of this study are briefly
summarised in this Chapter.
Following the simulation study results, the method proposed in Chapters 4 and
5 is extended in this Chapter to correct for both cardiac and respiratory induced
non-rigid motion of the heart. This is achieved through the implementation of a
simultaneous dual-phase CMRA and cardiac PET data acquisition that provides: (1)
coronary anatomy visualisation from CMRA acquisition, (2) left ventricular function
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from a dual-phase anatomic whole-heart MR acquisition, and (3) assessment of
myocardial integrity from cardiac and respiratory motion-corrected 18F-FDG PET
data, in a single efficient examination.
Using the same framework described in Chapters 4 and 5, respiratory motion
is estimated from 2D iNAVs, acquired now at each heartbeat before both the sys-
tolic and diastolic CMRA phases, and from high-resolution 3D CMRA images re-
constructed at different respiratory positions for each cardiac phase. Furthermore,
estimation of non-rigid cardiac motion fields is performed by image registration of
the systolic and diastolic 3D images obtained from the proposed dual-phase CMRA
acquisition. The MR-derived deformation fields are used to correct both the dual-
phase CMRA (respiratory motion correction for each cardiac phase) and the simul-
taneously acquired cardiac PET data (respiratory and cardiac motion correction).
This approach is highly efficient, because it uses all the acquired PET and dual-
phase CMRA data for image reconstruction, and it produces good quality images
with both modalities within a short and predictable acquisition time.
The motion-corrected dual-phase CMRA image reconstruction was tested in
eight healthy subjects. CMRA images were reformatted to visualise the coronary and
cardiac anatomy, and left ventricular function (systolic and diastolic volumes, ejec-
tion fraction and stroke volume) derived from the proposed dual-phase 3D CMRA
sequence was compared against reference values obtained from a conventional stack
of 2D cine images. The whole respiratory and cardiac PET-CMRA motion correc-
tion framework was then tested in six cardiac patients with coronary artery disease,
using 18F-FDG for assessing either myocardial viability or inflammation. Some of
the results presented in this Chapter have been published as a journal article [28].
6.1 Impact of Spatio-Temporal Resolution of Motion
Fields on Cardiac Motion-Corrected PET
As described above, a simulation study was performed to evaluate the impact of
cardiac motion correction on myocardial PET imaging. The effect of varying the
spatial and temporal resolution of cardiac motion information on image quality
and quantitative standardised uptake values (SUV) was analysed. This study was
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performed using the commercially available XCAT digital phantom [225], which
provides a numerical representation of a human torso and parameterised models of
motion for each organ in the thorax. The software can be used for simulation of
cardiac motion only, respiratory motion only or both cardiac and respiratory motion
simultaneously. Detailed information about the motion can be obtained from the
XCAT software as a set of vectors that describe the 3D position of each voxel relative
to the first generated frame. For the purposes of this study, only cardiac motion was
used. The XCAT software generates emission maps, in which user-defined activity
values are assigned to each tissue class, and attenuation maps created using realistic
energy-dependent attenuation coefficients. These emission and attenuation maps
are produced for each motion state of the simulation.
6.1.1 Methods
Using the XCAT phantom, four myocardial viability lesions with different degrees of
transmurality (100%, 50% and 25%), and varying extension and location (anterior
and lateral wall) were simulated using realistic 18F-FDG uptake values [226]. A short
axis view of the resulting emission maps for each case can be observed in Figure 6.1.
Figure 6.1: Example short-axis slice of the simulated myocardial viability defects.
Left (LV) and right (RV) ventricles are indicated in the images, as well as the
simulated defects (red arrow).
Cardiac motion was simulated based on a normal cardiac cycle with an RR
interval of 1 s and 20 cardiac phases. Analytical PET simulations were performed
using the STIR software [227], with the geometry of the Siemens Biograph mMR
scanner, i.e. 60 cm bore size, 8 rings of 4 × 4 × 20 mm3 LSO crystal detectors,
resulting in an axial field of view of 258 mm. The simulation of PET data acquisition
comprised the 3D forward-projections of emission maps at each motion state and
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the application of corresponding attenuation factors. Background coincidences from
scattered and random coincidences were not included in these simulations. Emission
maps were scaled to produce a total of 35× 106 counts over the entire cardiac cycle,
which is representative of the number of true counts acquired in a 5-minutes 18F-
FDG cardiac scan. Poisson noise was introduced to each cardiac phase to simulate
coincidence counting.
Motion information was obtained from the XCAT software with five temporal
resolutions, i.e. 20, 10, 5, 2 and 2∗ cardiac phases, and four spatial resolutions, i.e. 2,
4, 5.68 and 9.84 mm3 isotropic voxel size, resulting in twenty sets motion operators of
varying spatial and temporal resolution. The 2∗ non-uniform division of the cardiac
cycle groups two thirds of the cardiac cycle around maximum relaxation in one
cardiac phase, approximately corresponding to diastole, and the remaining third as
the second phase, representing systole.
The motion fields were interpolated to PET image resolution and used as input
in an ordered-subsets motion compensated PET image reconstruction algorithm,
also provided by the STIR software [171]. The reconstruction used 21 subsets and 3
iterations, a voxel size of 2.03×2.08×2.08 mm3, a matrix size of 127×285×285 and a
4 mm full-width at half-maximum (FWHM) isotropic Gaussian post-reconstruction
filter. Additionally, a motion-free image was simulated and reconstructed for refer-
ence purposes, and an uncorrected reconstruction was performed for further com-
parison.
Reconstructed PET images were assessed based on clinical metrics, including
detectability of damaged segments in high-resolution AHA polar plots computed
from the left ventricular myocardium [50], and extent and degree of transmurality
(i.e. fraction of the wall affected) of the myocardial lesion. Detectability of the
lesion was defined such that segments with an SUV 2.5 standard deviations below the
mean myocardial SUV were labelled as non-viable [228], and the number of segments
labelled as non-viable was used for approximating the lesion extent. For assessing
degree of transmurality, three image profiles were placed across the damaged and
healthy myocardium in a short-axis slice. For improved robustness, the background
signal was thresholded and a Gaussian curve was fitted to each profile. An example
of healthy and damaged myocardium profiles, with their corresponding Gaussian
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Figure 6.2: (a) Example of profiles used for transmurality analysis in the damaged
(blue) and healthy (red) myocardium. Background signal is removed prior to the
gaussian fit for the (b) damaged and (c) healthy myocardium using a threshold
indicated as ‘th’. The standard deviation of the fitted curve is used to estimate the
full-width at half-maximum (FWHM) thickness of the myocardium.
fits are shown in Figure 6.2. The average standard deviation of the Gaussian curve
was used to estimate the FWHM thickness of the myocardium. Then, the degree
of transmurality was defined as one minus the ratio between the FWHM of the
affected and healthy myocardium, so that 100% represents a transmural defect and
0% implies a non-damaged myocardium, following Equation 6.1.






For both transmural and non-transmural defects, results showed that although image
quality degrades when reducing temporal and spatial resolution of the motion fields,
non-viable myocardium can be detected even without motion correction, as shown
in Figure 6.3. For defects 1 (transmural) and 2 (50% transmural), a resolution
of 10 mm and 2∗ phases allowed the detection of more of 90% of the non-viable
segments. For defects 3 (25% transmural) and 4 (50% transmural), a minimum
resolution of 2 mm and 2∗ cardiac phases was required to detect more than 90% of
the non-viable segments correctly.
For the transmurality analysis both the 2 mm-20 phases resolution and the 2 mm-
2∗ phases resolution lead to accurate results; considering only the non-transmural
defects, an average error of 7.17± 3.44% and 5.58± 1.53% compared to the motion-
free reference was obtained, respectively. A summary of the transmurality analysis
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Figure 6.3: Polar plots for all simulated defects, showing reference motion-free,
uncorrected, and motion-corrected images with highest, minimum and lowest spatio-
temporal resolutions. Damaged segments are indicated in each plot with a black X.
When using 2∗ phases and an appropriate spatial resolution, more of 90% of the
non-viable segments can be detected. (A: anterior, S: septal, L: lateral, I: inferior)
for these defects is shown in Figure 6.4. For defects 2 and 3, using 2 cardiac phases
leads to an underestimation of the degree of transmurality of the defect, indepen-
dently of the spatial resolution used. For defect 4, located in an area of large cardiac
motion amplitude, when no motion correction is performed, the lesion is erroneously
detected as transmural, as depicted in Figure 6.5.
6.1.3 Conclusion
This preliminary simulation study assessed the impact of spatial and temporal reso-
lution of motion fields for cardiac motion-corrected myocardial integrity PET imag-
ing. Results showed that non-viable myocardium can be detected even without
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Figure 6.4: Transmurality estimation for 50% transmural viability defects located
in areas of small (defect 2) and large (defect 4) cardiac motion amplitude, and for a
small transmural defect (defect 3). For all defects resolution can be reduced to 2 mm-
2∗phases without losing accuracy. For defect 4, the lesion appears erroneously as
100% transmural in the uncorrected and 2-phases motion-corrected reconstructions.
Figure 6.5: Short axis slices for motion free, uncorrected and two motion compen-
sated reconstructions for defect 4 alongside profiles through the lesion. For the
uncorrected reconstruction, the remaining healthy myocardium cannot be identified
so the lesion appears erroneously as transmural.
motion correction, however, motion correction is essential for accurate estimation of
the size and degree of transmurality of defects.
The non-uniform two-phase division of the cardiac cycle achieved less than 10%
error in the estimation of extent and transmurality of all simulated defects using a
spatial resolution of 2 mm. Thus, temporal resolution of the motion fields can be
significantly reduced without losing diagnostic accuracy. In the context of simul-
taneous CMRA-PET imaging, these results suggest that including one additional
cardiac phase in the CMRA acquisition sequence would enable accurate motion es-
timation for cardiac motion correction in PET, provided that such acquisition is
performed during systole.





The proposed PET-CMRA acquisition protocol consists of an ECG triggered free-
breathing dual-phase CMRA sequence simultaneously acquired with list-mode PET
data on a 3 T hybrid PET-MR system as shown in Figure 6.6. Similarly to the
framework introduced in Chapter 4, a standard 2-point Dixon-based attenuation
map (µ-map) is acquired during breath-hold at end-expiration before the simultane-
ous PET-MR acquisition [117]. A 2D cine acquisition is performed to determine two
subject specific trigger delays, which coincide with the mid-systolic and mid-diastolic
quiescent periods of the cardiac cycle, and the length of the acquisition window for
3D CMRA. As the acquisition window is the same in both cardiac phases, its length
is defined by the shortest quiescent period, usually mid-systole.
The dual-phase CMRA data is acquired using a 3D spoiled gradient echo se-
quence with a fully sampled golden-step Cartesian spiral profile order sampling tra-
jectory [155], with one spiral interleaf acquired both in mid-systole and mid-diastole
at each cardiac cycle as shown in Figure 6.6a. A low-resolution 2D iNAV [78] is ac-
quired before each 3D CMRA acquisition by adding spatially encoded low flip-angle
lines. Finally, the same preparatory pulses used for the single-phase CMRA method
are performed before data acquisition, to enhance the contrast between the coro-
nary arteries and surrounding tissues: an adiabatic T2 preparation pulse is used to
improve contrast between blood and myocardium without the use of exogenous con-
trast agents [91], and fat saturation is used to reduce the signal from subcutaneous
and epicardial fat.
6.2.2 Respiratory and Cardiac Motion Estimation and Motion-
Corrected Dual-phase CMRA Reconstruction
Before PET and CMRA image reconstruction, the acquired 2D iNAVs are used to
estimate the translational respiratory motion of the heart in the foot-head (FH)
and right-left (RL) directions by tracking a rectangular template positioned around
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Figure 6.6: Simultaneous dual-phase CMRA and cardiac PET acquisition scheme.
(a) A 2D CINE image, used for defining the mid-systolic and mid-diastolic delays,
and a MR-based µ-map, used for attenuation correction of PET data, are obtained
before the PET-CMRA acquisition. Dual-phase CMRA data is acquired following
a golden-step spiral ordering in a Cartesian grid, so that at each heartbeat, a spiral
interleaf is acquired both in systole and diastole. Fat saturation (Fat Sat) and T2
preparation (T2 prep) pulses are used to enhance the contrast between the coronary
arteries and surrounding tissues. (b) A low-resolution coronal 2D iNAV is acquired
before the 3D CMRA for foot-head (FH) and right-left (RL) respiratory motion
estimation in both cardiac phases. (c) FH motion is used to define a number of
respiratory bins, each containing the same amount of CMRA data, and FH and
RL motion are used to correct the CMRA data (2D translational correction) to the
centre of each respiratory bin (green arrows).
the apex of the heart using rigid image registration (Figure 6.6b). The FH motion
is then used to define Nbins respiratory bins, ranging from end-expiration to end-
inspiration, each containing approximately the same amount of dual-phase CMRA
data.
CMRA data acquired during deep breaths are excluded from image reconstruc-
tion at this point, by rejecting k-space data acquired outside two standard deviations
from the mean FH translation [27,159]. Additionally, FH and RL translational mo-
tion estimates are used to correct the dual-phase CMRA data to the centre of each
respiratory bin by applying a linear phase to the k-space data according to Equation
3.48, as represented in Figure 6.6c (green arrows).
The motion estimation and respiratory motion-corrected dual-phase CMRA im-
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age reconstruction approach is shown in Figure 6.7. The translationally corrected
dual-phase CMRA data is divided into the two cardiac phases (Figure 6.7a), and
the following steps of the image reconstruction process are performed in each one of
them separately.
Figure 6.7: Motion-corrected dual-phase CMRA reconstruction scheme. (a) Res-
piratory bins (Figure 6.6c) are used to bin the dual-phase CMRA. (b) MR images
reconstructed at each cardiac and respiratory phase are used for estimation of non-
rigid respiratory motion fields (in green). (c) Respiratory motion-corrected CMRA
images for systole and diastole are reconstructed by including the respiratory mo-
tion fields in a generalised matrix description framework, and (d) used to estimate
cardiac motion (in orange).
In the first step, the Nbins undersampled bins are reconstructed with a soft-
binning iterative SENSE [150] approach with exponential decay weighting by solving
Equation 6.2 for each of them:
x̂b = arg min
xb
‖Wb (Exb − kb)‖22 (6.2)
where x̂b are the reconstructed bin images, Wb is a diagonal matrix containing
data weights for bin b, E is the encoding operator, including the discrete Fourier
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transform and coil sensitivities, and kb is the data acquired at each respiratory bin
after 2D translational motion correction to the centre of the bin. In this Chapter,
the diagonal elements of Wb are defined as an exponential decay function of the
respiratory position where the k-space data was acquired, so that points that belong
to the respiratory bin being reconstructed will have a unitary weight, and points
acquired outside the bin have a weight that decreases exponentially to zero as the
distance to the centre of the bin increases. This ensures that each bin contains
information from the centre of k-space, allowing for an increased homogeneity in
the image contrast in all the respiratory bins.
After the Nbins respiratory bins have been reconstructed, 3D non-rigid deforma-
tion fields that represent the respiratory motion are estimated in the second step
of the reconstruction scheme (Figure 6.7b) via free-form image registration using
the end expiratory bin as reference, with normalised mutual information as simi-
larity metric [213]. Finally, the motion compensated CMRA image reconstruction
problem is formulated using the generalised matrix description approach described
before [158], so that if xc is the motion-free image to be reconstructed for cardiac
phase c (c = systole, diastole), then the motion-corrupted measured k-space acquired





where Ub,c are the motion operators which transform the cardiac phase c at the
reference position to any respiratory position b, and Sb corresponds to the sampling
matrix containing the k-space points acquired at respiratory bin b and cardiac phase
c. Each motion free image can then be reconstructed by solving Equation 6.3 for xc
using the linear CG algorithm [145].
At the end of the dual-phase CMRA reconstruction process, one systolic and one
diastolic respiratory motion-corrected CMRA image is obtained, as shown in Figure
6.7c. These images can be used both for visualisation of the coronary anatomy
in systole and diastole and estimation of ventricular function. Furthermore, these
images can be used to estimate the non-rigid motion of the heart Uc between systole
and diastole, as shown in Figure 6.7d.
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Figure 6.8: Cardiac and respiratory motion-corrected PET reconstruction scheme.
(a) Respiratory bins (Figure 6.6c) and ECG signal are used to dual-gate the PET
data. (b) Respiratory and cardiac motion fields estimated from MR are used for
transforming the static µ-map to each cardiac and respiratory position, and (c) to
produce a motion-corrected PET image.
6.2.3 Motion-Corrected PET Reconstruction
List-mode PET acquisition is synchronised with the dual-phase CMRA acquisition
using the ECG signal time stamps, so that only PET data acquired simultaneously
with MR is selected for image reconstruction. For each heartbeat, one third of
the data acquired around maximum contraction of the left ventricle is assigned
to the systolic phase, and the remaining two thirds are assigned to the diastolic
phase, as indicated by the preliminary simulation study (Section 6.1). The cardiac
binned PET data is then assigned to the corresponding respiratory bin, using the
same respiratory windows defined in the dual-phase CMRA reconstruction. Thus,
list-mode PET data is dual-gated into respiratory and cardiac phases as shown in
Figure 6.8a.
Chapter 6. Respiratory and Cardiac Motion-Corrected Simultaneous
Dual-Phase CMRA-PET
150
The static attenuation map acquired at end-expiration is transformed to each
cardiac and respiratory phase using the corresponding cardiac and respiratory de-
formation fields estimated during CMRA image reconstruction, as represented in
Figure 6.8b. Using a RTA approach [164], each gate is independently reconstructed
with an ordered-subsets expectation-maximisation (OSEM) algorithm [161], includ-
ing normalisation, attenuation, random and scatter corrections.
Omitting the subsets division for simplicity, the iterative PET reconstruction










NAb,cPρ(it)b,c + r + s
(6.4)
where ρ(it)b,c is a vector that contains the PET image for respiratory bin b and cardiac
phase c (b = 1...Nbins,c = s, d) after (it) iterations of the algorithm, P is the matrix
that models the system forward projection considering the scanner geometry, N and
Ab,c are diagonal matrices with entries down the diagonal equal to the reciprocal of
the normalisation and attenuation correction factors for respiratory bin b and cardiac
phase c, respectively, mb,c is a vector that contains the dual-gated data corresponding
to respiratory bin b and cardiac phase c, and r and s represent estimations of random
and scattered coincidences, respectively.
Finally, the images reconstructed at each respiratory and cardiac phase are trans-
formed back to the diastolic and end-expiratory phase (Figure 6.8c), and aggregated
to produce a motion-compensated PET image ρ, according to Equation 6.5. It is
worth noting that only systolic images require transformation in the cardiac dimen-




U−1c U−1b,sρb,s + U−1b,dρb,d (6.5)
6.3 Experiments
For this study two in vivo experiments were performed. The aim of the first ex-
periment was to validate the motion-corrected dual-phase CMRA framework for
estimating left ventricular function, and was performed in a cohort of eight healthy
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subjects, using only the MR capabilities of a 3 T hybrid PET-MR scanner (Biograph
mMR, Siemens Healthcare, Erlangen, Germany). Then, the whole motion-corrected
dual-phase CMRA-PET framework was tested in a cohort of six patients with known
coronary artery disease. Written informed consent was obtained from all subjects
according to institutional guidelines and the institutional ethics committee approved
the study.
6.3.1 Healthy Subjects Data Acquisition
Eight healthy subjects (age 29.9±3.4 years, 4 male) were scanned during free breath-
ing using a prototype implementation of the proposed dual-phase CMRA sequence.
The following acquisition parameters were used: coronal slices, RL phase encoding,
1×1×2 mm3 resolution, field of view 304×304×80−96 mm3 with a subject-specific
number of slices covering the whole heart, TR/TE = 3.7/1.7 ms, flip angle = 12◦,
readout bandwidth = 685 Hz/px. Two subject-specific trigger delays were set target-
ing the mid-systolic and mid-diastolic rest period and an acquisition window ranging
from 82 to 104 ms (corresponding to 22 to 28 k-space lines acquired per heartbeat)
was used depending on the minimal length of the quiescent periods of the subject.
Contrast between the arteries and surrounding tissues was enhanced using an adi-
abatic T2 preparation pulse of 50 ms and a conventional fat saturation pulse. For
the 2D iNAV acquisition, the following parameters were used: high-low Cartesian
trajectory, coronal orientation, RL phase encoding, flip angle = 3◦, 14 readouts with
the same field of view of the CMRA acquisition, resulting in a 1×21.7 mm2 acquired
in-plane resolution (reconstructed to 1× 1 mm2).
Additionally, a conventional multi-breath-hold of 2D short-axis CINE acquisition
was performed and used as reference standard for left ventricular function estima-
tion. The stack of 2D CINE images was acquired with an in-plane resolution of
1.5× 1.5 mm2, using GRAPPA parallel imaging [148] with an undersampling factor
of 2 and 24 calibration lines, slice thickness of 8 mm, 8 to 10 slices covering the whole
left-ventricle and 25 cardiac phases.
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6.3.2 Patient Data Acquisition
Six patients with symptomatic CAD (angina or angina equivalent, excluding acute
ST-elevation myocardial infarction patients) and known chronic total occlusion of
at least one of the coronary arteries (ages 66.3 ± 8.6 years, 5 male) received an
18F-FDG injection of 330.7 ± 30.3 MBq and were scanned 1.73 ± 0.77 hours after
injection. The simultaneous PET-CMRA acquisition was performed ∼1–2 minutes
after injection of a Gadolinium-based contrast agent, during the 10–15 minutes
waiting time required for optimal contrast in conventional LGE imaging. Before
the dual-phase CMRA acquisition, a µ-map was acquired during a 19 s breath-hold
at end-expiration using the vendor’s standard 2-point Dixon acquisition (coronal
orientation, FH phase encoding, TR/TE1/TE2 = 3.60/1.23/2.46 ms, 2.604×2.604×
3.12 mm3 resolution, field of view 328×500×399 mm3, no ECG triggering). Following
this, the subjects were scanned during free-breathing using the proposed dual-phase
CMRA sequence with the same acquisition parameters described for the healthy
subjects. List-mode PET data was acquired during the whole dual-phase CMRA
scan, resulting in a patient-specific PET acquisition duration.
6.3.3 PET-CMRA Image Reconstruction
For all datasets, dual-phase CMRA image reconstruction was performed offline in
MATLAB (Mathworks, Natick, Massachusetts, USA) using custom developed soft-
ware. CMRA data were reconstructed offline with the proposed motion correc-
tion approach (MC) and without motion correction (NMC) for comparison pur-
poses. Image registration for estimating respiratory and cardiac motion operators
was performed using a free-form deformation algorithm [213], that provides both
forward and inverse motion fields. The MC dual-phase CMRA reconstruction re-
quired 2D translational motion-corrected soft-binning iterative SENSE reconstruc-
tions to produce 3D images at each cardiac and respiratory phase (reconstruction
time of ∼3.6 min per bin), followed by 3D respiratory bin-to-bin non-rigid regis-
tration at each cardiac phase (registration time of ∼40 s per bin) and finally, the
motion-corrected CMRA reconstruction (reconstruction time of ∼30 min per cardiac
phase), with a total reconstruction time of ∼103 min. Reconstruction of the stack
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of 2D CINE images was performed directly on the scanner.
PET image reconstruction was performed offline using MATLAB and e7 Tools
(Siemens Healthcare, Knoxville, USA) using the OSEM algorithm, with 3 iterations
and 21 subsets, point spread function modelling, voxel size = 2.03×2.08×2.08 mm3,
matrix size = 127× 344× 344. PET images were reconstructed using both cardiac
and respiratory motion correction (MC), using only respiratory motion correction
(RespMC) and without motion correction (NMC) for comparison purposes. The
MC PET image reconstruction required OSEM reconstructions at each cardiac and
respiratory phase (∼4 min per bin), followed by 3D non-rigid deformation (∼10 s
per bin) and finally adding, with a total reconstruction time of ∼42 min.
6.3.4 Image Analysis
For assessment of image quality, reconstructed systolic and diastolic CMRA images
were reformatted to visualise the left anterior descending (LAD) and right coro-
nary artery (RCA) simultaneously using dedicated software [49]. For the healthy
subjects, left ventricular function was estimated using dedicated commercially avail-
able software (OsiriX, Geneva, Switzerland). For the diastolic and systolic CMRA
images, end-diastolic (EDV) and end-systolic (ESV) volumes were obtained from
semi-automatic segmentations of the left ventricular blood pool. For the 2D CINE
images, EDV and ESV were obtained by semi-automatically contouring the left
ventricle. In both cases, stroke volume (SV) and ejection fraction (EF) were then
derived by subtracting the ESV from the EDV and by taking the ratio between SV
and EDV, respectively, as described in Chapter 2. A Bland-Altman analysis [229]
was performed for each of the indices in order to assess the agreement between both
measurements.
Reconstructed 18F-FDG PET images were analysed using the AHA 17-segment
model for the left ventricular myocardium [50] using dedicated software (Munich-
Heart, [220]). The relative increase in 18F-FDG signal of RespMC and MC images
over uncorrected images was computed for each of the 17 segments for each patient.
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Figure 6.9: Reformatted dual-phase CMRA images showing uncorrected (NMC) and
motion-corrected (MC) images for both systole and diastole in two representative
healthy subjects. MC improves the visualisation of both the left (LAD) and right
coronary arteries (RCA), allowing for the depiction of both proximal and distal
segments (blue arrows). In (B), the tortuous anatomy of the LAD in systole prevents
the visualisation of the artery in the reformatted coronal plane (dashed red box) but
this is solved when reformatting in the transverse plane (solid red box).
6.4 Results
Scans were successfully completed in all subjects, with an average acquisition time
of 12.72± 2.29 minutes for the proposed PET-CMRA framework. For all subjects,
3 to 5 respiratory bins (4.5 ± 0.8 bins on average) and 2 cardiac phases were used
for both PET and MR data. For the patients with cardiovascular disease, this
binning process resulted in 30.09 ± 14.50 million counts for the PET systolic bins,
and 52.97± 25.67 million counts for the PET diastolic bins on average.
Figures 6.9 and 6.10 show reformatted uncorrected (NMC) and motion-corrected
(MC) systolic and diastolic CMRA images for representative healthy subjects and
patients, respectively. It can be observed that MC improved the delineation of
the vessels, allowing for visualisation of both the RCA and LAD in all cases. For
the healthy subjects, it can be observed that MC increased the visible length of
the vessels, allowing for visualisation of the distal segment of the arteries in both
systole and diastole (Figure 6.9a, blue arrows). For the second healthy subject, the
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Figure 6.10: Reformatted dual-phase CMRA images showing uncorrected (NMC)
and motion-corrected (MC) images for both systole and diastole in two represen-
tative patients with coronary artery disease. MC improves the visualisation of the
proximal left (LAD) and right coronary arteries (RCA), and in (a) allows for the
depiction of non-stented distal segments of the RCA (blue arrows). In both cases,
the LAD can be clearly depicted despite the presence of a stent (green arrows) in
the mid segment of the vessel.
tortuous anatomy of the LAD in systole prevented an appropriate reformatting in
the coronal plane, as shown in Figure 6.9b (dashed red box). However, changing
the reformatting plane solved this issue, and the vessel is clearly depicted in the
transverse plane (Figure 6.9b, solid red box).
In the CAD patients, who have more irregular breathing patterns and larger
respiratory amplitude as shown in previous Chapters, improvements in the delin-
eation of the vessels after MC become even more apparent (Figure 6.10). In both
cases, the proximal RCA and LAD were well depicted in the MC images, and the
presence of a stent in the mid segment of the LAD did not prevent visualisation of
the distal segment of the vessel, as shown in Figure 6.10a,b (green arrow). For the
second CAD patient (Figure 6.10b), residual cardiac motion was observed in the
MC systolic CMRA, affecting the sharpness of the mid and distal RCA.
Conventional orthogonal planes obtained from MC systolic and diastolic CMRA
images of a representative subject are shown in Figure 6.11a, in addition to the
corresponding volumetric rendering of the left ventricular blood pool. It can be
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Figure 6.11: Dual-phase CMRA approach for estimation of left ventricular function.
(a) Semi-automatic segmentation for a representative subject, showing three orthog-
onal planes for systole and diastole and corresponding rendering of the left ventric-
ular cavity. Bland-Altman plots of (b) end diastolic volume (EDV), (c) end systolic
volume (ESV), (d) stroke volume (SV) and (e) ejection fraction (EF) comparing
dual-phase 3D CMRA images and conventional multi-slice 2D CINE acquisition.
Middle red line: mean difference; upper and lower dashed red lines: 95% limits of
agreement.
observed that the contrast between blood pool and myocardium was sufficient, and
allowed for semi-automatic segmentation of the left ventricular cavity in both cardiac
phases. Figure 6.11b-e shows Bland-Altman plots for left ventricular volumes and
indices obtained for the cohort of healthy subjects, indicating in each case the average
bias (solid red line) and 95% limits of agreement (dashed red lines). EDV and ESV
estimated from dual-phase 3D CMRA images are comparable to the estimation
from multi-slice multi-breath-hold 2D cine images, with an average underestimation
of 4.61 ± 4.03 mL and 1.54 ± 1.75 mL respectively (Figure 6.11b,c). Functional
indices obtained from dual-phase CMRA therefore resulted in good agreement with
the standard 2D CINE approach, with an average bias of −3.07 ± 3.26 mL and
−0.30± 1.01% for the SV and EF respectively (Figure 6.11d,e).
Respiratory motion-corrected systolic and diastolic CMRA and PET images for
a representative patient are shown in Figure 6.12, alongside the respiratory motion-
corrected (RespMC) PET image. Differences in the anatomy of the heart between
the two cardiac phases are apparent in both imaging modalities, including thick-
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Figure 6.12: Coronal views from a cardiac patient, showing respiratory motion-
corrected (a) systolic and (b) diastolic CMRA and 18F-FDG PET images, alongside
(c) respiratory motion-corrected (RespMC) PET image. RespMC aggregates data
acquired at different cardiac phases, resulting in cardiac-induced blurring of small
structures (blue arrow) and apparent thickening of the myocardium (green arrow).
ening of the left ventricle myocardium in the systolic phase as compared to the
diastolic phase. RespMC aggregates data acquired at both cardiac phases, result-
ing in cardiac-induced blurring of small structures, such as the papillary muscles,
compared to diastolic PET images (Figure 6.12b-c, blue arrow). Furthermore, the
RespMC image depicts a thicker myocardium than the diastolic PET image, due
to signal arising from the systolic phase (Figure 6.12a-c, green arrow). It is worth
noting that the myocardium depicted by the RespMC image is dominated by the
diastolic image, since diastole comprises a longer fraction of the cardiac cycle.
Cardiac PET images reconstructed without motion correction (NMC), with res-
piratory motion correction only (RespMC) and with both cardiac and respiratory
motion correction (MC) from three representative patients together with profiles
across the left ventricle myocardium obtained from transverse slices are shown in
Figure 6.13. RespMC improved image quality by increasing the sharpness of the
myocardium in all cases, as can be observed in the narrowing of the peak in the
profiles. MC further increased myocardial sharpness and improved delineation of
features such as the papillary muscles (as can be observed for cardiac patients 2 and
4) and the right ventricle myocardium (cardiac patient 4, white arrow).
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Figure 6.13: Uncorrected (NMC), respiratory motion-corrected (RespMC) and car-
diac and respiratory motion-corrected (MC) cardiac PET images for three cardiac
patients, including transverse and coronal views alongside profiles across the my-
ocardium (intensity in arbitrary units). RespMC increases sharpness of the my-
ocardium, and MC further improves sharpness, illustrating the impact of cardiac
motion correction in both the left and right ventricle myocardium (white arrow).
Figure 6.14 shows standard 17-segment plots for three representative patients,
displaying the relative increase of the 18F-FDG signal in each myocardial segment
after RespMC and MC compared to uncorrected images. In all cases, an increased
signal in the basal segments of the myocardial wall was observed after RespMC, with
a maximum relative increase ranging from 6.8 to 11.2% compared to uncorrected
images. Further increase was observed in MC images, ranging from 13.1 to 28.7%,
the latter observed in the anteroseptal segments in cardiac patient 5.
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Figure 6.14: 17-segment polar maps of the relative increase (%) in 18F-FDG PET
signal after respiratory motion correction only (RespMC) and after cardiac and
respiratory motion correction (MC) for the left ventricular myocardium in three
representative patients.
6.5 Discussion
In this Chapter, a novel approach for the simultaneous acquisition of coronary MR
angiography, left ventricular function and motion-corrected cardiac PET has been
introduced. This approach extends the framework described in Chapter 4 to a dual-
phase acquisition, so that a systolic and a diastolic CMRA image are acquired in a
single examination, allowing quantification of left ventricular volumes and functional
indices, in addition to providing cardiac motion deformation fields for motion correc-
tion of PET images. This approach is highly efficient, as it uses all the acquired data
for image reconstruction (100% scan efficiency after outlier rejection) and produces
co-registered high quality images in both modalities from a single examination of
∼12.7 minutes.
The proposed approach was tested in eight healthy subjects (MR-only acqui-
sitions) and six patients with coronary artery disease (PET-MR acquisition), and
an improved delineation and increased visible length of both the RCA and LAD
arteries after motion correction was observed for all subjects. For the healthy sub-
jects, proximal and distal segments of the coronary arteries are clearly depicted in
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both systole and diastole. It is worth noting the significant change in the coronary
anatomy between the two cardiac phases: for one of the subjects (Figure 6.9b), a
tortuous anatomy of the proximal LAD in systole prevented its visualisation in the
coronal view, requiring an additional view in the transverse plane for appropriate
depiction of the vessel. For the CAD patients, improved delineation of the coronary
arteries after motion correction was observed even for stented vessels, as shown in
Figure 6.10a,b. In one of the patients, a short systolic quiescent period resulted in
residual cardiac motion, as can be observed in Figure 6.10b. However, the coronary
anatomy could be assessed in the diastolic CMRA, while the systolic CMRA still
provided sufficient information for estimating cardiac motion.
Left ventricular function estimation was validated in the cohort of eight healthy
subjects, by comparing volume quantification and functional indices obtained from
systolic and diastolic CMRA images to a conventional stack of 2D CINE images. Re-
sults suggest that quantification of left ventricular function from dual-phase CMRA
data is in agreement with the reference method, with an average underestimation
in stroke volume of 3.07 ± 3.26 mL and a 0.30 ± 1.01% underestimation of ejection
fraction. These results are comparable to the study presented in [230], where left
ventricular volumes obtained from a prospectively ECG-triggered dual-phase whole-
heart cardiac MR with a balanced steady-state free-precession acquisition performed
on a 1.5 T system were compared to conventional retrospectively gated 2D CINE
images, finding an underestimation of 0.95 mL and 0.67% in stroke volume and ejec-
tion fraction, respectively. In this study, systolic and diastolic CMRA datasets were
acquired during mid-systole and mid-diastole to minimise the effect of cardiac mo-
tion in the coronary arteries, however, this might produce an underestimation of the
ventricular volumes compared with conventional CINE imaging. This bias could be
reduced by acquiring data towards the end of systole and diastole.
Reconstructed cardiac PET images showed that motion correction improves im-
age quality compared to uncorrected images. For all subjects, it was observed that
respiratory motion correction increased the sharpness of the myocardium and def-
inition of small features, and incremental improvements were obtained when both
respiratory and cardiac motion correction was performed. This is consistent with
findings in [211], where minor visual improvements were observed after cardiac mo-
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tion correction in patients with suspected liver or lung metastasis that exhibited
myocardial uptake during the PET examination.
Quantitative analysis of 17-segment polar plots obtained from the reconstructed
PET images showed that motion correction increased 18F-FDG signal in the basal
segments of the myocardial wall compared to uncorrected images. Across the whole
cohort, maximum increase in the signal was observed when both cardiac and res-
piratory motion correction was applied, in the anterior and septal basal segments,
corresponding to the regions of larger cardiac motion. As described in previous
Chapters, this increase of signal corresponds to the combined effect of reduced im-
age blurring and improved alignment between attenuation maps and emission data.
In this work, the vendor provided acquisition protocol for MR-based attenua-
tion correction was used. This protocol has a higher voxel size than PET images,
potentially affecting the accuracy of PET attenuation correction due to partial vol-
ume effects. Furthermore, the protocol does not include ECG-triggering, in practice
averaging data over the entire cardiac cycle. Since the diastolic phase comprises
the majority of the cardiac cycle, the produced µ-map is an approximation of the
diastolic µ-map, and in this study it was used as such. In order to acquire a true di-
astolic µ-map, ECG-triggering would be required, resulting in a clinically unfeasible
breath-hold time. In Chapter 7, a novel method that could enable the acquisition of
high-resolution free-breathing ECG-triggered diastolic µ-maps is presented, which
could potentially improve attenuation correction of cardiac PET data.
Conventionally, 3D CMRA imaging at 3 T uses spoiled gradient-echo sequences
in order to minimise artefacts due to field inhomogeneity, relying on relatively long
times between acquisitions (∼800 ms for a heart rate of 60 bpm) to produce suffi-
cient longitudinal magnetisation recovery. For the dual-phase CMRA approach the
time between acquisitions is reduced by 50% approximately compared to conven-
tional mid-diastolic single-phase CMRA, producing a penalty in SNR, especially in
acquisitions without contrast agent injection. Acceleration techniques that reduce
the length of the acquisition window without increasing total acquisition time would
allow for increased longitudinal magnetisation recovery between systolic and dias-
tolic acquisition, thereby improving SNR of the CMRA images. Furthermore, these
acceleration techniques could potentially alleviate the problem of residual cardiac
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motion during systolic CMRA acquisition.
The framework introduced here provides visualisation of the coronary anatomy
in systole and diastole and ventricular function by dual-phase CMRA and motion-
corrected myocardial viability by 18F-FDG PET in a single examination. However,
a comprehensive assessment of cardiac disease may require the acquisition of addi-
tional contrasts, for example LGE imaging for assessment of scar or T2 mapping for
quantification of oedema. In both cases similar motion-corrected approaches could
be used, for example, by extending the approach proposed in [222] to a 3 T PET-MR
system, allowing for simultaneous visualisation of the coronary anatomy and scar
by MR and myocardial viability by 18F-FDG PET. Similarly, simultaneous whole-
heart T2 mapping and myocardial viability by 18F-FDG PET could be achieved by
extending the approach proposed in [231].
Recently published approaches for cardiac and respiratory motion correction of
PET data have proposed the use of 8 to 12 [211, 212] cardiac phases, while the
approach described here considers motion correction only between the two extreme
cardiac phases to ensure good coronary MR depiction in at least one of the cardiac
phases. Preliminary results obtained from the described simulation study suggest
that accurate quantification of size and degree of transmurality of myocardial vi-
ability defects by PET can be obtained when correcting for cardiac motion using
only the systolic and diastolic cardiac phases. However, for radiotracers targeted
at different cardiac applications, such as 18F-NaF for imaging of inflammation and
calcification of coronary plaques, additional cardiac phases might be required for ac-
curate motion correction of PET data and therefore, further investigation is needed.
Finally, the feasibility of the proposed framework was demonstrated in a small
cohort of patients and further studies are now warranted to validate the whole-heart
PET-dual-phase CMRA method in larger cohorts of patients with heart disease.
6.6 Summary
A novel framework for the simultaneous acquisition of coronary MR angiography,
left ventricular function and motion-corrected cardiac PET for hybrid whole-heart
PET-MR imaging has been presented in this Chapter. This approach produces co-
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registered high quality images in both imaging modalities in short and predictable
scan time of ∼12.7 minutes, and thus is suitable for integration into clinical routine.
Left ventricular function quantification has been validated in a cohort of healthy
subjects, finding a good agreement between left ventricular volumes and functional
indices from the dual-phase CMRA and conventional multi-slice 2D CINE images.
Additionally, the feasibility of the proposed method was tested in patients with
known coronary artery disease. Using the proposed respiratory and cardiac motion
correction in both PET and MRI allowed visualisation of the coronary anatomy by
CMRA as well as an improved delineation of the left ventricular myocardium and




As described in previous Chapters, conventional whole-heart CMRA requires the
use of fat suppression techniques to produce a good quality depiction of the vessels,
because the coronary arteries are embedded in a thick layer of epicardial fat for
most of their course. The most common approach for fat suppression in CMRA
and other cardiac MR sequences is based on using a spectral pre-saturation with
inversion recovery (SPIR) preparation pulse, so that signal arising from the fat is
minimal during data acquisition. This is the method that has been used previously
in this thesis.
As described in Chapter 3, SPIR relies on the chemical shift and relaxation times
differences of water and fat to null or minimise the fat signal, but its intrinsic sensi-
tivity to field inhomogeneities impairs its performance at higher magnetic fields. In
fact, when observing the whole acquired field of view in some of the images obtained
with the methods proposed in previous Chapters, a non-homogeneous suppression
of the fat signal can be seen. Particularly, the subcutaneous fat tends to be poorly
suppressed around the edges of the field of view (Figure 7.1a). In some subjects,
this unsuppressed fat signal can introduce ghosting artefacts after translational mo-
tion correction, which can negatively impact the image quality of the coronary MR
angiography (Figure 7.1b).
An alternative approach is to exploit the chemical shift between water and fat
to produce images where the two species are fully separated, by acquiring images
at multiple echo times and then processing them using so-called water/fat or Dixon
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Figure 7.1: Example of (a) incomplete fat suppression in subcutaneous fat (red
arrows) in a non-motion-corrected image and (b) ghosting (blue arrows) due to
translational motion correction of unsuppressed static fat tissue.
separation methods [99]. As briefly discussed in Chapter 3, Dixon-based CMRA
imaging has been shown to improve image quality at 1.5 T [105] and 3 T [106] com-
pared to conventional SPIR fat suppression, increasing the SNR of the blood and
improving the blood-to-fat CNR in the water images. So far, these methods have per-
formed respiratory motion compensation using 1D diaphragmatic navigators only,
resulting in prolonged and unpredictable scan times.
The water/fat separation approach for CMRA also has the benefit of provid-
ing a fat image that carries additional diagnostic value: studies have suggested
that increased epicardial and pericardial fat volumes are associated with increased
cardiovascular risk, including increased vascular calcification, luminal stenosis and
plaque burden, and increased likelihood of adverse cardiovascular events [232–235].
Furthermore, water/fat cardiac MR imaging has shown promising results for the as-
sessment of fibro-fatty infiltration in the myocardium and cardiac masses [236,237].
Finally, as discussed in previous Chapters, motion-compensated attenuation cor-
rection is fundamental for accurate quantification in cardiac PET. In the context
of thoracic PET-MR imaging, the conventional approach for attenuation correction
is to estimate an attenuation map (µ-map) from a segmented water/fat MR image
acquired during a ∼20 s breath hold before the clinical PET-MR protocol. However,
changes in the breathing pattern of the subjects during the rest of the examination
and/or incomplete breath holds can lead to errors in the µ-map, impacting severely
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PET image quality.
More recently, respiratory resolved attenuation maps have been proposed to al-
leviate this problem. In these approaches, a multi-echo MR dataset is acquired
throughout [238] or during the first minutes [239] of the PET acquisition, and µ-maps
estimated at different respiratory positions are used for motion-resolved attenuation
correction. However, such multi-echo sequences do not include preparatory pulses
for appropriate tissue contrast and have insufficient spatial resolution, preventing
the use of these MR images for diagnostic purposes and leading to long examination
times since diagnostic MR images are acquired subsequently.
In this Chapter a novel framework based on a dual-echo water/fat coronary MR
angiography acquisition is introduced, which is then combined with a respiratory
motion-corrected reconstruction scheme that extends the approach introduced in
Chapter 4. This framework allows for the simultaneous visualisation of the coronary
anatomy and cardiac fat, and enables the calculation of respiratory-resolved high-
resolution µ-maps for accurate attenuation correction in cardiac PET imaging. The
proposed scheme can potentially be used for accurate and highly efficient whole-heart
motion-corrected cardiac PET-MR imaging, ensuring alignment between emission
PET data, attenuation maps and diagnostic MR images, exploiting the improved
contrast of Dixon-based MR methods.
A first study to demonstrate the feasibility of the dual-echo water/fat CMRA
acquisition and accuracy of the respiratory motion-corrected reconstruction for wa-
ter/fat CMRA imaging was performed in a cohort of ten healthy subjects. This
study included an investigation about the accuracy of the 2D translational motion
estimated from the different iNAVs that can be obtained from the dual-echo acqui-
sition. After identifying the iNAV that produced the optimum motion estimates,
the non-rigid respiratory motion-corrected approach introduced in Chapter 4 was
extended to dual-echo acquisitions, and the resulting water/fat CMRA images were
compared to a reference scan with diaphragmatic navigator gating and tracking with
matching imaging parameters. As a proof of concept, motion-resolved µ-maps were
obtained for two subjects in order to test the feasibility of motion correction approach
to produce good quality tissue segmentation. Some of the results presented in this
Chapter have been presented as an abstract at an international conference [240].
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7.1 Methods
7.1.1 Image Acquisition
The proposed acquisition sequence consists of an ECG-triggered free-breathing dual-
echo CMRA sequence as shown in Figure 7.2a. Similarly to the acquisition protocol
introduced in Chapter 4, a 2D cine image is acquired before the CMRA acquisition
to determine a subject-specific trigger delay and acquisition window so that the
dual-echo 3D CMRA acquisition window coincides with the mid-diastolic period of
the cardiac cycle.
The dual-echo 3D CMRA data is acquired using a spoiled gradient echo sequence,
with a bipolar readout gradient, following a fully sampled golden-step Cartesian
spiral profile order sampling trajectory [155], so that one spiral interleaf is acquired
at each cardiac cycle for both in-phase and out-of-phase echo times. Using the 2D
iNAV framework already introduced, spatially encoded dual-echo low flip-angle lines
are acquired at each heartbeat before the 3D CMRA acquisition, and an adiabatic
T2 preparation pulse is used to improve contrast between blood and myocardium.
Contrary to the previously introduced scheme, the dual-echo approach does not
require the use of a fat suppression module, as the water/fat separation scheme
provides the blood/fat contrast required for coronary MR angiography.
7.1.2 Image Reconstruction
The image reconstruction scheme extends the non-rigid motion-corrected reconstruc-
tion method proposed in [27, 159] to a dual-echo acquisition as follows: in the first
step, the foot-head (FH) motion estimated from the 2D iNAVs is used to define
a number of respiratory bins, each containing approximately the same amount of
data, and the 3D k-space data are corrected to the centre of the corresponding bin
by applying a linear phase in the FH and right-left (RL) directions (Figure 7.2b).
In the second step, the acquired data are binned and echo images are reconstructed
for each respiratory bin using the soft-gated iterative SENSE approach with ex-
ponential decay weights introduced in Chapter 6, as shown in Figure 7.2c. These
images are used to estimate 3D non-rigid deformation fields via free-form image reg-
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Figure 7.2: Water/fat CMRA acquisition and reconstruction scheme. (a) Dual-echo
CMRA data is acquired following a golden-step spiral ordering in a Cartesian grid. A
low-resolution coronal 2D iNAV is acquired before CMRA acquisition, respiratory
motion estimation; and a T2 preparation (T2-prep) pulse is used to enhance the
contrast between the coronary arteries and myocardium (b) Foot-head motion is
used to define a number of respiratory windows, and correct the data to the centre
of the corresponding bin (red arrows). (c) Dual-echo CMRA data are binned, and
echo images reconstructed at different respiratory positions are used to estimate
non-rigid motion fields. (d) This non-rigid motion is used to reconstruct motion-
corrected echoes, which are finally used as an input in (e) the water/fat separation
algorithm to obtain motion-corrected water and fat CMRA images.
istration [213] using the end-expiratory bin as the reference position. In the third
step, motion-corrected images are reconstructed separately for each echo using the
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where xe are the images for each echo (e = in-phase, out-of-phase), ke is the transla-
tionally corrected k-space for echo e, E is the forward encoding operator, including
the discrete Fourier transform and coil sensitivities, Ub are the motion operators
which transform an image from the reference position to any respiratory position b,
and Sb corresponds to the sampling matrix containing the k-space points acquired
at respiratory bin b.
In the fourth and final step of the reconstruction (Figure 7.2e), water and fat
images are obtained with the B0-NICEbd method proposed in [103] for water/fat
separation of dual-echo acquisitions performed with bipolar gradients. This method
assumes that the total difference in phase between the in-phase and out-of-phase
images, ϕio, arises from three sources: first, the gain in phase between echoes due
to the water/fat chemical shift as described by Equation 3.24; second, a phase due
to field inhomogeneities, ϕB0, and third, a linear phase in the frequency encoding
direction due to the bipolar readout gradient, ϕbi. The method estimates each of
these components separately, and then uses Equation 7.2 to obtain the water and
fat images xw and xf respectively, with ∆ϕ = ϕio − ϕB0 − ϕbi representing the








The B0-NICEbd method estimates ϕio, ϕB0 and ϕbi following a 5-step algorithm,
depicted in Figure 7.3. In the first step, the element-wise Hermitian product between
the echo images is computed as xio = xinx∗out, to obtain the phase ϕio = arg{xio}.
In the second step, ϕbi is obtained following the method proposed in [241], which
uses the image xio(l,m, n) to estimate an average linear phase correction factor
assuming that ϕbi = φl, where l is the readout direction. This method estimates
φ by computing the product between xio and a shifted and complex conjugated
version of xio (Equation 7.3), which minimises the effect of any constant phase
present in xio. This factor φ is then used to produce a bipolar-gradient corrected
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Figure 7.3: Flowchart of the B0-NICEbd [103] water/fat separation method for dual-
echo MR acquisitions with bipolar readout gradients. See text for a full description.




x2io(l,m, n)x∗2io (l + 1,m, n)
 (7.3)
Chapter 7. Respiratory Motion-Corrected Water/Fat CMRA 171
In the third step, an initial estimate for ϕB0 is obtained using the method pro-




. Theoretically, if there are no errors
in ϕB0,ini, it would be possible to obtain water and fat images using Equation 7.2,
and the estimates obtained so far. However, as discussed by the authors in [103],
regional phase errors can occur, for example due to flow and low SNR, and as the
computed phase map is relative (i.e. it was obtained from xio instead of using the
absolute phase of each echo image), the B0 phase map might be shifted by ±π,
resulting in global phase errors. Therefore, the fourth and fifth steps of the method
aim to improve the estimation of ϕB0, in order to produce an accurate water/fat
separation.
In the fourth step, a binary mask of voxels belonging to fat tissue is created by
applying a threshold to |xin|. This step assumes that the acquired MR images have
some T1 weighting, so that the fat appears bright on the in-phase images. In the fifth
step, the global and regional errors in ϕB0,ini are corrected. First, three possible ϕB0
phase maps are created by using the original ϕB0,ini and by shifting ϕB0,ini by +π and
−π. An estimate of ∆ϕ is computed using each of these phase maps, and assuming
that voxels with a total phase close to zero are most likely water, while the ones with
a total phase close to π are most likely fat, a phase-based fat mask is obtained for
each of the ϕB0 estimates. Then, the final ϕB0 estimate is obtained by choosing on
a regional basis which of the three possible maps produces the best match between
the phase-based and the magnitude-based fat masks. Finally, Equation 7.2 is used
to compute the water and fat CMRA images.
7.2 Experiments
Ten healthy subjects (age 30.2± 2.8 years, 4 male) were scanned under free breath-
ing using a prototype implementation of the proposed dual-echo 3D CMRA se-
quence, with the following imaging parameters: coronal orientation, RL phase en-
coding, bipolar readout acquisition, resolution = 1.3 mm isotropic, field of view =
312× 312× 78–104 mm covering the whole heart, flip angle = 20◦, TR/TE1/TE2 =
5.26/2.46/3.69 ms, bandwidth = 1302 Hz/px, and a T2-prep duration of 50 ms. The
2D dual-echo iNAVs were acquired with the following parameters: high-low Carte-
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sian trajectory, coronal orientation, RL phase encoding, 14 low flip-angle lines (flip
angle = 3◦), same TR/TE1/TE2 and field of view as the 3D CMRA acquisition, re-
sulting in an acquired resolution of 1.3×22.8 mm, interpolated to 1.3×1.3 mm during
reconstruction. A subject-specific trigger delay and acquisition window (95–115 ms,
corresponding to 18–22 lines in k-space) was set coinciding with the mid-diastolic
quiescent period of the cardiac cycle, resulting in a total acquisition time of approx-
imately 15 min.
In order to evaluate the performance of the motion correction approach, an addi-
tional Cartesian ECG-triggered dual-echo 3D CMRA scan with a 1D diaphragmatic
navigator was implemented in the scanner software. This acquisition was performed
in all subjects for comparison purposes, with respiratory gating (6 mm gating win-
dow) and tracking (tracking factor of 0.6 [41]) and matching imaging parameters. In
order to reduce scan time, this acquisition was performed using GRAPPA parallel
imaging [148] with 24 calibration lines and an undersampling factor of 2.
All the in vivo experiments were performed on a 3 T hybrid PET-MR scanner
(Biograph mMR, Siemens Healthcare, Erlangen, Germany). Written informed con-
sent was obtained from all subjects according to institutional guidelines and the
institutional ethics committee approved the study.
7.2.1 Preliminary Study: Comparison of Image Navigators
As the 2D iNAVs are acquired with a dual-echo bipolar readout, it is possible to
reconstruct image navigators with different contrasts from the data acquired. The
objective of this preliminary study was to compare the performance of water, fat,
in-phase and out-of phase iNAVs for 2D translational motion estimation. For this
purpose, FH and RL motion were estimated from each iNAV using the same tem-
plate. Then, 3D CMRA in-phase and out-of-phase images were reconstructed with
translational motion correction only, and were then used to obtain translationally-
corrected water and fat CMRA images using the B0-NICEbd method described
above.
Three representative subjects were selected for this preliminary study, covering
a range of motion amplitude and volume of epicardial and pericardial fat. Recon-
structed images were assessed in terms of presence of blurring and artefacts due
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to residual water/fat swaps, and visually compared to the reference 1D gated and
tracked reference water/fat images.
7.2.2 Main Study: Validation of the Respiratory Motion Cor-
rection Approach
After finding the best iNAV for FH and RL estimation, three reconstructions were
performed for each acquired dataset: (a) the proposed non-rigid respiratory motion-
corrected reconstruction approach described in Section 7.1.2 (TC+GMD), (b) 2D
translational motion correction only (TC) and (c) without motion correction (NMC)
for comparison purposes. All of these reconstructions were performed offline in
MATLAB (Mathworks, Natick, Massachusetts, USA). For these datasets, the B0-
NICEbd water/fat separation was performed using available MATLAB code, pro-
vided by the authors of the paper1.
The water/fat CMRA data acquired with 1D diaphragmatic respiratory gating
and tracking (called Gated hereafter) was reconstructed in the scanner software,
including water/fat separation, for comparison purposes.
Water CMRA images were reformatted to simultaneously visualise the right
coronary artery (RCA) and the left anterior descending (LAD) artery, and the same
reformatting was applied to the corresponding fat images. Image quality metrics of
visible vessel length and sharpness were obtained for the water images only, with
sharpness computed for both the first 4 cm and the whole visible length of each
coronary artery. Vessel sharpness values were normalised to the signal intensity of
the centre line of each vessel, so that 100% sharpness refers to a maximum signal
intensity change at the vessel edge. The difference between the image quality metrics
(vessel length and sharpness) for each reconstructed image was evaluated with a
paired t-test with a p value of 0.01 considered statistically significant, including
corrections for multiple comparisons.
1Available at https://uk.mathworks.com/matlabcentral/fileexchange/60660-b0-mapping-for-
bipolar-two-point-dixon-mri
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7.3 Results
Scans were successfully completed in all subjects. The average acquisition time
for the proposed motion-corrected water/fat CMRA sequence was 15.28± 1.13 min,
while the average acquisition time for the 2× accelerated water/fat Gated acqui-
sition was 27.03 ± 6.16 min. The minimum, maximum and average (and standard
deviation) efficiency of the latter was 32%, 63% and 47.3 ± 11.5% respectively, for
a 6 mm gating window.
7.3.1 Preliminary Study: Comparison of Image Navigators
Figure 7.4 shows example water, fat, in-phase and out-of-phase iNAVs for two sub-
jects. It can be observed that subcutaneous fat is accurately separated in the wa-
ter/fat iNAVs for both subjects. However, as the iNAVs are a projection of the
excited volume in the anterior-posterior (AP) direction, and were acquired with a
low spatial resolution in the RL direction, smaller fat structures, such as the epicar-
dial and pericardial fat are not clearly depicted in the fat iNAV.
Figure 7.4: Example iNAVs for two subjects, showing water, fat, in-phase and out-
of-phase navigators. In both cases, water/fat separation results in a clear depiction
of subcutaneous fat in the fat iNAVs. Reduced spatial resolution prevents the visu-
alisation of smaller fatty structures.
The presence and distribution of cardiac fat significantly affects the estimation
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of translational motion, as can be observed in Figure 7.5, that shows the FH and RL
motion estimated from each of the reconstructed iNAVs for the same two subjects.
It can be observed that for both subjects, the estimation of FH motion is consistent
across the different navigators, while differences are apparent in the RL estimation.
In Subject 1, water and in-phase iNAVs result in larger RL estimates compared
to fat and out-of-phase iNAVs. A more extreme case can be observed for Subject
2, where the lack of defined structures in the fat iNAVs resulted in unrealistic RL
motion estimation, impacting the accuracy of FH motion estimation.
Figure 7.6a shows reformatted water images obtained after translational motion
correction, with FH and RL motion estimated from each of the iNAVs for three
subjects, alongside the corresponding Gated images. Corresponding reformatted fat
images are shown in Figure 7.6b for the same subjects. From both the water and
fat reformatted images it can be observed that for Subject 1, water and in-phase
iNAVs result in blurring in the mid and distal segments of the LAD (red arrows),
preventing the visualisation of the vessel, while additional artefacts can be seen in
the RCA when using the water iNAVs (light blue arrow). On the contrary, when
using the fat or the out-of-phase iNAVs, the resulting image quality improves, with
no apparent artefacts and a depiction of the coronary arteries similar to the one
observed in the Gated images. On the contrary, for Subjects 2 and 3, water and in-
phase iNAVs result in similar image quality, with no presence of localised artefacts
and enough sharpness to visualise the vessels in the resulting water images. When
using fat iNAVs, however, the RCA appears blurred (green arrows), due to errors in
motion estimation. Finally, for these two subjects, using out-of-phase iNAVs results
in a slight improvement in vessel sharpness, particularly in the LAD, compared to
water or in-phase iNAVs.
Overall in this cohort of subjects, using out-of-phase iNAVs for translational
motion estimation resulted in consistently good image quality, for subjects with
varying respiratory motion amplitude and amount of visceral and cardiac fat. These
iNAVs were therefore used for estimating motion for the remainder of this Chapter.
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Figure 7.5: Foot-head (FH) and right-left (RL) motion estimation from water, fat,
in-phase and out-of-phase iNAVs for two subjects. In both subjects, FH estimation is
consistent across different iNAVs, while differences are apparent in RL estimation.
In particular for subject 2, fat iNAVs result in unrealistic RL motion estimation
(> 12 mm, green arrows).
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Figure 7.6: Reformatted translationally motion-corrected (a) water and (b) fat im-
ages for 3 subjects, with motion estimated from water, fat, in-phase and out-of-phase
iNAVs, alongside corresponding Gated water and fat images. Water and in-phase
iNAVs resulted in blurring and artefacts for Subject 1 (red and blue arrows), while
fat iNAVs resulted in blurring in Subjects 2 and 3 (green arrows). Out-of-phase
iNAVs resulted in good image quality across subjects, with a delineation of the coro-
nary arteries comparable to the Gated water images and a depiction of the fat tissue
comparable to the Gated fat images.
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7.3.2 Main Study: Validation of the Motion Correction
Figure 7.7 shows reformatted water CMRA images for four representative subjects
for the NMC, TC and TC+GMD reconstructions, alongside Gated images for com-
parison purposes. Corresponding reformatted fat images for the same cases are
shown in Figure 7.8. For all subjects, an improved delineation of the RCA and LAD
can be observed in the water CMRA images after applying TC, in terms of visible
length and delineation of the vessels. Further improvements are observed when the
TC+GMD approach is used, particularly in the depiction of the distal segments of
the arteries, resulting in images that are visually comparable to the Gated images.
Similarly, in the corresponding cardiac fat images, it can be observed that TC and
TC+GMD improve depiction of the epicardial fat compared to NMC images, and
delineation of the vessels is also significantly improved.
The observed improvement in image quality was quantified by measuring visible
vessel length and vessel sharpness of the first 4 cm and the full length of each of
the arteries in the water CMRA images. These results are summarised in Figure
7.9, which shows that measured vessel lengths for TC+GMD images was similar
to the one obtained from Gated images. In particular, visible length of RCA and
LAD in the TC+GMD images was on average 102.0 ± 5.8% and 104.9 ± 12.0% of
the length measured in Gated images, respectively. Lower values were obtained for
TC and NMC, with an average of 92.6± 14.1% and 67.6± 16.6% for the RCA and
77.5 ± 28.2% and 88.5 ± 20.5% for the LAD, respectively. Statistically significant
differences were found in the visible vessel length between NMC and gated images
for both coronaries.
A similar trend was observed when analysing the sharpness of the coronaries.
Statistically significant differences between Gated and NMC were obtained when
analysing either the proximal segment (first 4 cm) or the full length of both the
RCA and LAD. Furthermore, significant differences were also observed in vessel
sharpness between Gated and TC for the RCA only. No statistically significant
differences were observed between the Gated and the TC+GMD approach for any
of the image quality metrics.
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Figure 7.7: Reformatted CMRA water images for four representative subjects (rows)
showing uncorrected (NMC), translational motion-corrected (TC), translational plus
non-rigid motion-corrected (TC+GMD) and Gated images. TC improves depiction
of both the RCA and LAD in all cases. Further improvements are obtained with
the TC+GMD approach, which results in images comparable to the Gated images.
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Figure 7.8: Reformatted cardiac fat images corresponding to the four representative
subjects (rows) in Figure 7.7; showing NMC, TC, TC+GMD and Gated images.
Similarly to the water CMRA images, depiction of the vessels improves in both TC
and TC+GMD images, compared to NMC images.
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Figure 7.9: Image quality metrics for the RCA and LAD arteries for ten healthy
subjects, for NMC, TC, TC+GMD and Gated images. The metrics included: visible
vessel length along the (a) RCA and (d) LAD, where each measure is normalised to
the length observed in the corresponding Gated image; vessel sharpness for the (b,c)
RCA and (e,f) LAD, for both the first 4 cm and full length of each vessel. *denotes
a statistically significant difference with p < 0.01 compared to the Gated images.
Finally, Figure 7.10 shows example Dixon-based µ-maps for two subjects, show-
ing three different respiratory positions in each case. It can be observed that the
water/fat CMRA approach allows the segmentation of the images into the three
tissue classes (soft-tissue, fat, lungs), potentially allowing for accurate motion-
compensated attenuation correction for cardiac PET-MR imaging.
7.4 Discussion
In this Chapter a novel approach for respiratory motion-corrected water/fat CMRA
imaging was introduced. This approach enables the simultaneous visualisation of
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Figure 7.10: Attenuation maps for two subjects (rows), for three different respira-
tory positions and three tissue classes (soft-tissue, fat, lungs). A reference red line
indicates the position of the liver in end-inspiration. Respiratory motion can be
observed in both subjects, particularly in the dome of the liver.
coronary arteries in the water CMRA images and the cardiac fat, while potentially
producing motion-resolved attenuation maps for accurate attenuation correction of
simultaneously acquired PET data. This approach extends the respiratory motion-
corrected acquisition and reconstruction presented in Chapter 4 to a dual-echo se-
quence, allowing the acquisition of two datasets: a first one acquired when water
and fat signals in-phase and a second one when such signals are out-of-phase. The
framework performs translational plus non-rigid motion correction separately for
each of the echoes. Then, the motion-corrected echoes are used to obtain water and
fat cardiac CMRA images by using a water/fat separation algorithm available in the
literature [103] specifically designed for dual-echo acquisitions with bipolar readout
gradients.
A first preliminary study to compare the performance of the different iNAVs that
can be obtained from dual-echo acquisitions (water, fat, in-phase, out-of-phase)
for estimating 2D translational motion was performed in three healthy subjects.
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Results showed that FH motion estimation was similar when using different image
navigators, whereas apparent differences were observed in RL motion estimation.
The iNAVs are designed to provide accurate information in the main direction of
the respiratory-induced motion of the heart. Therefore, they are acquired with high-
resolution in the FH direction, resulting in stable and consistent motion estimation
across navigators. On the other hand, the iNAVs are heavily interpolated in the
RL direction, so that changes in tissue contrast in that direction have a significant
impact in the motion estimation. For subjects with larger amount of adipose tissue
around the heart, such as Subject 1, fat iNAVs were shown to provide accurate RL
motion, outperforming water and in-phase iNAVs, which in turn resulted in blurring
and artefacts due to erroneous motion estimation. However, for subjects with less
visceral and/or cardiac fat, such as Subjects 2 and 3, these fat iNAVs resulted in
erroneous RL motion estimation, impacting the quality of translationally motion-
corrected images. Furthermore, water and in-phase iNAVs were shown to perform
better in the latter cases. Interestingly, out-of-phase iNAVs was observed to perform
consistently well in all studied cases. This is likely due to the high-contrast edge
between myocardium and epicardial fat produced by the chemical shift between
water and fat, which can be accurately tracked by the image registration algorithm.
In the main study, performance of the translational correction only (TC) and the
translational plus non-rigid motion correction (TC+GMD) was compared to uncor-
rected (NMC) images and to a reference diaphragmatic 6 mm gated and tracked
acquisition for the whole cohort of ten subjects. In all cases, improvements are
apparent in the delineation of the coronary arteries when using TC compared to
NMC, and additional improvements are observed when using the TC+GMD ap-
proach. Metrics of image quality showed no statistically significant difference be-
tween TC+GMD and gated water CMRA images for the visible vessel length and
vessel sharpness for both the right and left coronary arteries.
These results are consistent with previous findings in this thesis (Chapter 4), and
other studies using the TC+GMD approach in conventional fat-suppressed CMRA
imaging at 1.5T [159]. This indicates that the 2D iNAV-based TC+GMD approach
is robust and reliable for coronary imaging, and can be used with different image
contrasts and in different sequence configurations.
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This study had some limitations. First, the introduced approach used conven-
tional in-phase and out-of-phase echo times to produce the water/fat CMRA images.
This restriction in the echo times resulted in an increased TR compared to conven-
tional fat-suppressed CMRA approaches. Indeed, while in Chapters 4 to 6, a TR
of ∼3.7 ms was used, allowing for ∼26 lines of k-space to be acquired in the mid-
diastolic quiescent period for an average subject, the dual-echo approach introduced
in this Chapter required a minimum TR of ∼5.3 ms, reducing the number of k-space
lines that can be acquired at each heartbeat to ∼19, producing a significant increase
in total acquisition time. In future studies, this problem can be alleviated by using
flexible echo time approaches [104,243]. These flexible echo-times approaches allow
the echo images not to be acquired at exact in-phase and out-phase times, enabling
the use of reduced TEs and therefore, for reduced TRs.
Although a proof of concept segmentation of the water/fat CMRA images for
generating motion-resolved µ-maps was shown, the anterior-posterior coverage of the
images acquired for this study is insufficient for performing full thoracic attenuation
correction. Indeed, 3D images were acquired with whole-heart coverage, excluding
the chest and back of the subjects. If the introduced approach is to be used as
the only source for creating attenuation maps, a significant increase in the anterior-
posterior coverage is fundamental. Alternatively, the water/fat CMRA-based µ-
maps could be integrated in approaches that aggregate information from multiple
scans, such as [244], so that attenuation of static tissues are obtained from a separate
sequence, while the water/fat CMRA can provide information about the attenuation
of moving organs through the respiratory cycle.
Future work includes accelerating the introduced approach using variable density
trajectories that allow undersampled acquisitions, such as the ones described in
[245, 246], in order to increase spatial resolution and anterior-posterior coverage
without increasing acquisition time. Furthermore, future studies are required for
a clinical validation of the introduced water/fat PET-CMRA approach in patients
with cardiovascular disease, including an assessment of the impact of motion-resolved
attenuation correction in PET image quality.
Chapter 7. Respiratory Motion-Corrected Water/Fat CMRA 185
7.5 Summary
A framework for respiratory motion-corrected water/fat coronary MR angiography
has been introduced. The framework allows the simultaneous visualisation of the
coronary anatomy, cardiac fat and generation of motion-resolved attenuation maps
throughout the respiratory cycle. This approach provides 100% scan efficiency, as
all the acquired data is used for image reconstruction, and has a predictable scan
time that only depends on the heart rate of the subject being scanned. The motion-
corrected reconstruction framework was tested in a cohort of ten healthy subjects
and compared to a reference 1D diaphragmatic gated and tracked acquisition. No
statistically significant differences were found between them when quantifying image
quality in the water CMRA images, in terms of visible length and sharpness of the
vessels. However, the motion-corrected approach was faster and enables the creation
of motion-resolved attenuation maps for accurate attenuation correction in cardiac
PET-MR imaging. Future work includes accelerating the acquisition for improved
spatial resolution and coverage, and validating the whole water/fat PET-CMRA
framework in patients with cardiovascular disease.
Chapter 8:
Discussion and Final Remarks
This thesis introduced a novel approach for motion-corrected simultaneous cardiac
PET-MR imaging. Instead of using MR images for motion estimation purposes
only, as most of the current approaches for MR-based motion correction in cardiac
PET-MR do, a novel MR acquisition scheme was designed in this work, in order
to simultaneously provide diagnostic-quality images and motion information. This
was achieved by integrating a 2D image navigator (iNAV [78]) to a CMRA acquisi-
tion sequence, so that the position of the heart could be tracked at each heartbeat.
Furthermore, by using a golden-step Cartesian spiral profile order sampling trajec-
tory for the 3D CMRA acquisition [155], the acquired data could be retrospectively
sorted into a number of respiratory windows. Due to the properties of this tra-
jectory, 3D images could be reconstructed at different respiratory positions from
undersampled data, enabling the measurement of the complex non-rigid motion of
the heart throughout the respiratory cycle. A general PET-CMRA motion-corrected
reconstruction framework was then developed, so that the motion information esti-
mated from MR was used to correct both the PET and CMRA datasets to the same
position, resulting in intrinsically aligned, good quality images in both modalities
from a single efficient examination with short and predictable scan time.
In Chapter 4, a framework for respiratory motion-corrected PET-CMRA was
introduced. Although the non-rigid motion correction scheme for CMRA had been
previously validated against a diaphragmatic gated and tracked CMRA acquisition
for visualisation of the coronary anatomy at 1.5 T, using a balanced SSFP readout
and a golden radial phase-encoding trajectory [159], such acquisition approach is
not directly applicable to a 3 T PET-MR system. Magnetic field inhomogeneities
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prevent the use of balanced SSFP readouts, so a spoiled gradient echo acquisition
was used in this thesis instead. Furthermore, the acquisition trajectory was modi-
fied to a Cartesian spiral-like trajectory, simplifying the MR reconstruction problem
and reducing image reconstruction time. In order to enhance contrast between the
coronary arteries and surrounding myocardium without using exogenous contrast
agents, an adiabatic T2 preparation module was implemented in the scanner soft-
ware. Finally, a framework for motion compensation of the simultaneously acquired
PET data was developed, based on a reconstruct-transform-average approach [164],
where motion information was used both to create attenuation maps at each respi-
ratory position, and to transform PET images reconstructed at different respiratory
positions to the end-expiration position.
In order to study the performance of the proposed respiratory motion correction
framework for PET-CMRA, three studies were performed. First, an MR-only vali-
dation study was performed in a cohort of healthy subjects; comparing the motion-
corrected CMRA images to reference diaphragmatic gated and tracked images. Re-
sults showed no statistically significant difference in metrics of image quality between
both approaches, but the motion-corrected CMRA resulted in significantly reduced
scan time (30% faster than a 2× accelerated gated acquisition on average) and
importantly provides motion information for MR-based motion correction of PET
images. A second study was performed in a small cohort of oncology patients that
had received an injection of 18F-FDG for a conventional PET-CT examination. This
study served as proof-of-concept for the whole motion-corrected PET-CMRA frame-
work. In these patients, significant improvements in the depiction of the coronary
arteries was observed in the CMRA images after motion correction, while motion-
corrected PET images showed improvements in the delineation of small structures
such as the papillary muscles, and increased the sharpness of the left ventricular
myocardial wall compared to uncorrected images.
In Chapter 5 a third study was presented, describing the performance of the
approach introduced in Chapter 4 in a cohort of patients with known cardiovas-
cular disease. In particular, patients with chronic total occlusion of at least one
of the coronary arteries were scanned with the proposed PET-CMRA sequence,
allowing simultaneous visualisation of the coronary anatomy by CMRA and my-
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ocardial viability by 18F-FDG PET. Results obtained in this cohort were consistent
with previous findings, with an improved delineation of relevant cardiac structures
in both PET and MR after motion correction, suggesting that the framework is
robust in cases of more irregular breathing patterns. Furthermore, when visually
comparing the coronary anatomy as depicted by motion-corrected CMRA and the
invasive gold-standard (X-ray angiography), a good agreement between modalities
was found. Similarly, a visual comparison between motion-corrected 18F-FDG PET
images and LGE-MRI showed a good correspondence between modalities in the
depiction of both transmural and non-transmural myocardial viability defects. Ad-
ditional tests in patients with different cardiovascular conditions and using novel
PET radiotracers were also presented in this Chapter, demonstrating the versatility
and robustness of the motion correction approach and its potential for enabling the
simultaneous acquisition of diagnostic images with both modalities.
In order to address the effect of cardiac motion in PET image quality, Chapter
6 extended the framework introduced in Chapter 4 to a dual-phase CMRA-PET
acquisition. By acquiring CMRA data in systole and diastole, cardiac motion could
also be estimated and used to correct the simultaneously acquired PET data. Fur-
thermore, these two 3D CMRA images can be used to estimate left ventricular
function, including relevant functional indices such as ejection fraction and stroke
volume. Therefore, this approach potentially allows for a comprehensive assess-
ment of coronary artery disease from a single examination, including visualisation
of the coronary anatomy and estimation of ventricular function from the systolic and
diastolic CMRA images, and assessment of myocardial integrity by cardiac and res-
piratory motion-corrected PET imaging. A first MR-only study in healthy subjects
was performed to study the accuracy of the dual-phase CMRA for estimating left
ventricular function, and good agreement with conventional 2D cine MR imaging
was found. A preliminary study using the whole dual-phase CMRA-PET approach
in patients with cardiovascular disease was also performed. Results suggest that the
respiratory motion correction has a stronger impact than cardiac motion correction
in terms of increased SUV in PET images and improvements in image quality, but
nonetheless, incremental improvements were observed. Although this is consistent
with findings in the motion-corrected cardiac PET-MR literature [211] which has
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focused on 18F-FDG or 13N-ammonia for myocardial PET imaging, this may not
be the case for PET radiotracers that target smaller structures, such as 18F-NaF
for plaque imaging. Further studies are required to ascertain the impact of cardiac
motion correction in these cases.
Finally, Chapter 7 explored an alternative method for enhancing the contrast
between coronary arteries and epicardial fat. Instead of using a conventional fat
suppression preparation pulse to minimise the fat signal, a dual-echo acquisition
approach was introduced, so that separate water and fat CMRA images could be
produced. In this Chapter, the performance of iNAVs with different contrast for
estimation of respiratory motion was studied. Results from three healthy subjects
suggest that out-of-phase iNAVs produce accurate estimates of foot-head and right-
left motion of the heart, for subjects with varying amount of visceral and cardiac
fat. The non-rigid respiratory motion-corrected reconstruction scheme introduced in
Chapter 4 was extended to dual-echo imaging, and tested in a cohort of healthy sub-
jects. A validation study comparing motion-corrected and gated water/fat CMRA
images was performed, and similarly to Chapter 4, findings suggest that image qual-
ity obtained with the motion-correction approach is not significantly different to the
gated images, but scan time is significantly reduced (45% faster than a 2× accel-
erated gated acquisition) and motion information is available for motion correction
of simultaneously acquired cardiac PET data. Furthermore, as water/fat images
can be reconstructed at different respiratory positions throughout the breathing cy-
cle, the proposed water/fat CMRA approach allows the computation of respiratory
motion-resolved attenuation maps, which can be used for attenuation correction of
the PET data. Due to its intrinsic robustness to field inhomogeneities, the water/fat
scheme could potentially improve the robustness of the iNAV-based CMRA in larger
patients, where conventional fat suppression is challenging. Moreover, it can provide
additional diagnostic information from the fat image, and potentially improve the
accuracy of the attenuation correction of PET images.
Although the respiratory motion-corrected CMRA images were compared to a
reference diaphragmatic gated and tracked acquisition for healthy subjects in Chap-
ters 4 and 7, such validation was not performed in patients with cardiovascular
disease, where respiratory motion can be more variable. Furthermore, comparison
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between motion-corrected CMRA and invasive X-ray angiography in terms of de-
piction of the coronary anatomy was performed only visually in Chapter 5. Further
validation of the introduced approach for respiratory motion-corrected CMRA in
larger cohorts of patients with known or suspected coronary artery disease is re-
quired, including a comparison between clinical findings from the motion-corrected
CMRA approach and a gold standard method, such as invasive X-ray angiography
or coronary CT angiography.
For all the proposed methods, 2D translational correction for the CMRA ac-
quisition was implemented in the scanner software, so that a first correction could
be immediately visualised after scanning. However, PET-MR data synchronisa-
tion, and both the non-rigid motion-corrected CMRA and the motion-compensated
PET reconstruction were performed offline. Indeed, PET-MR synchronisation was
performed offline using the ECG R-wave detection tags in the raw data of each
modality, ensuring less than 2.5 ms uncertainty in synchronisation between PET
and MR, which was sufficient for motion-compensated static PET imaging. Fu-
ture work includes implementing the whole motion compensation framework on the
scanner software, including improved PET-MR synchronisation, as well as non-rigid
motion estimation from MR and motion-corrected reconstruction for both PET and
CMRA. This would enable a smoother integration of the proposed methods into
clinical routine.
Throughout this thesis, attenuation correction of PET data was performed using
attenuation maps produced by a 4-tissue class segmentation of MR images. While
investigating novel MR-based attenuation correction approaches was out of the scope
of this thesis, and thus the conventional method provided by the vendor was used,
such an approach has several limitations. First, MR data is acquired during a ∼19 s
breath-hold, which can be challenging for some patients. Although not observed
in this thesis, incomplete breath-holds can result in segmentation errors and tissue
misclassification, producing erroneous attenuation maps. Second, the 4-tissue class
model only considers homogeneous attenuation values for air, lung tissue, soft-tissue
and adipose tissue. Therefore, inaccuracies arise from the presence of other tissues
and materials, such as bone tissue, coronary stents, or mixtures of any of these
tissues. Furthermore, the MR-based attenuation maps assign a unique attenuation
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value to the lung tissue. However, studies have shown wide intra an inter-patient
variability in lung tissue density, including variations throughout the respiratory
cycle. While these inaccuracies in MR-based attenuation correction might impact
absolute PET quantification, this is rarely the task of clinical cardiac PET imaging.
Moreover, if more accurate MR-based attenuation maps become clinically available,
they can be readily incorporated into the motion-compensated PET framework pro-
posed in this thesis.
A conventional spatially-invariant resolution model was considered in this work,
neglecting the spatially-variant effect of the scanner geometry. This approach also ig-
nores the effects of non-isotropic and tissue-dependent positron range on PET image
resolution. Although in whole-body PET-MR scanners for 18F-based radiotracers
these effects are typically smaller than the component arising from detector width,
they might become significant for other radionuclides. In the future, spatially-variant
resolution modelling, including the effects of tissue-dependency and anisotropy of
positron range, could be incorporated into the PET reconstruction method. This
might be particularly important for absolute PET quantification in regions where
there is a sharp transition in tissue density, such as the lung/soft-tissue interface.
In this thesis, a reconstruct-transform-average (RTA) approach was used for mo-
tion compensation of PET data. Studies have shown that this approach might result
in image degradation due to interpolation, and that including motion directly in the
image reconstruction algorithm can address this issue, however at the expense of
longer reconstruction times. Moreover, including the motion directly in the recon-
struction might reduce the bias associated to low counts in each bin when using the
RTA approach. In this thesis, such bias was not observed, probably due to the high
count levels associated to 18F-FGD. However, a larger impact could potentially be
observed when using radiotracers that target smaller structures, such as 18F-NaF, in
low-dose imaging, or in dynamic PET imaging. Implementing an iterative motion-
corrected PET image reconstruction framework and comparing it to the approach
used in this thesis remains for future work. Furthermore, the proposed scheme only
enables motion correction of the PET data acquired simultaneously with the CMRA
data, preventing motion correction of PET data acquired before or after this window.
In future, a motion model could be generated during the simultaneous PET-CMRA
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acquisition, and used to correct for motion in subsequent PET acquisitions using
appropriate surrogate signals.
The reconstruction framework proposed in this thesis used MR-based motion
information to correct both the PET and CMRA datasets. However, 18F-FDG
myocardial PET images can also provide information about the physiological motion
of the heart. Joint motion estimation techniques such as the one proposed in [209]
could improve the robustness of the proposed method. Furthermore, in this thesis,
PET and MR images were reconstructed separately. Recent advances in the joint
PET-MR image reconstruction literature have shown potential for improvements
in image quality in both PET and MR for brain imaging [247–249]. The impact
and applicability of such techniques to cardiac PET-MR imaging remains an open
question.
Although the image resolution used for CMRA in this thesis was enough to depict
the proximal coronary anatomy (i.e. 1×1×2 mm3 in Chapters 4, 5 and 6 and 1.3 mm
isotropic in Chapter 7), an accurate depiction of distal segments and stenosis might
require higher spatial resolution. In order to increase image resolution without
increasing total acquisition time, novel acquisition trajectories and more advanced
undersampled reconstruction techniques can be incorporated to the proposed PET-
CMRA framework. Indeed, a variable-density version of the golden-step Cartesian
spiral profile order sampling trajectory has recently been introduced for CMRA with
sub-millimetre resolution in a 1.5 T MR system [246], which could be adapted for
PET-CMRA at 3 T.
Furthermore, novel undersampled reconstruction techniques for CMRA imaging
such as [250] could enable the extension of the proposed MR acquisition framework to
multiple contrasts without increasing total scan time. For instance, the recently in-
troduced multi-contrast BOOST sequence [176,222], that allows simultaneous bright
and black-blood imaging at 1.5 T could be extended to a 3 T PET-MR system for
use with a range of PET radiotracers. For example, a motion-corrected 18F-NaF
PET-BOOST CMRA scan could provide simultaneous co-registered images for the
visualisation of coronary anatomy and intra-plaque haemorrhage by MR and plaque
calcification by PET. Alternatively, used after injection of a Gadolinium-based con-
trast agent, a 18F-FDG PET-BOOST CMRA scan could provide visualisation of the
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coronary lumen from CMRA and fibrosis visualisation from black-blood LGE-MRI,
in addition to quantification of myocardial inflammation from 18F-FDG PET, which
could be beneficial in the differential diagnosis of cardiac sarcoidosis.
The research developed throughout this dissertation focused on the use of si-
multaneous PET-MR imaging for a comprehensive assessment of coronary artery
disease, including visualisation of the coronary anatomy by CMRA and myocardial
integrity by 18F-FDG PET. However, the flexibility and robustness of the motion-
corrected simultaneous PET-CMRA framework introduced in this thesis could en-
able a whole range of exciting new research opportunities for whole-heart PET-MR
imaging for a range of cardiac conditions. For instance, as mentioned above, the pro-
posed PET-CMRA approach could have a significant role in atherosclerotic plaque
imaging, by providing detection of plaque micro-calcification by 18F-NaF and pre-
cise localisation within the coronary tree from the simultaneously acquired CMRA.
Moreover, in inflammatory diseases such as cardiac sarcoidosis or myocarditis, the
proposed motion-corrected approach could improve the confidence in interpreting
the findings observed in both modalities (i.e. myocardial inflammation by 18F-FDG
and fibrosis or oedema from MR), by ensuring accurate alignment between both
PET and MR images. Furthermore, in such diseases, PET-CMRA imaging could
potentially be used to guide the biopsy of areas with active inflammation detected
by PET through anatomical localisation provided by the whole-heart CMRA im-
age [251]. The ability of the proposed framework for producing co-registered diag-
nostic PET and MR images that provide complementary information about different
disease processes would be beneficial for encouraging the adoption of PET-MR for
cardiac imaging in routine clinical practice.
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